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BRIEF REPORT
17th SNIP Scientific Conference
Clearwater Beach, FL
April 5–10, 2011
Society on NeuroImmune Pharmacology Administrative Meetings
Tuesday, April 5, 2011
1:00 PM Opening of Conference Office
3:00–4:30 PM SNIP Executive Committee Meeting
4:30–6:30 PM SNIP Meetings Committee
7:00–9:30 PM SNIP Council Dinner
Wednesday, April 6, 2011
8:30–9:00 AM Awards Committee
9:00–10:00 AM Finance Committee
10:00–11:00 AM Communications Committee
11:00 AM–Noon Membership Committee
Noon–1:15 PM Lunch—on your own
1:15–3:00 PM Council Meeting and Committee Reports
2:00 PM Conference Office opens
Scientific Sessions
Wednesday, April 6, 2011
3:00–6:00 PM Registration Opens
4:45–7:15 PM Opening Reception
4:45–7:15 PM POSTER SESSION I—Young Investigators Session
Please have ALL posters mounted on poster boards BY 4:45 PM.
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59
DOI 10.1007/s11481-011-9264-9Odd numbered posters (W1, W3, etc.) to be presented from 4:45–6:00 PM
Even numbered posters (W2, W4, etc.) to be presented from 6:00–7:15 PM
Please remove all posters after the session
Poster Titles listed by assigned Poster Board Numbers (To be announced)
7:30–9:00 PM Meet the Mentors Dinner
Hosted by Sylvia Kiertscher, Ph.D. (David Geffen School of Medicine/UCLA)
Brian Wigdahl, Ph.D. (Drexel University College of Medicine)
and the Young Investigator's Award Committee
Featured speaker: Larry Robinson, Ph.D., Provost, Seton Hall University
Lecture: “The Value of Mentoring”
For Young Investigators who are presenting their work at the Conference and who have Confirmed
their Dinner Reservation with the YITA Awards Committee
Thursday, April 7, 2011
7:00–8:00 AM Continental Breakfast
Reminder—Put up Posters for Poster Session II
8:00–8:15 AM INTRODUCTION TO THE MEETING
Welcome from the Society on NeuroImmune Pharmacology
8:00–8:10 Toby K. Eisenstein, Ph.D.—SNIP President
(Temple University School of Medicine, Philadelphia, PA)
–Acknowledgement of NIH Staff and Officials
–Acknowledgement of Key Sponsors, Committees and Chairs
8:10–8:15 Sulie L. Chang, Ph.D.—Chair, SNIP Meetings Committee
(Seton Hall University, South Orange, NJ)
–Conference Overview & Business
8:15–9:05 AM PLENARY LECTURE I: Horace H. Loh, Ph.D.—University of Minnesota
8:15–8:20 Introduction by Toby K. Eisenstein, Ph.D.—SNIP President
8:20–9:05 Lecture: “Receptor Engineering in the Treatment of Pain—Our Search for the Ideal Analgesic”
9:10–11:20 AM SYMPOSIUM I: Neuroimmune Interactions—The New Frontier for Drugs of Abuse and their
Endogenous Ligands
Session Co-Chairs: Martin W. Adler, Ph.D.—Temple University School of Medicine, Philadelphia, PA
Toby K. Eisenstein, Ph.D.—TempleUniversitySchoolofMedicine,Philadelphia,PA
9:10–9:30 Lecture 1: Toby K. Eisenstein, Ph.D.—Temple University School of Medicine, Philadelphia, PA
“Neuroimmune Interactions and Drugs of Abuse Come of Age”
9:35–9:55 AM Coffee Break
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S59:55–10:25 Symposium Lecture: Kevin J. Tracey, Ph.D.—Director, Feinstein Institute for Medical Research,
Manhasset, NY
“The Cholinergic Anti-Inflammatory Pathway and Innate Immunity”
10:30–10:50 Lecture 2: Lynn Kirby, Ph.D.—Temple University School of Medicine
“Chemokines as Neuromodulators”
10:55–11:15 Lecture 3: Virginia M. Sanders, Ph.D.—Ohio State University College of Medicine
“Sympathetic Nervous System and Norepinephrine: Adrenergic Receptor- Mediated Effects on Immune
Function”
11:20–12:20 PM Lunch on your own
12:20–1:20 PM SNIP Annual Business Meeting
All Society Members are requested to attend and all attendees welcome
1:20–3:20 PM POSTER SESSION II—General Poster Session
Please have ALL posters mounted on poster boards BY 1:20 PM.
Odd numbered posters (T1, T3, etc.) to be presented from 1:20–2:20 PM
Even numbered posters (T2, T4, etc.) to be presented from 2:20–3:20 PM
Note: Coffee Break at 2:45–3:15 PM during the Poster Session
Poster Titles listed by assigned Poster Board Numbers (To be announced)
Please remember to take down all posters immediately after the session
3:20–5:35 PM SYMPOSIUM II: Modulation of the Peripheral Immune System by Drugs of Abuse and HIV
Session Co-Chairs: Guy A. Cabral, Ph.D.—Virginia Commonwealth University, School of
Medicine, Richmond, VA
Sabita Roy, Ph.D.—University of Minnesota Academic Health Center,
Minneapolis, MN
3:20–3:50 Symposium Lecture: Satya Dandekar, Ph.D.—University of California at Davis, Davis, CA
“Gut, Germs and HIV Pathogenesis of Immune and Neurological Disease”
3:55–4:15 Lecture 1: Lena Al-Harthi, Ph.D.—Rush University Medical Center, Chicago, IL
“The Role of T cell Activation and T cell Subset in Anti-HIV Immunity”
4:20–4:40 Lecture 2: Tom Molitor, Ph.D.—University of Minnesota College of Veterinary Medicine,
Minneapolis, MN
“Drug Abuse Modulates Maternal Immunity and its Influence on Neonatal Immune Development”
4:45–5:00 Lecture 3: Honghong Yao, Ph.D.—University of Nebraska Medical Center, Omaha, NE
“Cocaine-Mediated Induction of Platelet-Derived Growth Factor: Implication for Increased Vascular
Permeability”
5:05–5:20 Lecture 4: Li Liu, Ph.D.—The University of Hong Kong, Hong Kong SAR, China
“The Effect of Tetrahydrocannabinol (THC) on SIVmac251 Infection in Chinese Macaques”
5:25–5:45 PM Refreshments and Late Afternoon Appetizers
S6 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S595:45–7:00 PM Special Session
Teaching and Learning in Neuroimmune Pharmacology
Session Co-Chairs: Thomas J Rogers, Ph.D.—Temple University Schoolof Medicine, Philadelphia, PA
Tom Molitor, Ph.D.—University of Minnesota College of Veterinary Medicine,
Minneapolis, MN
Presentation on "Video Research Coming of Age" and a Round-Table Discussion of important issues related to
teaching in the field of Neuroimmune Pharmacology with:
Shilpa Buch, Ph.D., Guy Cabral, Ph.D., Sulie L. Chang, Ph.D., Yun-Hsiang Chen, Ph.D., Yuh-Fung Chen,
Ph.D., Howard E. Gendelman, M.D., Tom Molitor, Ph.D., Thomas Rogers, Ph.D. and Valerie Wojna, M.D.
Friday, April 8, 2011
7:00–8:00 AM Continental Breakfast
8:00–11:00 AM SYMPOSIUM III: Management of Neuropsychiatric Complications of Infectious Diseases and
Substances of Abuse
Session Co-Chairs: Jag Khalsa, Ph.D.—Chief, Medical Consequences Branch, Division of
Pharmacotherapies and Medical Consequences of Drug
Abuse, NIDA
Michael Roth, M.D.—David Geffen School of Medicine, UCLA, Los Angeles, CA
8:00–8:20 Lecture 1: Dave Thomas, Ph.D.—Johns Hopkins University of School of Medicine, Baltimore, MD
“Natural History and Pathogenesis of HIV and Hepatitis C”
8:25–8:45 Lecture 2: Glen Treisman, M.D.—Johns Hopkins University of School of Medicine, Baltimore, MD
“Management of Neuropsychiatric Complications of Infection (HIV, HCV)
8:50–9:10 Lecture 3: Susanna Naggie, M.D.—Duke University School of Medicine, Durham, NC
“Investigational Agents for Chronic Viral Infections: HIV and HCV”
9:15–9:30 AM Coffee Break
9:35–11:00 AM SYMPOSIUM IV: Therapeutic Strategies Targeting Neuroimmune Modulation
Session Co-Chairs: Abraham P. Bautista, Ph.D.—Director, Office of Extramural Activities/(NIAAA/NIH)
Jeymohan Joseph, Ph.D.—Chief, HIVPathogenesis,NeuropsychiatryandTreatment
Branch/Division of AIDS Research (NIMH/NIH)
9:35–9:55 Lecture 1: Ru-Band Lu, M.D. National Cheng Kong University, Taiwan
“Genetic Validation in the Subtypes of Alcoholism.”
10:00–10:20 Lecture 2: Paul D. Drew, Ph.D.—University of Arkansas for Medical Sciences
“Role of Neuroimmune Signaling Molecules in the Neuropathology of Fetal Alcohol Spectrum
Disorders”
10:25–10:45 Lecture 3: Adron Harris, Ph.D.—University of Texas at Austin, Austin, TX
“Therapeutic Strategies Targeting Neuroimmune Modulation”
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S710:50–11:10 Lecture 4: Jialin C. Zheng, M.D.—University of Nebraska Medical Center, Omaha, NE
“Neurogenesis, Brain Inflammation and its Links to the Pathogenesis and Potential Therapy of
Neurodegenerative Disorders”
11:15–11:30 PM PICK-UP LUNCHES FOR NIH WORKSHOP
11:30–1:00 PM NIH WORKSHOP:
Session Co-Chairs: David Shurtleff, Ph.D.—Acting Deputy Director (NIDA/NIH)
Jeymohan Joseph, Ph.D.—Chief, HIV Pathogenesis, Neuropsychiatry and Treat-
ment Branch/Division of AIDS Research (NIMH/NIH)
Abraham P. Bautista, Ph.D.—Director, Office of Extramural Activities/
(NIAAA/NIH)
Participants
David Shurtleff, Ph.D.—Acting Deputy Director (NIDA/NIH)
Jag Khalsa, Ph.D.—Chief, Medical Consequences Branch, Division of Pharmacotherapies and
Medical Consequences of Drug Abuse (NIDA/NIH)
Diane M. Lawrence, Ph.D.—Associate Director AIDS Research Program (NIDA/NIH)
Albert Avila, Ph.D.—Program Director, Division of Basic Neuroscience and Behavioral Research
(NIDA/NIH)
Woody Lin, M.D., Ph.D.—Health Scientist Administrator, Division of Clinical Neuroscience and
Behavioral Research (NIDA/NIH)
Jeymohan Joseph, Ph.D.—Chief, HIV Pathogenesis, Neuropsychiatry and Treatment Branch/Division
of AIDS Research (NIMH/NIH)
Abraham P. Bautista, Ph.D.—Director, Office of Extramural Activities (NIAAA/NIH)
Kindall Bryant, Ph.D.—Director, Alcohol and HIV/AIDS Research, OD (NIAAA/NIH)
Ranga Srinivas, Ph.D.—Chief, Extramural Project Review Branch, OEA (NIAAA/NIH)
Changhai Cui, Ph.D.—Program Director, Division of Neuroscience and Behavior (NIAAA/NIH)
Eduardo A. Montalvo, Ph.D.—Scientific Review Officer, Center for Scientific Review (NIH)
1:00–2:30 PM YOUNG INVESTIGATOR’S SYMPOSIUM
Session Co-Chairs: Albert Avila, Ph.D.—Program Director, Division of Basic Neuroscience and
Behavioral Research (NIDA/NIH)
Sylvia M. Kiertscher, Ph.D.—David Geffen School of Medicine at UCLA
Pre-Doctoral Presentations:
1:00–1:10 Crystal Bethel-Brown—Department of Pharmacology and Experimental Neuroscience, University
of Nebraska Medical Center, Omaha, NE
“HIV-1 Tat Mediated Induction of Platelet-Derived Growth Factor in Astraocytes: Role of Early
Growth Response Gene 1”
1:15–1:25 Sharrón L. Manuel—Drexel Institute for Biotechnology & Virology Research, Drexel University
College of Medicine, Philadelphia, PA
“Dynamics of Dendritic Cells and T Cells in HTLV-1-Associated Neuroinflammatory Disease:
Implications in Immunomodulatory Therapies and Diagnostic Tools”
1:30–1:40 Ankit Shah—Division of Pharmacology and Toxicology, University of Missouri-Kansas City,
Kansas City, MO
“HIV-1 Glycoprotein 120 Induces the Pro-Inflammatory Cytokine IL-6 via the NF-Kappa-B Pathway
and Methamphetamine Can Synergistically Potentiate gp120-Mediated IL-6 Induction”
S8 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59Post-Doctoral Presentations:
1:45–1:55 Ming D. Duan, Ph.D.—Department of Pharmacology and Experimental Neuroscience, University of
Nebraska Medical Center, Omaha, NE
“Cocaine Increases Platelet-Derived Growth Factor Expression in Human Brain Microvessel
Endothelial Cells Through Notch-1 Signaling”
2:00–2:10 Lei Chen, Ph.D.—Department of Neurosurgery, University of Kentucky, Lexington, KY
“Autophagy is Involved in the Neurovascular Toxicity of Nanoalumina”
2:15–2:25 Shinsuke Nakagawa, Ph.D.—Department of Neurosurgery, University of Kentucky, Lexington, KY
“Human Immunodeficiency Virus Type 1 (HIV-1) Infects Human Brain Pericytes In Vitro”
2:30 PM FREE TIME—Enjoy the Beach!
YES!—THE AFTERNOON AND EVENING ARE FREE
7:30–9:30 PM Journal of Neuroimmune Pharmacology Editorial Board Meeting
Saturday, April 9, 2011
7:00–8:15 AM Continental Breakfast
8:15–9:00 AM PLENARY LECTURE II: Steve Nelson, M.D.—Dean, LSU School of Medicine, New Orleans, LA
8:15–8:20 Introduction by Sulie L. Chang, Ph.D.—Chair, SNIP Meetings Committee
8:20–9:00 Lecture: “Alcohol, Immunosuppression and HIV”
9:05–11:10 AM SYMPOSIUM V: Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction
Session Co-Chairs: Norman Haughey, Ph.D.—Johns Hopkins University School of Medicine,
Baltimore, MD
Michal Toborek, M.D., Ph.D.—University of Kentucky School of Medicine,
Lexington, KY
9:05–9:35 Symposium Lecture: Tsung-Ping Su, Ph.D.—Chief, Cellular Pathobiology Section, Cellular
Neurobiology Research Branch, NIDA/NIH
“Molecular Chaperone and Interorganelle Signaling in Diseases”
9:40–10:00 Lecture 1: John Q. Wang, Ph.D.—University of Missouri-Kansas City School of Medicine, Kansas
City, MO
“Molecular Neurobiology of Drug Addiction: Role of NMDA Receptors”
10:05–10:20 AM Coffee Break
10:20–10:40 Lecture 2: Gayle C. Baldwin, Ph.D.—David Geffen School of Medicine at UCLA, Los Angeles, CA
“Defining Mechanisms of Cocaine and HIV Co-Morbidity In Vivo: The Potential and Pitfalls of
Mouse/Human Chimera Models”
10:45–11:05 Lecture 3: Avi Nath, M.D.—Johns Hopkins University School of Medicine, Baltimore, MD
“Fulminant Encephalopathy in HIV-infected Cocaine Abusers”
11:10–12:00 Noon “Bill” Narayan Lecture: Shilpa Buch, Ph.D.—University of Nebraska Medical Center, Omaha, NE
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S911:10–11:20 Introduction by David Volsky, Ph.D.—Columbia University, New York, NY
11:20–12:00 Lecture: “HIV Infection and Cocaine Abuse Go Hand in HAND”
Noon–1:00 PM Lunch on your own
1:00–2:50 PM SYMPOSIUM VI: HIV-Associated Neurocognitive Disorders (HAND) and Drug Abuse
Session Co-Chairs: Linda Chang, M.D.—University of Hawaii, Honolulu, HI
Mahendra Kumar, Ph.D.—Miller School of Medicine, University of Miami,
Miami, FL
1:00–1:30 Symposium Lecture: Bob Heaton, Ph.D.—University of California San Diego, San Diego, CA
“Prevalence and HIV Disease Correlates of HAND in the Pre-CART and CART Eras”
1:35–1:55 Lecture 1: Eileen Martin, Ph.D.—University of Illinois, Chicago, IL
“NeuroAIDS and Substance Use Disorders”
2:00–2:20 Lecture 2: Marilou Andres, Ph.D. University of Hawaii at Manoa
“Effects of APOE-epsilon4 Allele on Brain Function and Structures in HIV Patients”
2:25–2:45 Lecture 3: Valerie Wojna, M.D.—University of Puerto Rico, Medical Sciences
“Challenges in the Diagnosis of HAND in a Hispanic Cohort of HIV-seropositive Women”
2:50–3:05 PM Coffee Break
3:05–5:20 PM SYMPOSIUM VII: The Consequences of Substance Abuse and HIV on Stem Cell Biology
Session Co-Chairs: Changhai Cui, Ph.D.—Program Director, Division of Neuroscience and Behavior
(NIAAA/NIH)
Kurt Hauser, Ph.D.—Virginia Commonwealth University, School of Medicine,
Richmond, VA
3:05–3:35 Symposium Lecture: Pamela Knapp, Ph.D.—Virginia Commonwealth University, School of
Medicine, Richmond, VA.
“Stage Specific Effects of Opiates and HIV on the Differentiation and Function of CNS Progenitors”
3:40–4:00 Lecture 1: Amelia Eisch, Ph.D.—UT Southwestern Medical Center at Dallas
“Adult Hippocampal Neurogenesis and Opiates: Implications for Addiction“
4:05–4:25 Lecture 2: Ping Zhang, Ph.D.—Lousiana State University Medical Center at New Orleans, New
Orleans, LA
“The Effects of Excessive Alcohol Consumption on the Development of Myelosuppression During SIV
Infection”
4:30–4:50 Lecture 3: Pankaj Seth, Ph.D.—National Brain Research Centre, India
“Neuron-Glia Crosstalk in HIV-1 Neuropathogenesis”
6:45–10:00 PM EVENING BANQUET AND AWARDS CEREMONY
Hosted by Guy A. Cabral, Ph.D.—incoming SNIP President
Special Dinner Presentation: Timothy Yeatman, M.D.—Moffitt Cancer Center, University of South
Florida & Chief Scientific Officer, M2Gen
“The M2Gen Approach to Personalized Medicine and Drug Development”
S10 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59Meeting Adjourned!
☼☼☼
Sunday, April 10, 2011—Departure Day
INVITED SPEAKER ABSTRACTS
(in alphabetical order by presenting author)
The Role of T Cell Activation and a T Cell Subset in
Anti-HIV Immunity. L Al-Harthi; Department of Immu-
nology/Microbiology, Rush University Medical Center,
Chicago, IL 60612, IL, USA.
CD8+ T cells contain a subset that expresses CD4 dimly on
their surface (CD4dim/CD8bright Tcells) and constitute 3%
of peripheral CD8+ T cells of healthy individuals. In vitro,
CD4dim/CD8bright T cells are induced in response to T cell
activation. Ex vivo, percent expression of CD4dim/
CD8bright T cells is fivefold higher among HIV long-term
nonprogressors than HIV seronegative and chronically HIV-
infected donors. CD4dim/CD8bright T cells exhibited
greater than 55% of CD8+ T cell antigen recognition
and effector response to HIV, which were CD4- and
MHC-II-dependent. β-catenin expression is higher in
CD4dim/CD8bright T cells than their CD4-CD8+ T cell
counterpart and mediates CD4 and Bcl-xL expression in
this subset. We have shown that β-catenin signaling
inhibits HIV replication suggesting that endogenous b-
catenin expression in CD4dim/CD8bright T cells may
serve as an anti-viral factor inhibiting HIV replication
and/or mediating protection against apoptosis. Finally, we
demonstrate that a common psychostimulant, metham-
phetamine, inhibits β-cantenin signaling suggesting that
drug use may impact the generation and/or persistence of
CD4dim/CD8bright T cells. Collectively, these data
demonstrate that CD4dim/CD8bright T cells designate
an enriched subpopulation of anti-HIV CD8+ T cells and
that biologic or exogenous factors (drugs of abuse) that
down regulate β-catenin signaling may adversely affect
the generation and/or persistence of this population.
Supported by RO1 NS060632, R21 A1077329, R03
DA026723-01, and D-CFAR P30AI082151.
Effects of APOE-ε4 Allele on Brain Function and
Structure in HIV Patients. MA n d r e s
1,TE r n s t
2,S
Sadino
2, C Jiang
2, H Nakama
3, S Munsaka
2, L Chang
2;
1Pacific Biosciences Research Center, University of Hawaii
at Manoa, Honolulu, HI 96822, USA,
2Department of
Medicine, John A. Burns School of Medicine, University of
Hawaii at Manoa, Honolulu, HI 96813, USA,
3Department
of Psychiatry, John A. Burns School of Medicine, Univer-
sity of Hawaii at Manoa, Honolulu, HI 96813, USA.
Carrying the APOE4 (ε4) allele is a risk factor for
Alzheimer’s disease, and may also play a role in promoting
HIV-associated neurocognitive disorder. Recent studies
demonstrated that homozygosity (but not heterozygosity)
for the ε4 allele accelerated the progression of HIV. While
several studies investigated the effects of the APOE4 allele
on cognitive function in HIV patients, none have evaluated
the effects of the ε4 allele on the brain structure of HIV-
infected individuals. Therefore, we genotyped a total of 139
subjects (70 seronegative (SN) controls and 69 HIV+
subjects) and used MR morphometry to assess brain
volumes. We found that younger (<50 years) but not older
(≥50 years) HIV+ subjects who are ε4 carriers have brain
atrophy in many subcortical regions compared to younger
(<50 years) HIV+ subjects without the ε4 allele. Converse-
ly, among SN controls, this brain atrophy occurred only in
older SN subjects with the ε4 allele. HIV+ subjects carrying
the ε4 allele also performed worse on cognitive tests than
HIV+ subjects without the ε4 allele and SN controls (with
and without the ε4 allele). Among HIV+ individuals, those
with the ε4 allele had higher levels of CSF APOE and also
performed worse on the HIV Dementia scales and had
lower Global Cognitive Scores than those without the ε4
allele. Together, these findings suggest that the APOE4
allele and the levels of encoded APOE proteins negatively
impact brain function and structure and may facilitate earlier
onset of neurodegeneration in the setting of HIV. Supported
by 2R01MH61427, 5R25MH080661 2K24DA016170,
1R24DA027318, and 1U54-NS056883.
Defining Mechanisms of Cocaine and HIV Co-Morbidity
In Vivo: The Potential and Pitfalls of Mouse/Human
Chimera Models. GC Baldwin, J Zhuo, KM Whittaker, D
Vatakis, MD Roth, SM Kiertscher; Department of Medi-
cine, David Geffen School of Medicine at UCLA, Los
Angeles, CA 90095, USA.
Mouse/human chimera models, in which human cells or
tissues are transplanted into immunodeficient strains of
mice, have enabled researchers to model disease mecha-
nisms and to characterize the role of potential co-factors
relevant to HIV pathogenesis. Humanized mouse models
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S11include (1) those transplanted with human stem cells alone
or in combination with fetal tissues, which result in a slower
but more extensive immune reconstitution and (2) those
transplanted with fully differentiated human peripheral
blood leukocytes (PBL), which lead to a more rapid but
targeted immune reconstitution. We have utilized both types
of chimeric models to assess the impact of acute cocaine
exposure on HIV replication in vivo, and to study broader
issues relevant to the mechanisms underlying the co-
morbidity resulting from the combination of HIV and
cocaine. Using conventional SCID, as well as NOD-SCID/
IL2rγnull mice as recipients for human PBL, we have
shown that acute cocaine exposure significantly enhances
HIV infection. We are currently utilizing the huPBL-NOD/
SCID model to assess underlying mechanisms, including
the impact of cocaine on the induction of Ag-specific
responses. To study the impact of chronic cocaine and HIV
co-exposure in the periphery and CNS, we are utilizing two
chimeric models: NOD-SCID/IL2rγnull mice (transplanted
with human CD34+ cord blood stem cells), and BLT mice
(transplanted with fetal liver-derived CD34+ stem cells in
combination with a fetal liver/thymus implant). Although a
number of practical limitations still exist, mouse/human
chimera models have made tremendous progress since their
inception and are useful tools for understanding the
mechanisms of human disease. Supported by NIH/NIDA
R01DA023386.
HIV-1 Tat Mediated Induction of Platelet-Derived
Growth Factor in Astrocytes: Role of Early Growth
Response Gene 1. C Bethel-Brown
1,HY a o
2, S Callen
2,
YH Lee
3, PK Dash
2, A Kumar
4, S Buch
2;
1Molecular and
Integrative Physiology, University of Kansas Medical
Center, Kansas City, KS 66160, USA,
2Pharmacology and
Experimental Neuroscience, University of Nebraska Medi-
cal Center, Omaha, NE 68137, USA,
3Institute of Biomed-
ical Science and Technology, Konkuk University, Seoul,
South Korea 143–701,
4Pharmacology, University of
Missouri Kansas City, Kansas City, MO 64108, USA.
HIV-associated neurological disorders (HAND) are esti-
mated to affect almost 60% of HIV infected individuals.
HIV-encephalitis (HIVE), the pathological correlate of the
most severe form of HAND is often characterized by
glial activation, cytokine/chemokine dysregulation, and
neuronal damage and loss. However, the severity of
HIVE correlates better with glial activation rather than
viral load. Using the macaque model, it has been
demonstrated that simian immunodeficiency virus en-
cephalitis correlates with increased expression of the
mitogen platelet-derived growth factor-B (PDGF-B) chain
in the brain. The present study was aimed at exploring
the role of PDGF-B chain in HIV-associated activation
and proliferation of astrocytes. Specifically, the data
herein demonstrate that exposure of rat and human
astrocytes to the HIV-1 protein, Tat resulted in the
induction of PDGF at both the mRNA and protein levels.
Furthermore, PDGF-BB induction was regulated by
activation of ERK1/2 and JNK signaling pathways and
the downstream transcription factor, early growth re-
sponse 1 (Egr-1). Chromatin immunoprecipitation assays
demonstrated binding of Egr-1 to the PDGF-B promoter.
Exposure of astrocytes to PDGF-BB, in turn, led to both
increased proliferation and release of pro-inflammatory
cytokines MCP-1 and IL-1β. Since astrogliosis is linked
to disease severity, understanding its regulation by
PDGF-BB could aid in the development of therapeutic
intervention strategies for HAND. Supported by MH-
068212, DA020392, DA023397, DA024442, and
DA0277729.
HIV-1 Infection and Cocaine Go Hand in HAND. SJ
Buch, H Yao; Pharmacology, University of Nebraska
Medical Center, Omaha, NE 68198, USA.
Cocaine, often abused by HIV-infected patients, has been
suggested to worsen HIV-associated neurocognitive disor-
ders (HAND) via unknown mechanisms. Our recent
research interest has focused on understanding molecular
mechanisms by which cocaine accelerates pathogenesis of
HAND by impacting the functioning of various CNS cell
types. In this area, we have demonstrated that: (1) in
macrophages, cocaine enhances virus replication and acti-
vation, (2) in microglia, cocaine upregulates the expression
of key chemokine MCP-1, leading to increased influx of
inflammatory cells in the brain; (3) in neurons, cocaine
potentiates neurotoxicity mediated by HIV-1 envelope
protein gp120; (4) In human brain microvascular endothe-
lial cells, cocaine induces the expression of the adhesion
molecule ALCAM as well as the vascular permeant platelet-
derived growth factor (PDGF)-B chain, both of which
impair the blood–brain barrier integrity resulting again in
augmentation of endothelial permeability as concomitant
increased monocyte transmigration; (5) more recently, we
have also shown that cocaine-mediated targeting of Notch-1
receptor in brain endothelial cells can also result in
induction of PDGF-BB. Functional implication of up-
regulated PDGF-BB as a vascular permeant was confirmed
both in cell culture and in vivo model systems using
permeability and transmigration assays. In summary, be-
sides its addictive role in the CNS, cocaine also has the
capacity to negatively impact the functioning of almost all
the cells of the CNS leading to increased neuroinflamamtion
and thus contributing to the pathogenesis of HAND.
Supported by NIDA grants DA020392, DA023397,
DA024442, and DA030285.
S12 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59Autophagy is Involved in the Neurovascular Toxicity of
Nanoalumina. L Chen
1, B Hennig
2, M Toborek
1;
1Neuro-
surgery, University of Kentucky, Lexington, KY 40503,
USA,
2College of Agriculture, University of Kentucky,
Lexington, KY 40503, USA.
Engineered nanomaterials (ENMs) have been widely used
for various applications; however, their potential toxic
effects are not fully understood. The current study focused
on blood–brain barrier (BBB) disruption and neurovascular
damage induced by treatment with one of the most
abundantly manufactured ENMs, nanoalumina. Exposure
of cultured human cerebral endothelial cells to nanoalumina
(size 8–12 nm) elevated cellular oxidative stress, induced
mitochondrial potential collapse, decreased tight junction
expression, and cellular viability. Nanoalumina also induced
activation of lysosomes and formation of autophagic
vacuoles associated with elevated levels of autophagic
marker proteins, p62 and LC-3. Delivery of nanoalumina
into mouse cerebral circulation using a carotid surgical
method altered expression of autophagy-related genes as
detected by the brain DNA microarray. In addition, in situ
immunostaining of brain slices detected time-dependent
increases in LC-3 levels in different cell types of the
neurovascular unit. Systemic treatment with nanoalumina
elevated also autophagic activity in cerebral vessels,
decreased tight junction expression, and elevated BBB
permeability. Finally, exposure to nanoalumina increased
brain infarct volume in mice subjected to a focal ischemic
stroke model. Collectively, our study reveals that autophagy
constitutes one of the critical mechanisms involved in
nanoalumina-induced neurovascular toxicity in the central
nervous system. Supported by American Heart Association
Postdoctoral Scholarship, NIH ES 07380, DA027569,
MH63022, MH072567, and NS39254.
Gut, Germs and HIV Pathogenesis of Immune and
Neurological Disease. S Dandekar; Department of Medical
Microbiology and Immunology, University of California at
Davis, Davis, CA 95616, USA.
Gastrointestinal and neurological abnormalities are common
features of progressive HIV infection. Chronic immune
activation in HIV infection serves as a correlate of disease
progression and contributes to gastroenteropathy and neu-
ropathology. Mechanisms contributing to the chronic
immune activation need to be fully defined in order to
prevent HIVassociated damage of the immune and neuronal
functions. The gut-associated lymphoid tissue is an impor-
tant site of early host–virus interactions and for establish-
ment of persistent viral reservoir in HIV-infected patients
and in the simian immunodeficiency virus-infected rhesus
macaque model of AIDS. Rapid onset of CD4+ T cell
depletion and epithelial barrier disruption set the stage for
the development of stable viral reservoirs and chronic
immune activation. The anti-retroviral therapy fails to either
eradicate the viral reservoirs or fully restore mucosal and
neuronal functions. A better understanding of the impact of
HIV infection on the mucosal immune system and its
systemic impact will help define the mechanisms of HIV
pathogenesis and novel HIV preventive and therapeutic
strategies. Supported by NIH.
Role of Neuroimmune Signaling Molecules in the
Neuropathology of Fetal Alcohol Spectrum Disorders.
PD Drew, L Han, RR Smith, JC Douglas, KD Phelan, CJ
Kane; Department of Neurobiology & Developmental
Sciences, University of Arkansas for Medical Sciences,
Little Rock, AR 72205, USA.
Fetal alcohol spectrum disorders (FASD), which include
fetal alcohol syndrome and alcohol-related neurodevelop-
mental disorder, occur in 1% of children in the US. FASD is
the leading cause of mental retardation and is characterized
by mild to severe cognitive and behavioral defects and
neuropathology that persist throughout life. Despite our
understanding that fetal alcohol exposure is associated with
loss and dysfunction of neurons, the underlying cellular and
molecular mechanisms of pathogenesis remain largely
unknown. This knowledge is critical to develop intervention
strategies. Recent studies are elucidating a new mechanistic
paradigm that may allow intervention. This is built on the
discovery that glia are direct targets of alcohol in the
developing brain and, thus, may play a role in FASD
etiology. Using the neonatal rodent model of FASD and
primary cell cultures, we have found that alcohol exposure
causes significant loss of microglia and neurons. Because
normal microglial–neuronal interactions are important to
neuron survival, depletion of microglia may limit their
neuroprotective capacity during alcohol exposure. Surviving
microglia exhibit altered expression of neuroimmune mole-
cules and an activated cell phenotype. Analysis of alcohol
effects on intracellular signaling pathways has revealed
potential mechanisms by which microglia may contribute to
alcohol-induced neurodegeneration. Thus, definition of alco-
hol effects on microglia and neuroimmune processes holds
potential for intervention in the neuropathology associated
with fetal alcohol exposure. Supported by NIH-NIAAA
AA14645, AA14888, AA18834, AA18839, and AA19108.
Cocaine Increases Platelet-Derived Growth Factor
Expression in Human Brain Microvessel Endothelial
Cells Through Notch-1 Signaling. MD Duan, HY Yao,
SB Buch; Department of Pharmacology and Experimental
Neuroscience, University of Nebraska Medical Center,
Omaha, NE 68198, USA.
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S13Neuroinflammation associated with advanced HIV-1 infec-
tion is often exacerbated in cocaine-abusing, HIV-infected
individuals. The underlying mechanisms could, in part, be
attributed to the increased impairment of blood brain barrier
integrity in the presence of cocaine. Platelet-derived growth
factor-BB (PDGF-BB) has been implicated in a number of
pathological conditions, specifically attributable to its potent
mitogenic effects. Its modulation by drug abuse, however,
has received very little attention. In the present study, we
demonstrated cocaine-mediated induction of PDGF-BB and
Notch1 in human brain microvascular endothelial cells. In
this study, we link Notch1 signaling to PDGF-BB and show
that PDGF-BB is a novel immediate Notch target gene.
PDGF-BB expression induced by cocaine was abrogated by
gamma secretase inhibitor-DAPT. Furthermore, over-
expression of intracellular domain of Notch1 significantly
increased PDGF-BB expression. Functional implication of
up-regulated PDGF-BB as a vascular permeant was con-
firmed in cell permeability and transmigration assays. In
vivo relevance of these findings was further corroborated in
cocaine-treated mice that were administered DAPT
(i.p. 40 mg/kg). Cocaine exposure resulted in increased
permeability of the endothelial barrier and this effect was
abrogated in mice exposed to DAPT, thus underscoring
its role as a vascular permeates. Understanding the
regulation of PDGF-BB expression may provide insights
into the development of potential therapeutic targets for
neuroinflammation associated with HIV infection and
drug abuse.
Adult Hippocampal Neurogenesis and Animal Models
of Drug Addiction: Implications for Substance Abuse.
AJ Eisch; Psychiatry Department, University of Texas
Southwestern Medical Center, Dallas, TX 75390–9070,
USA.
Drugs of abuse, like morphine, heroin, and cocaine, produce
robust changes in the birth and survival of neurons in the
postnatal hippocampal subgranular zone (SGZ). This is
intriguing since the hippocampus is central to many aspects
of the addictive process, including drug-context associations
and relapse to drug taking. Also, the functional integration of
postnatally generated neurons into hippocampal circuitry and
the role of new neurons in memory formation raise the
possibility that decreased adult SGZ neurogenesis may alter
hippocampal function in such a way as to maintain addictive
behavior or contribute to relapse. We will review our work on
the impact of opiates and cocaine on the different stages of
postnatal neurogenesis, focusing on recent data exploring
whether cells “born” during opiate exposure have altered
dendritic processes and on animal models of morphine self-
administration. Understanding the relationship between drugs
of abuse and SGZ neurogenesis opens the possibility of
understanding brain functions subserved by neurogenesis,
such as memory, and also of harnessing neural stem cells for
repairofthediseasedandinjuredbrain.SupportedbyNational
Institute on Drug Abuse, NASA.
Neuroimmune Interactions and Drugs of Abuse Come of
Age. T Eisenstein; Center for Substance Abuse Research,
Temple University School of Medicine, Philadelphia, PA
19140, USA.
Neuroimmunology used to be synonymous with the study
of inflammation in the nervous system, frequently caused
by leukocyte infiltrates with subsequent tissue and neuronal
damage. With the discovery that IL-1, a cytokine, was the
“endogenous pyrogen” and caused fever, the idea of a
neural–immune connection with a physiological basis was
born. Among the salient subsequent discoveries were the
observations of Wybran, from which he inferred that
leukocytes express opioid receptors, providing an example
of a circuit in which a neuronal product modulates the
immune system. We now have a significant panel of
molecules originally discovered in the nervous system or
the immune system that have been found to be present in
the other system or to target the other system, including
Substance P, Vasoactive Intestinal Peptide, epinephrine,
acetylcholine, IL-6, and the chemokines. An unpredicted
and intriguing finding is that neurons have receptors for
chemokines and can secrete them. In the last 10 years, it has
been found that leukocytes are the primary cells in the body
that express cannabinoid receptor 2 (CB2), and that CB2
agonists are anti-inflammatory. Some of the ligands in these
diverse systems have homeostatic functions. Research on
drugs of abuse and the immune system has been at the
forefront of the discoveries that are uncovering the intimate
interactions between the neural and immune systems. This
Symposium will explore some of the novel findings in this
important and growing area of neuroimmune interactions.
Supported by NIDA P30 DA13429.
Immune Signaling Regulates Alcohol Consumption:
Role of Neuroimmune Gene Expression. A Harris,I
Ponomarev, Y Blednov; Waggoner Center for Alcohol and
Addiction Research, University of Texas at Austin, Austin,
TX 78712, USA.
Immune/stress response genes are a prominent functional
group with differential expression in frontal cortex and VTA
of alcoholics in comparison to non-alcoholics. In addition,
brain gene expression in mice that are genetically predis-
posed to alcohol consumption implicates these pro-
inflammatory mediators in regulating alcohol intake. We
selected six genes [β-2-microglobulin (B2M), cathepsin S
(CTSS), cathepsin F (CTSF), interleukin 1 receptor antag-
S14 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59onist (IL1RN), CD14 (CD14) and interleukin 6 (IL6)] for
behavioral validation. Null mutant mice were tested for
ethanol intake in three tests: 24-h two-bottle choice, limited
access two-bottle choice and limited access to one bottle of
ethanol. Ethanol consumption and preference were reduced
in all the null mutant mice in the 24-h two-bottle choice test,
the test that was the basis for selection of these genes. No
major differences were observed in consumption of saccha-
rin in the null mutant mice. Deletion of B2M, CTSS,
IL1RN, CD14, and IL6 also reduced ethanol consumption
in the limited access two bottle choice test for ethanol
intake; with the IL1RN and CTSS null mutants showing
reduced intake in all three tests (with some variation
between males and females). We next asked if activation
of the immune system could promote excessive alcohol
consumption. TLR4 signaling (LPS, 1 mg/kg ip, C57/Bl6
mice) promoted alcohol consumption, an effect persisting at
least 3 months after a single LPS dose and not associated
with general changes in taste perception or palatability. The
lack of CD14 (CD14 knockout mice) as well as IL6 (IL6
knockout mice) prevented the increase of alcohol intake
after LPS. Taken together, this provides compelling evi-
dence that global gene expression analysis can identify
novel genetic determinants of complex behavioral traits and
suggests a novel role for neuroimmune signaling in
regulation of alcohol consumption. Supported by the
National Institute on Alcohol Abuse and Alcoholism (AA
U01 13520 - INIA Project; and AA06399).
Prevalence and HIV Disease Correlates of HAND in the
Pre-CART versus CART Eras. RK Heaton
1, D Franklin
1,
R Ellis
1, S Letendre
2, JA McCutchan
2, I Grant
1;
1UCSD
Department of Psychiatry, University of California, San
Diego, La Jolla, CA 92093, USA,
2Department of Medi-
cine, University of California San Diego School of
Medicine, La Jolla, CA 92093–0671, USA.
Combination antiretroviral therapy (CART) has greatly
reduced the incidence of opportunistic disease and mortality
in HIV-infected individuals, but studies of its effect on
neurocognitive impairment (NCI) have been mixed. Here,
we examined NCI in the pre-CART and CART eras in
persons at various stages of HIV infection. Eight hundred
fifty-seven adults (HIV−, n=179; non-AIDS, n=516; AIDS,
n=162) from the pre-CART era (1988–1995) were com-
pared to 937 (HIV−, n=94; non-AIDS, n=336; AIDS, n=
506) from the CART era (2000–2007). Treatment era
cohorts received comparable, comprehensive neuromedical
and neuropsychological evaluations, and similar, rigorous
screening to exclude non-HIV CNS comobidities. Overall,
40% of HIV-infected individuals had NCI in the CART era
vs. 33% in the pre-CART era. Analysis by CDC Stages
showed a significantly higher rate of NCI for CART era in
CDC A only (36% post-CART vs. 25% pre-CART, p=
0.001). Infected CART era individuals were more likely to
be on ARVs (70% vs. 47%; p<0.0001). History of severe
immunosuppression (low nadir CD4) was the only robust
predictor of NCI in both eras. NCI remains prevalent
despite CART. Of interest, more CART-era non-AIDS cases
have NCI than pre-CART. This suggests negative CNS
effects of longer survival in a pre-AIDS state during which
the brain remains exposed to repeated fluxes in HIV and/or
chronic immune stimulation. HNRC supported by a Center
Award (MH62512) with the CNS HIV Antiretroviral
Therapy Effects Research (CHARTER) study supported by
Award N01 MH22005, both from the National Institute of
Mental Health/NIH.
Chemokines as Neuromodulators. LG Kirby, S Heinisch;
Center for Substance Abuse Research, Temple University
School of Medicine, Philadelphia, PA 19140, USA.
Chemokines are a class of small, secreted cytokines mediating
leukocyte mobilization to sites of inflammation in the
periphery. Chemokines and their receptors are also present in
the central nervous system, localized to neurons and glia.
Some chemokines constitutively colocalize with neurotrans-
mitters and neuropeptides including acetylcholine, dopamine,
and vasopressin. These findings have been expanded in our
laboratory to indicate expression of chemokines and their
receptors in serotonin neurons as well as colocalization of
chemokine and opioid receptors on individual neurons in
several brain areas. Several laboratories have demonstrated
that chemokines modulate neurotransmission through effects
on neuronal membrane properties, GABA/glutamate synaptic
activity and Ca++ currents in a variety of brain regions. To
extend our anatomical findings, we showed that chemokines
regulateserotoninneuronsviaactionsonGABAergicsynaptic
activity.Insupport ofearlier molecular and behavioralstudies,
we further showed desensitization of opioid receptor function
by chemokines at the single-cell level in brain slices. These
anatomical and functional studies have led to the hypothesis
that the endogenous chemokine system represents a “third
major system” of communication in the brain, acting in
concert with neurotransmitter and neuropeptide systems to
govern brain function. Chemokine over-expression in a
number of chronic immune diseases may have additional
pathological consequences through dysregulation of the
neurotransmitter and neuropeptide systems to which they
have been linked. Supported by NIH DA 20126, 06650,
13429 and Pennsylvania Department of Health Research
Formula Fund.
Stage Specific Effects of HIV and Opiates on the
Differentiation and Function of CNS Progenitors. PE
Knapp
1, YK Hahn
1, CM Bull
1, KF Hauser
2;
1Department of
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S15Anatomy and Neurobiology, Virginia Commonwealth Uni-
versity, Richmond, VA 23298, USA,
2Department of
Pharmacology and Toxicology, Virginia Commonwealth
University, Richmond, VA 23298, USA.
Injection drug abuse and HIV infection are interlinked
epidemics. HIV patients who abuse opiates appear to have
higher incidence of neurologic dysfunction. HIV infection is
almost exclusively propagated in immune cells. CNS
pathology is thus largely secondary to processes driven by
glial cells or to toxic effects of released viral proteins. The
potential for synergy between HIV and opiates in the CNS
is extensive since opioid receptors are widely expressed by
neural and glial precursors, their mature derivatives, and
microglia. CNS neural/glial progenitors are not thought of
as classical HIV targets, but our studies show that critical
progenitor behaviors are affected by exposure to HIV
proteins, and that opiate co-exposure is synergistic for
certain outcomes. In vitro, HIV-1 Tat, but not morphine or
gp120, stimulates progenitors to secrete CCL5, MIP-1α and
MIP-1β, with effects on CCR5-mediated microglial migra-
tion. HIV-1 Tat and morphine separately reduce progenitor
motility, but have a robust interactive effect on proliferation
and lineage progression among Sox2+ and Olig2+ progeni-
tors. In vivo studies using inducible Tat transgenic mice have
confirmed certain findings. Tat expression reduces overall and
Olig + proliferation (Ki67+) in striatum; Tat and morphine
interaction reduces oligodendrocyte numbers in corpus cal-
losum. Overall, many aspects of CNS progenitor function are
vulnerable to individual or combined effects of Tat and
opiates. Depending on timing, exposure may alter neuron/
glial populations in specific regions, affecting gliosis, inflam-
mation and CNS repair. Supported by NIH DA24461.
The Effect Of Δ-9-Tetrahydrocannabinol (THC) on
SIVmac251 Infection in Chinese Macaques. L Liu
1,Q
Wei
2, Z Cong
2, P Molina
3, C Qin
2, ZW Chen
1;
1AIDS
Institute of Li Ka Shing Faculty of Medicine, The
University of Hong Kong, Hong Kong, China,
2Institute
of Laboratory Animal Science, CAMS and Peking Union
Medical College, Beijing, China 100021,
3Department of
Physiology, Louisiana State University Health Sciences
Center, New Orleans, LA 70112–1393, USA.
Δ-9-tetrahydrocannabinol (THC) is the main psychologi-
cally active ingredient of the cannabis plant. THC has been
used as the active ingredient of Marinol as an appetite
stimulant for AIDS patients yet its impact on HIV infection
remains unclear. Here, we aim to determine the chronic
effect of THC on SIVmac251 infection in Chinese
macaques (0.32 mg/kg im, 2× daily, 428 days). Sixteen
animals were divided into four study groups: THC+SIV+,
THC+SIV-, THC-SIV+, and THC-SIV- with four macaques
in each group. One month post-THC administrations, mac-
aques in group one and three were challenged with
SIVmac251/CNS derived from the brain of an end-staged
SAIDS Chinese macaque with neurological disorders. On
average, group one macaques maintained better body weight
when compared with group three animals. There were no
significant differences of body mass index, body fat distribu-
tion, peak and steady state plasma viral loads and proviral
loads between THC-treated and -untreated infected animals.
All infected macaques, however, displayed significant drop of
CD4/CD8 T cell ratio, loss of central memory CD4+ T cells
and higher levels of Ki67+ CD8 T cells overtime when
compared to uninfected macaques. Moreover, THC adminis-
tration likely attenuates the production of peripheral IgE.
Three infected macaques, one out of four in group one with a
paralyzed limb and two out of four in group three, died of
SAIDS with high viral loads before the cessation of THC. The
withdrawal of THC has led to reduced food intake among
THCtreatedanimals,whichrequiresfurtherfollow-upstudies.
Our Search for the "Ideal Analgesic" in Pain Treatment.
HH Loh; Department of Pharmacology, University of
Minnesota, Minneapolis, MN 55455, USA.
Opioid analgesics are efficacious in controlling pain, but
have adverse effects, e.g., addiction. Much research has
focused on designing an opioid analgesic with morphine’s
efficacy, but without morphine’s adverse effects—an ideal
analgesic. The analgesic action of opioid agonists (e.g.,
morphine) is mediated via the mu-opioid receptor (MOR).
Opioid antagonists (e.g., naloxone) block the agonist effect
via its interaction at MOR, but have no efficacy themselves.
We found that a mutation of a conserved serine in the
(TM04) region of all opioid receptors confers agonistic
properties to antagonists. The observed agonists properties
was due to the mutations of the conserved serine to leucine
(or ala) in the 4th TM domain (S196L). We introduced
MOR-S196A mutants into mouse MOR gene. In homozy-
gous mice, the opioid antagonists elicited antinociceptive
effects like agonists. Importantly, chronic treatment of these
mice with antagonists killed pain but did not produce the
tolerance and dependence associated with morphine treat-
ment. We have had success using gene therapy approaches
and can see expression of this mutant receptor in the
nociceptive neurons of the spinal cord. By administrating
opioid antagonists, which are devoid of opioid side effects,
activation of this mutant MOR occurred while the endog-
enous wild-type MOR were not activated, providing a proof
of principal that this should be a feasible approach making
an ideal pain killing paradigm for treatment of pain. Our
group has developed a new target to screen for new non-
addictive narcotic analgesic, which I will present in my talk.
Supported by NIH/NIDA.
S16 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59Genetic Validation in the Subtypes of Alcoholism. RB Lu;
Department of Psychiatry, College of Medicine, National
Cheng-Kung University, Tainan, Taiwan, 70428, ROC.
Alcoholism is a high heterogeneity and high genetic
component mental illness. No subtype has genetic valida-
tion. We reclassified the subtype of alcoholism divided
into pure alcoholism, anxiety–depression alcoholism, anti-
social alcoholism and set up genetic validation. We found
pure alcoholism is related to the MAOA gene; the
ADH1B and ALDH2 genes are associated with Anxiety–
depression and pure alcoholism but antisocial alcoholism
is only weakly associated with the ALDH2 gene. Anxiety-
depression alcoholism is related to the DRD2 A1/A1
genotype and after stratifying by the ALDH2 *1/*1
genotype which is the same association with antisocial
alcoholism. One of the major differences between the two
subtypes of alcoholism is that antisocial alcoholism was
linked to the 3-repeat of the MAOA-uVNTR gene while
the anxiety-depression alcoholism was associated with the
interaction of the MAOA and ALDH2 genes. These results
may be interpreted as the reason that about 54% of
antisocial personality disorder comorbid with anxiety
disorder and the lifetime prevalence rate of antisocial
personality disorder in Han Chinese is only 0.100 but
3.3% in Western population because about only 50% Han
Chinese population have the ALDH2 *1/*1 genotype but
almost 99–100% of the Western population belong to the
ALDH2 *1/*1 genotype. Rice et al. (2001) reported that
the lower prevalence of a disease shows the higher
statistical meaning for a fixed heritability and a fixed
number of trait loci. Han Chinese may provide a specific
contribution to the worldwide study of alcoholism at the
genetic molecular level. Supported by National Cheng
Kung University ProjectforPromotingAcademicExcellence
and Developing World Class Research Centers, Taiwan.
Dynamics of Dendritic Cells and T Cells In HTLV-1-
Associated Neuroinflammatory Disease: Implications in
Immunomodulatory Therapies and Diagnostic Tools. SL
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HTLV-1-associated myelopathy/tropical spastic parapare-
sis (HAM/TSP) is a debilitating neurodegenerative dis-
ease characterized by a robust immune response
including the oligoclonal expansion of cytotoxic T
lymphocytes (CTLs) specific for the viral oncoprotein
Tax. However, the underlying mechanism resulting in the
disease process is currently unknown. The CTL response
is affected by many factors including the efficiency of
epitope processing and presentation. In this respect,
dendritic cells (DCs), the most potent antigen presenting
cells, have long been recognized as key regulators of the
immune system. We have previously demonstrated that
DCs are capable of priming a pronounced Tax-specific
CTL response in naïve PBLs and in HLA-A*0201
transgenic mice. Since DCs are such crucial cells of the
immune system, an extensive assessment of their function
and interaction with T cells in HAM/TSP is critical.
Therefore, utilizing a newly standardized DC and a pre-
standardized T cell polychromatic antibody cocktail, we
have investigated the immune activation of these cells in
HTLV-1 infected samples from the Jamaican region
including seronegative controls, asymptomatic carriers
(ACs), and HAM/TSP patients. The extensive immune
cell profiling was compared to the matched proviral loads
and Tax mRNA levels leading to the identification of
unique signatures distinguishing ACs from HAM/TSP
patients. Collectively, these studies possess great potential to
enableimmunecellmonitoringanddevelopmentofdiagnostic
and therapeutic strategies for the HTLV-associated neuro-
inflammatorydisease.SupportedbyNIHgrantR01AI077414
(NIAID) to Pooja Jain and a Philadelphia NeuroAIDS
Research Training Grant T32 MH079785 (NIMH).
Neuroaids and Drug Abuse: Risk Factors for
Neurocognitive Impairment. EM Martin,VM e y e r -
Grauzas, PM Maki; Department of Psychiatry, University
of Illinois, Chicago, IL 60612, USA.
Essentially all substances of abuse in combination with
HIV result in significant cellular damage that can exceed
effects of one or the other via multiple mechanisms
including increased immunosuppression, enhanced viral
replication, release of various neurotoxic cytokines and
breakdown of blood–brain barrier. However, findings
from the literature on brain function and neurocognition
among HIV-infected substance-dependent individuals
(SDIs) are considerably more variable. This presentation
will address current knowledge of risk factors influencing
vulnerability to HIV-associated neurocognitive dysfunction
among SDIs, with a primary focus on gender. Findings
will be presented from recent studies in Chicago of
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S17potential gender differences in neurocognitive probes of
neostriatal integrity among HIV+ SDIs and differential
susceptibility of HIV+ women to effects of cocaine
dependence on neurocognitive dysfunction. Supported by
National Institute on Drug Abuse.
Investigational Agents for Chronic Viral Infections: HIV
and HCV. SN Naggie; Duke Clinical Research Institute,
Duke University Medical Center, Durham, NC 27710,
USA.
Chronic infections from hepatitis C virus (HCV) and
human immunodeficiency virus (HIV) are a global health
problem. The introduction of protease inhibitors to HIV
treatment combinations in 1996 significantly reduced
morbidity and mortality due to HIV infection, meanwhile
the current therapy for HCV is effective in less than 50%
of genotype 1 infected patients. Over the past decade,
advances in HIV therapeutics have produced new drug
classes and fixed dose combinations, changing the face of
HIV medicine. The next decade in HCV therapeutics
promises to be quite similar. With advances in cell
culture systems over the past decade, the development
of directly acting antiviral (DAA) agents has become
possible. There are currently over 50 active clinical trials
in this therapeutic area, and NS3/4A protease inhibitors
will be the first DAA FDA approved in 2011. This will
summarize (1) the most current information regarding the
effectiveness of protease inhibitors in treating chronic
HCV, (2) the possibility of combination therapies for
HCV, and (3) the now smaller pipeline for HIV therapies
and the role these therapies may play in the management
of HIV-infected patients.
Human Immunodeficiency Virus Type 1 (HIV-1) Infects
Human Brain Pericytes In Vitro. S Nakagawa,M
Toborek; Department of Neurosurgery, University of Kentucky,
Lexington, KY 40536, USA.
Human immunodeficiency virus type 1 (HIV-1) infection
of the central nervous system (CNS) causes disruption of
the blood–brain barrier (BBB) and contributes to the
development of neurological dysfunctions. The BBB
strictly regulates the transport of blood-borne cells and
substances into the brain. Brain capillary endothelial
cells are a major component of the BBB and have a
dynamic interaction with other neighboring cells, namely,
astroglia, pericytes, perivascular microglia, and neurons.
The cross-talk between cells of the neurovascular unit is
crucial for the formation and maintenance of a functional
BBB. There are many reports related to the effects of
HIV-1 on astrocytes, microglia, neurons, and endothelial
cells. However, no study addressed the effects of HIV-1
infection on pericytes. The purpose of this study was to
evaluate whether pericytes can be infected with HIV-1.
To determine the expression of HIV-1 receptors on
human brain pericytes, confocal microscopy and western
blots were performed. Human brain pericytes expressed
the HIV-1 receptor and co-receptors (CD4, CXCR4, and
CCR5). Confirmation of HIV replication in human brain
pericytes was performed by HIV-1 p24 ELISA. Low
viral replication was detected after exposure to the X4
and R5 strains of HIV. These findings indicate that
human brain pericytes can be infected with HIV-1.
Infected pericytes may be involved in progression of
the HIV-1-induced CNS damage. Supported by in part
by ES 07380, DA027569, MH63022, MH072567, and
NS39254.
Fulminant Encephalopathy in HIV-Infected Cocaine
Abusers. A Nath, S Newsome, C Pardo, JC McArthur;
Department of Neurology, Johns Hopkins University,
Baltimore, MD 21287, USA.
The clinical spectrum of neurological complications of
active drug abusers in HIV-infected patients is not well
defined. Further, multiple comorbidities may contribute
to these clinical subtypes. In a retrospective review
conducted at Johns Hopkins Hospital from 1993 to
2008 HIV-infected patients who were actively abusing
drugs and had bilateral basal ganglia lesions on MRI
were identified. The following databases were searched:
radiology, autopsy, and the Moore HIV clinic database.
Clinical, laboratory, and radiographic findings were
correlated to define the syndrome. Ten individuals were
identified who presented with a change in mental status
or seizures, used cocaine or cocaine with heroin, had
uncontrolled HIV infection (>190,000 copies/mL of
plasma), elevated CSF protein (63–313 mg/dL), and
diffuse hyperintense bilateral basal ganglia lesions on
imaging. The majority of patients (8/10) had renal failure
and despite supportive therapy, most (7/9) ultimately died
(median survival 21 days). Postmortem examination in
one individual showed the presence of overwhelming
microglial activation in the basal ganglia. The two
surviving individuals were s t a r t e do nc o m b i n e da n t i r e -
troviral therapy (CART) during hospitalization. We
describe a rare but unique clinical syndrome of a
fulminant encephalopathy associated with prominent
basal ganglia involvement in HIV-infected drug abusers.
This syndrome is associated with high mortality. Early
CART institution may be useful and neuroprotective in
S18 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59this disorder, although this requires further investigation.
Supported by NIDA, NINDS.
Alcohol, Immunosuppression, and HIV. S Nelson; Com-
prehensive Alcohol Research Center, Louisiana State
University Health Sciences Center, New Orleans, LA
70112, USA.
Alcohol abuse and HIV-infection are major public health
problems and frequently coexist in the same individual.
While several studies have shown a significant association
between alcohol consumption and the risk of being infected
with HIV, it is unclear whether this association is due to
behavioral and/or biomedical mechanisms. Studies of HIV-
infected patients are limited in their ability to control for
timing and dose of HIV exposure, nutrition, concurrent use
of other drugs of abuse, use of antiretroviral therapy, as well
as the frequency and amount of alcohol consumed. In order
to study the impact of alcohol on HIV infection, we
developed a model of chronic alcohol consumption in
rhesus macaques infected with simian immunodeficiency
virus (SIV). Our studies have shown that plasma viral loads
are significantly higher in alcohol-consuming macaques 60–
120 days post SIV infection (viral set point) compared to
control animals. The viral set point is predictive of disease
progression and in our studies alcohol consumption was
associated with accelerated disease progression to end-stage
disease. Alcohol consumption and SIV/HIV have been
shown to compromise intestinal barrier function resulting in
increased transfer of endotoxin and other antigens into the
systemic circulation which triggers a cascade of inflamma-
tory responses, which is a main driving force for HIV
replication and disease progression. Therapeutic ap-
proaches focused at restoring the integrity of the mucosal
barrier might prove effective in mitigating HIV replication
and disease progression. Supported by NIH/NIAAA/P60
AA009803.
Sympathetic Nervous System and Norepinephrine:
Adrenergic Receptor-Mediated Effects on Immune
Function. VM Sanders; Department of Molecular Virology,
Immunology and Molecular Genetics, Ohio State University
Medical Center, Columbus, OH 43210, USA.
Four key discoveries indicate that a mechanism exists by
which the sympathetic nervous system is able to commu-
nicate with cells of the peripheral immune system: (1) the
parenchyma of primary and secondary lymphoid organs are
innervated with sympathetic nerve fibers; (2) the sympa-
thetic neurotransmitter norepinephrine is released from
nerve terminals residing within lymphoid tissue upon
antigen or cytokine administration; (3) lymphoid cells,
except the Th2 cell, express the beta-2-adrenergic receptor
(β2AR) that binds norepinephrine; and (4) norepinephrine
regulates lymphocyte activity and the magnitude of an
immune response. Recent findings on β2AR adrenergic
receptor expression on lymphocytes and unexpected mech-
anisms by which β2AR engagement regulates the level of
immune cell activity will be discussed. Supported by NIH
AI37326.
Neuron-Glia Crosstalk in HIV-1 Neuropathogenesis.
PS e t h , P Garg; NeuroAIDS Laboratory, Cellular and
Molecular Neuroscience, National Brain Research Centre,
Manesar, India 122050.
Cell culture model system has been of immense importance
in understanding neuro-pathogenesis underlying HIV-
associated neurocognitive disorder. Previous studies have
reported an increase in Cx 43 expression at protein level
upon exposure of primary human astrocytes with live HIV
virus. However, the underlying signaling pathways and the
consequences of the augmented gap junction communica-
tion still remain unexplored. To gain better insights into the
molecular mechanisms underlying HIV-mediated neurotox-
icity, we used human neuron-astrocyte co-culture model
system using cells differentiated from human fetal brain-
derived neural precursor cells, thereby closely mimicking
the in vivo conditions of human brain. Gap Junction
Channels (composed of connexins as their key proteins)
are known to be one of the major modes of intercellular
communication as they allow the passage of various ions
and second messengers, thereby regulating signaling
pathways. In our study, we have observed a significant
increase in gap junction communication (Cx 40, 26, 36
and 43) post treatment with HIV-1 Tat protein. This
increase in gap junction communication promotes cell
d e a t ha se l u c i d a t e db yt h eT U N E La s s a y .F u r t h e r ,c e l l
proliferation was also inhibited because of increased
connexin expression as evidenced by Ki67 staining. This
effect is confirmed by the use of α-glycyrrhetinic acid
(Gap Junction blocker) that restores cell viability and
proliferation in the treated cells. Studies on signaling
pathways and role of cell cycle regulatory proteins are
c u r r e n t l yi np r o g r e s si no u rl a b .S u p p o r t e db yR e s e a r c h
grants from Department of Biotechnology and National
Brain Research Centre, India.
HIV-1 Glycoprotein 120 Induces the Pro-Inflammatory
Cytokine IL-6 via the NF-κB Pathway and
Methamphetamine can Synergistically Potentiate gp120-
Mediated IL-6 Induction. A Shah, A Kumar; Division of
Pharmacology & Toxicology, University of Missouri—
Kansas City, Kansas City, MO 64108, USA.
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S19HIV-1 gp120 facilitates the viral attachment and entry into
the CNS leading to infection of various regions of the brain,
resulting in HIV-1 associated neurocognitive disorders. In
this study, we sought to address whether gp120 can induce
the pro-inflammatory cytokine interleukin-6 (IL-6). We
also addressed whether exposure to methamphetamine can
induce IL-6 expression in astrocytes, either alone or in
synergy with gp120. The transfection of gp120 showed a
time dependent induction of IL-6 mRNA and protein
expression, with peak levels of 51.3±2.1- and 11.6±2.2-
fold, respectively. The induction of IL-6 could be
successfully abrogated by gp120-specific siRNA. Using
chemical antagonists and siRNA for the NF-κB pathway,
we demonstrated the involvement of this transcription factor
in gp120-mediated IL-6 induction. Both I-κB-α and IKK2
inhibitors could abrogate the gp120-mediated IL-6 induc-
tion by 56.5% and 60.8%, respectively. In this study, we
also report that exposure of SVGA cells to methamphet-
amine results in an increase in IL-6 expression by 4.9±
2.3-fold, which was blocked by mGluR5 inhibitor MPEP.
The expression of IL-6 increased further (76.0±12.1-fold)
when meth exposure was combined with gp120 transfec-
tion. Together, our results suggest NF-κBt ob ea
potential therapeutic target for HIV-1 infected patients.
We also demonstrate that methamphetamine can act
synergistically with gp120 to induce IL-6 expression.
Thus, HIV-infected individuals who consume metham-
phetamine are at higher risk of developing neuro-
inflammation than non-abusers.
Molecular Chaperone and Interorganelle Signaling in
Disease. TS u ; Cellular Pathobiology Section, Intramural
Research Program, National Institute on Drug Abuse,
National Institutes of Health, Baltimore, MD 21224,
USA.
The inter-organelle signaling plays important roles in
many physiological functions. The endoplasmic reticu-
lum (ER)-mitochondrion signaling affects intramitochon-
drial Ca2+ homeostasis and cellular bioenergetics. The
ER-nucleus signaling attenuates ER stress. The ER-
plasma membrane signaling regulates cytosolic Ca2+
homeostasis and the ER-mitochondrion-plasma mem-
brane signaling the hippocampal dendritic spine forma-
tion. The sigma-1 receptor (Sig-1R), an ER chaperone
protein, acts as an inter-organelle signaling modulator.
Sig-1Rs normally reside at the ER-mitochondrion con-
tact called the MAM (mitochondrion-associated ER
membrane) where Sig-1Rs regulate ER-mitochondrion
signaling and the ER-nucleus cross-talk. When cells are
stimulated by Sig-1R agonists or under prolonged stress,
Sig-1Rs translocate from the MAM to the ER reticular
network and plasma membrane to regulate a variety of
functional proteins including ion channels, receptors, and
kinases. Cocaine is a Sig-1R agonist. Cocaine causes the
translocation of a portion of Sig-1Rs from the MAM to
other areas of neurons including the general ER
membrane, plasma membrane, nucleus, and mitochon-
dria. Thus, in addition to the well-known action of
c o c a i n ei ni n c r e a s i n gB D N Fa n dD Ai nt h eb r a i n ,
cocaine may achieve its addictive action in part by
interacting with ion channels or receptors from inside of
the neuron via its interaction with Sig-1Rs. Supported
by Intramural Research Program, NIDA, NIH, DHHS.
Natural History and Pathogenesis of HIV and HCV. DL
Thomas; Infectious Diseases, Johns Hopkins School of
Medicine, Baltimore, MD 21205, USA.
Hepatitis C virus (HCV) coinfection occurs in an
estimated one-quarter of HIV-infected persons in Europe,
Australia, and the United States. HCV is especially a
problem for injection drug users as nearly all HIV-
infected drug users in some settings already has HCV
infection. As use of highly active antiretroviral drugs
has markedly reduced opportunistic infections, HCV-
related liver disease has emerged as a leading cause of
death. HIV infection adversely affects both the natural
history and the treatment of hepatitis C. Because there
are no experimental models of coinfection and because
the pathogenesis of each infection is incompletely
understood, how HIV infection alters hepatitis C is not
clear. Possible mechanisms will be discussed. Supported
by NIDA.
Neuropsychiatric Complications of HIV, HCV, and
Antiviral Treatment. G Treisman; Department of Psychia-
try and Behavioral Sciences, Johns Hopkins University
School of Medicine, Baltimore, MD 21287, USA.
Infectious diseases transmitted by specific behaviors
such as Hepatitis C and HIV have been shown to be
associated with psychiatric conditions. Psychiatric dis-
orders including addiction, major depression, personality
disorder, cognitive impairment, dementia, and major
mental illness increase risk behaviors for infection.
Additionally, CNS inflammation, depletion of resources,
hopelessness, and therapeutic nihilism increase these
psychiatric conditions, leading to poor adherence to
treatment and treatment failur e .F i n a l l y ,t h em e d i c a t i o n s
used to treat Hepatitis C and HIV cause psychiatric and
neurologic side effects that further complicate care.
Treatment is made more complex by conditions such
as neuropathic pain produced by antiviral medications,
S20 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59depression caused by interferon, and delirium caused by
ancillary medications. Additionally, the polypharmacy
required for treatment of substance abuse disorders,
affective disorders, schizophrenia, Hepatitis C, and HIV
create a variety of complex drug interactions that
undermine treatment. An integrated treatment plan with
an emphasis on collaborative efforts at surveillance for
side effects, drug interactions, treatment of non-
adherence, and the emergence of treatment related
complications has been shown in model programs to
improve outcomes and effectiveness of treatment. Co-
herent treatment of psychiatric, neurologic, and sub-
stance abuse disorders may also decrease the risk of
transmission and the development of viral resistance.
Molecular Neurobiology of Drug Addiction: Role of
NMDA Receptors. JQ Wang, LM Mao; Department of
Basic Medical Science, University of Missouri—Kansas
City School of Medicine, Kansas City, MO 64108, USA.
Plastic changes in glutamate receptors are critical for the
remodeling of excitatory synapses in limbic reward
circuits in response to chronic psychostimulant exposure.
Such remodeling is thought to directly link to enduring
drug-seeking behavior, although underlying mechanisms
are poorly understood. In this study, we investigated an
ionotropic glutamate receptor subtype, N-methyl-D-aspar-
tate receptors (NMDAR), in their adaptations to chronic
psychostimulant exposure and their roles in mediating
drug-stimulated synaptic and behavioral plasticity. By
focusing on the turnover and trafficking of NMDARs,
we found that chronic exposure to the psychostimulant
amphetamine (4 mg/kg, i.p., once daily for 7 days;
14 days of withdrawal) induces selective downregulation
of NMDAR NR2B subunit proteins in the confined
surface membrane pool of rat striatal neurons at synaptic
sites. Remarkably, this downregulation is a long-lived
event and results from the destabilization of surface-
expressed NR2B due to accelerated ubiquitination and
degradation of crucial NR2B-anchoring proteins by the
ubiquitin-proteasome system. The biochemical loss of
synaptic NR2B further translates to the significant
modulation of synaptic plasticity in the form of long-
term depression at cortico-accumbal glutamatergic syn-
apses. Behaviorally, genetic disruption of NR2B induces,
whereas restoration of NR2B loss prevents, behavioral
sensitization to amphetamine. Our data identify NR2B as
a key regulator in the remodeling of excitatory synapses
and persistent psychomotor plasticity in response to
amphetamine. Supported by NIH/R01 DA010355 and
R01 MH061469.
Challenges in the Diagnosis of HAND in a Hispanic
Cohort of HIV-Seropositive Women. V Wojna
1, R Mayo
1,
RL Skolasky
2, N Haughey
2, A Nath
2;
1NeuroAIDS Pro-
gram and Neurology Division, University of Puerto Rico
Medical Sciences Campus, San Juan, PR 00936–5067,
Puerto Rico,
2Neurology Department, Johns Hopkins
University, Baltimore, MD 21287, USA.
HIV-associated neurocognitive disorders (HAND) continues
to be a serious complication of HIV infection. Infected
patients using combined antiretroviral treatment (CART) are
at risk of developing milder forms of HAND since they are
living longer and may present other risk factors for
cognitive impairment such as aging effects and drug abuse.
The recommended nosology for the diagnosis of HAND
weights heavily on the performance of neuropsychological
(NP) tests. This may represent a challenge in settings where
there is limited NP normative data. We have designed a
cohort of HIV-seropositive women to study HAND since
women represent the fastest growing groups with HIV/
AIDS. Using the experience of the Hispanic-Latino Longi-
tudinal Cohort of HIV-seropositive Hispanic Women we
will discuss how we establish the NP battery tests and the
diagnosis of HAND, how we deal with the normative issue,
and how HAND criteria varies from previously establish
criteria. While our cohort does not recruit participants with
active drug abuse, a considerable amount have tested
positive to illicit drugs. Discussions will also include the
effects of drugs of abuse on HAND diagnosis and CSF
antioxidants and oxidative stress markers. Although we are
studying a cohort of Hispanic women, we understand that our
findings are relevant to HIV-seropositive women in general.
Supported by NIH grants U54NS43011, P20RR11126,
S11NS046278.
Cocaine-Mediated Induction of Platelet-Derived
Growth Factor: Implication for Increased Vascular
Permeability. HY a o , M Duan, SJ Buch; Pharmacology,
University of Nebraska Medical Center, Omaha, NE 68198,
USA.
Neuroinflammation associated with advanced HIV-1 infec-
tion is often exacerbated in cocaine-abusing HIV-infected
individuals. The underlying mechanisms could, in part,
be attributed to the increased impairment of blood brain
barrier integrity in the presence of cocaine. Platelet-
derived growth factor (PDGF) has been implicated in a
number of pathological conditions, specifically attributable
to its potent mitogenic effects. Its modulation by drug abuse,
however, has received very little attention. In the present
study, we demonstrated cocaine-mediated induction of
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S21PDGF-BB in human brain microvascular endothelial cells
through the binding to its cognate sigma receptor.
Furthermore, this effect was mediated, with subsequent
activation of mitogen-activated protein kinases (MAPKs)
and Egr-1 pathways, culminating ultimately into increased
expression of PDGF-BB. Cocaine exposure resulted in
increased permeability of the endothelial barrier and this
effect was abrogated in mice exposed to PDGF-BB
neutralizing antibody, thus underscoring its role as a
vascular permeant. In vivo relevance of these findings
was further corroborated in cocaine-treated mice that
were administered neutralizing antibody specific for
PDGF-BB as well as in Egr-1 −/− mice. Understanding
the regulation of PDGF-BB expression may provide
insights into the development of potential therapeutic
targets for neuroinflammation associated with HIV infec-
tion and drug abuse. Supported by NIDA/DA020392,
DA023397, DA024442, and DA030285.
The Effects of Excessive Alcohol Consumption on the
Development of Myelosuppression During SIV Infection.
P Zhang
1, RW Siggins
1,D AW e l s h
2, GJ Bagby
1,J P
Dufour
3, S Nelson
2;
1Department of Physiology, Louisiana
State University Health Sciences Center, New Orleans, LA
70112, USA,
2Department of Medicine, Louisiana State
University Health Sciences Center, New Orleans, LA 70112,
USA,
3Division of Veterinary Medicine, Tulane National
Primate Research Center, Covington, LA 70433, USA.
Myelosuppression is common in patients with human
immunodeficiency virus (HIV) infection. Granulocytope-
nia has been reported to occur in 60–80% of HIV-
infected individuals. Alcohol abuse is a co-factor for
progression of acquired immunodeficiency syndrome
(AIDS). Alcohol injures the bone marrow and impairs
myelopoiesis. This study investigated the effect of
chronic alcohol consumption on the development of
myelosuppression in rhesus macaques infected with
simian immunodeficiency virus (SIV). SIV infection
caused a significant decrease in blood granulocyte counts,
w h i c ho c c u r r e di na s s o c i a t i o nw i t ht h el o s so fC D 4 +
cells. Alcohol consumption caused a decrease in marrow
hematopoietic stem cells. Alcohol exaggerated the SIV-
induced reduction of the granulocyte storage pool in the
bone marrow and impaired the granulopoietic response to
secondary bacterial infection in the lung. Alcohol
consumption significantly increased CpG methylation in
the promoter region of the C/EBPα (a master transcript
factor for myeloid lineage development) gene and sup-
pressed C/EBPα gene expression by bone marrow cells.
In addition, alcohol disturbed the hematopoietic microen-
vironment by promoting a myeloid differentiation block.
These data show that alcohol exaggerates the develop-
ment of myelosuppression during SIV infection. Com-
pounding the direct lymphotoxicity of SIV, a defective
granulocytic response is an additional risk factor for
acceleration of AIDS progression. Supported by NIH
grants AA09803, AA019676, and AA07577.
Neurogenesis, Brain Inflammation and its Links to the
Pathogenesis andPotential Therapy of Neurodegenerative
Disorders. J Zheng
1,2,CT i a n
1,YW a n g
1, L Sun
1,KM a
1;
1Laboratory of Neuroimmunology and Regenerative Thera-
py, Department of Pharmacology and Experimental Neuro-
science, University of Nebraska Medical Center, Omaha, NE
68198–5930, USA,
2Department of Pathology and Microbi-
ology, University of Nebraska Medical Center, Omaha, NE
68198–5930, USA.
Neurogenesis is a highly regulated process responsible for the
generation of new neurons, astrocytes and oligodendrocytes
fromneuralstemcells. Itiswidelyacceptedthatneurogenesis
persists into adulthood and may play a crucial role in
complicated behaviors such as learning and memory. Accu-
mulating evidence suggests that impaired neurogenesis also
contributestothepathogenesisofseveralbraindisorders. This
has been investigated with an emphasis on how brain
inflammation may influence the pathogenesis of neurodegen-
erative diseases such as HIV-1 associated neurocognitive
disorders. Direct reprogramming of a variety of somatic cells
with the transcription factors Oct4 (also called Pou5f1), and
Sox2 with either Klf4 and Myc or Lin28 and Nanog generates
induced pluripotent stem cells (iPSCs) with marker similarity
to embryonic stem cells. However, the difference between
iPSCs derived from different origins is unclear. In this study,
we hypothesize that reprogrammed cells retain a “memory” of
their origin and possess an ehnahced potential for related
tissue differentiation. We reprogrammed primary mouse
astrocytes via ectopic retroviral expression (OCT3/4, Sox2,
Klf4, Myc) and found that the resulting mAsiPSCs expressed
stem cell markers and formed teratomas in SCID mice with
derivatives of all three germ layers in a manner similar to
mouse embryonic stem cells. To test our hypothesis, we
comparedEBsformationandneuronaldifferentiationbetween
iPSCs generated from mouse embryonic fibroblasts (MEF-
siPSCs) and our mAsiPSCs. mAsiPSCs grew slower and
possessed more potential for neuronal differentiation com-
pared to MEFsiPSCs. Our results suggest that mAsiPSCs
retain a “memory” of the central nervous system, conferring
added potential for neuronal differentiation. iPSC present
exciting avenues to study human disease as well as an
approach for cell therapy.
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Beneficial Effect of the Cannabinoid Receptor-2-
Selective Agonist in Spinal Cord Injury via Immune
Modulation. S Adhikary, H Li, M Skarica, RF Tuma, D
Ganea; Department of Physiology, Temple University
School of Medicine, Philadelphia, PA 19140, USA.
Previous studies from our laboratory showed that treatment
with the CB2R specific agonist O-1966 improved recovery
of motor and bladder function in mouse models of acute
spinal cord injury (SCI). In SCI, increased infiltration and
activation of inflammatory immune cells that follow the
initial injury exacerbate neuronal damage. In this study, a
murine thoracic SCI contusion model was used and spinal
cords were analyzed for expression of various cytokines and
chemokines as well as infiltration of peripheral immune
cells at various time-points. There were no differences in the
expression of inflammatory molecules or in the number of
infiltrating peripheral immune cells between controls and
mice treated with O-1966 at an early time-point. However,
at later time-points, we observed significant differences in
the expression of CXCL family chemokine members
CXCL9, 10, and 11, the CC family chemokine receptor
members CCR1, 2, 3, the cytokine IL-23 and its receptor,
and the Toll like receptors TLR1, 4, 6, and 7 in spinal cords
from mice treated with O-1966. This decrease correlated
with the reduction in number of infiltrating myeloid cells.
We also observed reduced microglia activation as deter-
mined by immunohistochemical staining for Iba1. Based on
these results, we postulate that the beneficial effect of CB2R
agonists in acute SCI is mediated, at least partially, through
the inhibition of CNS resident microglia/astrocyte activa-
tion, leading to reduced levels of chemokines and pro-
inflammatory cytokines, and reduced infiltration of periph-
eral immune cells. Supported by NIH/NIAID R01AI05230,
NIDA T32 DA07237.
Differential Expression of Cannabinoid Genes in
Alcoholics. M Agudelo, C Spadola, A Yndart, N Gandhi,
Z Saiyed, VB Pichili, T Samikkannu, MP Nair; Department
of Immunology, College of Medicine, Florida International
University, Miami, FL 33199, USA.
Cannabinoid genes are known to be involved in alcohol-use
disorders; and CB1 antagonists have been shown to reduce
alcohol drinking. Previous studies have focused on canna-
binoids and alcohol-related effects in the brain; however,
the role cannabinoid genes play on alcohol effects in the
immune system is not elucidated yet. Psychoactive sub-
stances such as alcohol and cannabinoids can affect immune
responses and have detrimental effects on immune cells
such as dendritic cells (DCs). We hypothesize that alcohol
can exert its effects on DCs by modulating changes in
cannabinoid genes. Therefore, we studied the expression of
cannabinoid receptors 1, 2 (CNR1 and CNR2), and the
novel cannabinoid G protein-coupled receptor 55 (GPR55)
in human monocyte-derived dendritic cells (MDDCs) from
non-alcoholic and alcoholic blood donors. CNR1, CNR2,
and GPR55 gene expression was measured by quantitative
real-time PCR. Our results show a significant upregulation
of CNR2 and GPR55; and a downregulation of CNR1 in
MDDCs from alcoholics compared to MDDCs from non-
alcoholics. These findings were further confirmed in vitro
using MDDCs treated with alcohol. Results of these
analyses provide insights into alcohol mechanisms of DC
regulation and suggest that alcohol is inducing CNR2 and
GPR55 genes in DCs. Supported by the National Institute
on Drug Abuse (NIDA).
HIV-1 Induced Amyloid Beta Accumulation in Brain
Endothelial Cells: Signaling Mechanisms Involved. IE
Andras
1, SY Eum
1, Y Zhong
1, W Huang
1, B Hennig
2,M
Toborek
1;
1Neurosurgery, University of Kentucky, Lexing-
ton, KY 40536, USA,
2College of Agriculture, University
of Kentucky, Lexington, KY 40536, USA.
Amyloid beta deposition is increased in HIV-1 infected
brains. Our previous study have shown that HIV-1 exposure
increased amyloid beta accumulation at the blood–brain
barrier (BBB) level in a model of human brain microvas-
cular endothelial cells (HBMEC) partly by increasing the
levels of RAGE, known to regulate amyloid beta transport
across the BBB. In this study, we proposed to investigate
further the mechanisms involved in amyloid beta accumu-
lation in HBMEC. Silencing of caveolin-1 diminished the
RAGE level increase and amyloid beta uptake in HIV-1
exposed cells as compared to control. Amyloid beta
accumulation was also lipid raft dependent as beta-methyl-
cyclodextrin pretreatment almost completely abolished it in
control and HIV-1 treated cells. The Ras inhibitor farne-
sylthiosalicylic acid (FTS) and the p38 MAPK inhibitor
SB203580 blocked the amyloid beta accumulation evoked
by HIV-1. In addition, HIV-1 exposure increased the levels
of early endosomal antigen-1 (EEA1) which partly colo-
calized with amyloid beta. EEA1 levels were reduced by
FTS in cells exposed to HIV-1 and amyloid beta. Our data
show that amyloid beta accumulation in HBMEC is lipid
raft dependent, involving the caveolae-associated Ras-
MAPK signaling pathway. In addition, this pathway may
alter the early endosomes which are likely to be involved in
the increased amyloid beta uptake in HBMEC in the
presence of HIV-1. Supported by MH63022, MH072567,
and NS39254.
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Dementia (HAD) using Targeted Nanoparticles for
TIMP-1 Delivery into CNS. F Ashutosh
1, K Borgmann
1,
L Tang
1, V Labhasetwar
2, A Ghorpade
1;
1Department of
Cell Biology and Anatomy, University of North Texas
Health Science Center, Fort Worth, TX 76107, USA,
2Department of Biomedical Engineering, Cleveland Clinic
Lerner College of Medicine, Cleveland, OH 44195, USA.
Astrocyte production of tissue inhibitor of metalloproteinases-
1 (TIMP-1) is important in inflammatory diseases such as
HIV-1-associated dementia. Previously, we have shown
acute activation of astrocytes increases TIMP-1 as a
neuroprotective response. However, in chronic activation,
TIMP-1-mediated responses fail due to down regulation
of TIMP-1. In this study, we explored the feasibility of
T I M P - 1g e n et h e r a p yi nt h eC N S .Ad u a la p p r o a c hu s i n g
a glial fibrillary acidic protein (GFAP)-promoter driven
TIMP-1 cDNA construct and CNS targeting nanoparticles
(NP) promotes astrocyte-specific TIMP-1 expression.
Two plasmid vectors, pGFAP-TIMP-1 and pGFAP-LUC
(luciferase) were constructed for TIMP-1 over-expression
and quantification/distribution of promoter activity, re-
spectively. Constructs were transfected into cultured
human astrocytes and various non-glial cells for evalua-
tion of GFAP-driven expression. Transfected cells were
also stimulated with HIV-relevant inflammatory stimuli.
Significant increases in TIMP-1 and LUC expression
w e r ef o u n di na s t r o c y t e s .T h e NP encapsulated plasmids
were evaluated for delivery, protein expression and
cytotoxicity in vitro. The neuroprotective effects of GFAP
promoter driven TIMP-1 expression in astrocytes were
assayed. Therefore, present studies demonstrate NP-
encapsulated pGFAP-TIMP-1 can be delivered into
astrocytes, is responsive to HIV-relevant inflammatory
stimuli and increases TIMP-1 levels. These studies
provide proof-of-concept and establish a foundation for
future gene therapeutic approaches. Supported by NIH/
2R01NS048837-06.
HIV-1 and Drugs of Abuse alter Neurotrophin Levels in
Human Lymphocytes. VAvdoshina
1, A Garzino-Demo
2,A
Bachis
1, Mc Monaco
3, C Liu
4, Ma Young
4, I Mocchetti
1;
1Department of Neuroscience, Georgetown University
Medical Center, Washington, DC 20057, USA,
2Institute
of Human Virology, University of Maryland, Baltimore,
MD 21201, USA,
3Laboratory of Molecular Medicine and
Neuroscience, NINDS/NIH, Bethesda, MD 20824, USA,
4Department of Medicine, Georgetown University Medical
Center, Washington, DC 20057, USA.
The neurotrophins (NT) brain-derived neurotrophic factor
(BDNF), nerve growth factor (NGF) and NT-3 are produced
by immune organs and immunocompetent cells, including T
cells and macrophages, and might play a role in various
functions of the immune system including lymphocyte
proliferation/survival. Little is known about the effect of
HIV-1 on the levels of NT in the blood. In this study, we
examined whether HIV-1 reduces NT levels in human blood
cells by comparing serum levels of BDNF, NGF, and NT-3
in HIV-infected and HIV-uninfected subjects using the
Women’s Interagency HIV Study cohort of the Washington,
DC area. We found that serum concentration of BDNF and
NGF but not NT-3 are decreased in HIV-positive subjects.
At least a third of HIV-positive subjects used for our
investigation were drug users. To examine whether drug
abuse and HIV infection interact to affect NTs, we analyzed
the levels of NT in HIV-positive and negative subjects as a
function of drug abuse. In HIV-positive drug abusers the
levels of BDNF and NGF were higher than those in HIV
positive non drug users, suggesting that drugs of abuse
might restore the levels of NT. To prove the hypothesis that
HIV lowers NT levels, we exposed human T cells in culture
to both strains of HIV (R5 and X4). Both strains reduced
BDNF mRNA and protein expression within 24 h. These
data suggest that reduced level of BDNF may increase the
risk of developing immunological and brain abnormalities
among HIV-positive individuals. Supported by DA026174,
NS066842, UO1-AI-35004, UO1-AI-31834, UO1-AI-
34994, UO1-AI-34989, UO1-AI-34993, UO1-AI42590,
UO1-HD32632, and UL1 RR024131.
Manufacture and Pre-Clinical Testing of Nanoformulated
Antiretroviral Therapeutics. S Balkundi, A Nowacek, J
McMillan, U Roy, A Martinez-Skinner, R Mosley, G
Kanmogne, A Kabanov, T Bronich, H Gendelman; Phar-
macology and Experimental Neuroscience, University of
Nebraska Medical Center, Omaha, NE 68128, USA.
Although antiretroviral therapy has resulted in increased
longevity and reduced morbidities for human immunodefi-
ciency virus-1 infection, limitations in compliance, pharma-
cokinetics, and drug toxicities remain at issue. We have
synthesized nanoformulated antiretroviral therapy (nano-
ART) with varied physical and chemical properties to
improve pharmacodynamics and bioavailability using wet
milling, homogenization, ultrasonication and micelles as
nanocontainers. Nanoformulations were characterized by
DLS. Uptake, retention, and release of nanoART into and
from human monocyte-derived macrophages (MDM) were
determined. Antiretroviral activities of the nanoART in
MDM were determined by RT and HIV-1p24 antigen
assays. Wet milled and homogenized nanoART formula-
tions of indinavir, ritonavir, atazanavir, and efavirenz ranged
in size from 252–418 nm with PDI of 0.152- 0.29 and zeta
potentials from −15.3 to −40.6 mv. The micellar formula-
S24 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59tions were <30 nm with PDI values of 0.019 to 0.08.
NanoART uptake by MDM was measured over 8 h and
cell retention and release were measured over 15 days.
Drug levels in nanoART-ladened MDM were detectable
by HPLC for crystalline and PLGA formulations up to
15 days but were limited in micelles. Efavirenz crystal-
line nanoparticles most effectively inhibited HIV-1 repli-
cation as demonstrated by reduction of RT activity and
p24 expression. The repackaging of clinically available
antiretroviral medications into nanoparticles for treatment
of HIV-1 disease may improve compliance notably in the
drug abusing population and positively affect disease
outcomes.
Morphine Modulation of IL17 Expression and Signaling
in Alveolar Epithelial Cells. S Banerjee, S Roy; Surgery,
University of Minnesota, Minneapolis, MN 55455, USA.
Chronic morphine has been shown to increase the patho-
genic load in lung infections, while its role in modulating
the barrier integrity has largely remained unexplored. The
protective role of IL-17A in this context has been well
documented in the past two decades. The existence of IL17
in the realm of both innate and adaptive immunity (γδ T
Cells and αβ T Cells, respectively) presents unique
perspective in its regulation and signaling. In the innate
realm, there are several reports of stimulated or constitutive
expression of IL-17A by various cell types of hematopoi-
etic/myeloid origin (γδ T cells, macrophages, neutrophils),
as well as epithelial cells (Paneth cells in the intestinal
mucosa). Furthermore, IL-17-mediated immune responses,
namely IL-6, IL-8, GM-CSF, defensins, S110A and lip-
ocalins, get induced within an hour of mucosal barrier
compromise or activation of the Pattern Recognition
Receptors. Our study specifically focuses on the barrier
function of the human alveolar epithelium, whereby, we
show that these cells are capable of inducing the “first
response” to extracellular pathogens, even in the absence of
resident immune cells, involving IL-17 and its signaling,
possibly in an autocrine fashion. We also show that these
cells possess the functional apparatus to induce IL-17
production in response to external stimuli, including
constitutive expression of the key transcription factor
RORγt. And finally, we elucidate the effects of chronic
Morphine in negatively modulating these responses. Sup-
ported by NIH grants: RO1 DA 12104; RO1 DA 022935;
KO2 DA 015349, and P50 DA11806.
The Effect of HIV-1 Tat on Intracellular Production and
Distribution of Abeta 1–42 in Hippocampal Neurons. SJ
Bertrand, MV Aksenova, MY Aksenov, CF Mactutus, RM
Booze; Department of Psychology, University of South
Carolina, Columbia, SC 29201, USA.
Epidemiological studies indicate a growing incidence of
amyloid beta peptide mediated brain pathology in aging
HIV patients. Effects of viral proteins (particularly Tat) on
Abeta biogenesis may be the key pathway that links chronic
HIV-1 infection to the onset of cognitive deficits in aging
cohort of HIV-positive patients. Our recent findings
demonstrate that HIV-1 Tat, clade B, promotes premature
release of Abeta1-42 and the accumulation of amyloidal
aggregates in long-term rat hippocampal cell cultures. Our
current study analyzes the level and distribution of Abeta1-
42 immunoreactivity in mature (21 DIV) hippocampal
neurons that incorporate Tat1-86B following the acute
exposure to a toxic (50 nM) dose of Tat1-86B. Co-
labeling of control and Tat treated rat hippocampal cultures
with anti-Tat and anti-Abeta1-42 antibodies has shown
increased intensity of the Abeta1-42 reactivity in Tat-
containing cells. Results of Abeta1-42 immunolabeling
revealed the presence of Abeta-positive conglomerates
associated with cell bodies and processes in 21 DIV Tat-
treated cell cultures. Hippocampal cells co-labeled with
anti-Abeta1-42/anti-Tat display increased Abeta1-42 reac-
tivity in dendrites as a result of Tat exposure. Results of
Congo Red/F-actin staining show beta-amyloid specific
labeling of the processes proximal and distant to cell bodies
in Tat treated cultures. Our cytomorphological observations
support the hypothesis that neurotoxic forms of misfolded
Abeta can mediate Tat-induced synaptodendritic injury.
Supported by University of South Carolina Research
Foundation Grant and NIH Grant # DA013137.
HIV-1 Tat Mediated Induction of Platelet-Derived
Growth Factor in Astrocytes: Role of Early Growth
Response Gene 1. C Bethel-Brown
1,HY a o
2, S Callen
2,
YH Lee
3, PK Dash
2, A Kumar
4, S Buch
2;
1Molecular and
Integrative Physiology, University of Kansas Medical
Center, Kansas City, KS 66160, USA,
2Pharmacology and
Experimental Neuroscience, University of Nebraska Medical
Center, Omaha, NE 68137, USA,
3Institute of Biomedical
Science and Technology, Konkuk University, Seoul, South
Korea 143–701,
4Pharmacology, University of Missouri
Kansas City, Kansas City, MO 64108, USA.
HIV-associated neurological disorders (HAND) are esti-
mated to affect almost 60% of HIV infected individuals.
HIV-encephalitis (HIVE), the pathological correlate of the
most severe form of HAND is often characterized by
glial activation, cytokine/chemokine dysregulation, and
neuronal damage and loss. However, the severity of
HIVE correlates better with glial activation rather than
viral load. Using the macaque model, it has been
demonstrated that simian immunodeficiency virus en-
cephalitis correlates with increased expression of the
mitogen platelet-derived growth factor-B (PDGF-B) chain
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S25in the brain. The present study was aimed at exploring
the role of PDGF-B chain in HIV-associated activation
and proliferation of astrocytes. Specifically, the data
herein demonstrate that exposure of rat and human
astrocytes to the HIV-1 protein, Tat resulted in the
induction of PDGF at both the mRNA and protein levels.
Furthermore, PDGF-BB induction was regulated by
activation of ERK1/2 and JNK signaling pathways and the
downstream transcription factor, early growth response 1
(Egr-1). Chromatin immunoprecipitation assays demonstrated
binding of Egr-1 to the PDGF-B promoter. Exposure of
astrocytes to PDGF-BB, in turn, led to both increased
proliferation and release of pro-inflammatory cytokines
MCP-1 and IL-1β. Since astrogliosis is linked to disease
severity, understanding its regulation by PDGF-BB could aid
in the development of therapeutic intervention strategies for
HAND. Supported by MH-068212, DA020392, DA023397,
DA024442, and DA0277729.
Norepinephrine Enhances the Vaginal Epithelial
Immune Response to a Staphylococcal Superantigen. A.
Brosnahan, B. Jones, L. Vulchanova, D. Brown; Depart-
ment of Veterinary and Biomedical Sciences, College of
Veterinary Medicine, University of Minnesota, St. Paul, MN
55108, USA.
Staphylococcus aureus is a Gram-positive pathogen that
resides in the reproductive tract of approximately 20% of all
women. It produces superantigen exotoxins which mediate
toxic shock syndrome (TSS) by cross-linking antigen
presenting cells and T cells to induce massive cytokine
release. TSS toxin-1 (TSST-1) is the superantigen respon-
sible for the majority of menstrual TSS cases. This toxin has
pro-inflammatory effects in vaginal epithelial cells, and it is
thought to induce migration of adaptive immune cells to the
vaginal submucosa. We have previously reported [J. Neuro-
immune Pharmacol., 5 (suppl. 1):S41, 2010] that cells
immunoreactive for the norepinephrine (NE) transporter, a
pharmacological target of cocaine, are present in human
cervicovaginal mucosa and that NE delays wound healing
in human vaginal epithelial cell (HVEC) monolayers. In this
study, we tested the hypothesis that NE alters immune
responses to TSST-1 in HVECs. Although it had no effect
alone, 10-μm NE enhanced IL-8 release in response to
TSST-1 (100 μg/ml). Propranolol and the β2-adrenergic
receptor antagonist ICI 118551 inhibited this effect.
Moreover, only the combination of TSST-1 and NE could
induce a significant increase in intracellular cAMP levels,
and this effect was also sensitive to ICI 118551. We are
presently investigating the HVEC signaling pathways that
mediate these effects. Psychostimulant drugs of abuse that
act to increase NE levels may alter the ability of the vaginal
mucosa to respond to pathogens and their associated
exotoxins. Supported by NIDA DA-10200 and NIDA
T32DA007097.
The Effects of Buprenorphine and CCL2 On Monocytes
and the Blood–Brain Barrier. L Carvallo
1,LL o p e z
1,F Y
Che
1,JL i m
1,LM i l l e r
1,LW e i s s
1, RH Angeletti
2,J W
Berman
1;
1Department of Pathology, Albert Einstein College
of Medicine, Bronx, NY 10461, USA,
2Department of
Developmental and Molecular Biology, Albert Einstein Col-
lege of Medicine, Bronx, NY 10461, USA,
3Microbiology and
Immunology, Albert Einstein College of Medicine, Bronx, NY
10461, USA.
HIV-1 enters the CNS, resulting in neurocognitive impair-
ment in many infected people. Many HIV-infected opiate
abusers have increased inflammation that contributes to this
impairment. Buprenorphine (bup) is used to treat opioid
addiction. The effects of bup on transmigration on HIV-
infected monocytes (MON) across the blood–brain barrier
(BBB) are unknown. We hypothesize that bup will alter
tight junction proteins (TJP) on MON and on BBB to
change the ability of HIV infected and uninfected MON to
transmigrate into the CNS in response to CCL2. We showed
that increased numbers of HIV infected MON cross the
BBB in response to CCL2. We are examining the effects of
bup and CCL2 on TJP of human MON and brain
microvascular endothelial cells (BMVEC) necessary for
MON to cross the BBB. We showed that CCL2 increased
JAM-A and PECAM phosphorylation whereas CCL2 + bup
exhibited less increase in phosphorylation on MON. These
phosphorylations are associated with MON migration.
Thus, bup could decrease neuroinflammation when CCL2
is increased in CNS HIV infection. Using proteomics, we
quantified membrane peptides of MON and showed
increased phosphorylation of leukosialin with bup +
CCL2. Using BMVEC, CCL2 decreased JAM-A phosphor-
ylation whereas CCL2 + bup increased it. We found that
CCL2 decreased total JAM-A and Claudin5 whereas CCL2 +
bup showed baseline levels. As TJP are important in barrier
integrity,bupcouldalterthisintegritywhenCCL2isincreased
in CNS HIV infection. Our data demonstrate some important
mechanisms by which bup may impact NeuroAIDS. Sup-
ported by NIDA, Grant # 5P20DA026149-02 Einstein
Proteomics Center for Study of the Neurological Consequen-
ces of HIVand Substance Abuse.
Protein Expression and Gene Regulation of CB2 in
Human Immune Cells. J Castaneda
1, SM Kiertscher
2,J D
Roth
2, MD Roth
1,2, A Harui
2;
1Interdepartmental Program
in Molecular Toxicology, University of California at Los
Angeles, Los Angeles, CA 90026, USA,
2Pulmonary and
Critical Care Medicine, David Geffen School of Medicine at
UCLA, Los Angeles, CA 90095–1690, USA.
S26 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59Cannabinoids, which represent the primary bioactive con-
stituents of marijuana, are known to activate cannabinoid
receptors CB1 and CB2 and interact with the endocanna-
binoid system. While these receptors are expressed in most
organ systems, their distribution and function within the
human immune system is poorly understood. In order to
gain greater insight into the role of the CB2 receptor in
human immune function, we are characterizing its protein
expression by peripheral blood mononuclear cells (PBMC)
with flow cytometry, and RNA expression by quantitative
real-time RT-PCR. Using a monoclonal anti-CB2 receptor
antibody, reproducible expression of CB2 was routinely
detected on the cell surface of fresh circulating human B
cells (CD19+) from both non-smoking and marijuana-
smoking subjects, but not on CD4+ T cells, CD8+ T cells,
CD56+ NK cells, or CD14+ monocytes. In contrast, when
cells were fixed and permeabilized to assess intracellular
staining, CB2 expression was observed in all cell subsets.
With 3–5 days of in-vitro culture, extracellular expression
of the CB2 receptor on B cells was down-regulated, but
intracellular expression was maintained on all cell
subsets. Quantitative real-time RT-PCR detected CB2
gene expression at baseline in whole PBMC and in
purified B cells, T cells, and monocytes, which decreased
with time in culture. This approach will allow us to
evaluate the role of intra- and extracellular CB2 receptor
expression and THC exposure in vitro and in marijuana
smokers. Supported by NIH/NIDA Grants #R21-DA021813
and R01-DA03018.
Autophagy is Involved in the Neurovascular Toxicity of
Nanoalumina. L Chen
1, B Hennig
2, M Toborek
1;
1Neuro-
surgery, University of Kentucky, Lexington, KY 40503,
USA,
2College of Agriculture, University of Kentucky,
Lexington, KY 40503, USA.
Engineered nanomaterials (ENMs) have been widely used
for various applications; however, their potential toxic
effects are not fully understood. The current study focused
on blood–brain barrier (BBB) disruption and neurovascular
damage induced by treatment with one of the most
abundantly manufactured ENMs, nanoalumina. Exposure
of cultured human cerebral endothelial cells to nanoalumina
(size 8–12 nm) elevated cellular oxidative stress, induced
mitochondrial potential collapse, decreased tight junction
expression, and cellular viability. Nanoalumina also induced
activation of lysosomes and formation of autophagic
vacuoles associated with elevated levels of autophagic
marker proteins, p62 and LC-3. Delivery of nanoalumina
into mouse cerebral circulation using a carotid surgical
method altered expression of autophagy-related genes as
detected by the brain DNA microarray. In addition, in situ
immunostaining of brain slices detected time-dependent
increases in LC-3 levels in different cell types of the
neurovascular unit. Systemic treatment with nanoalumina
elevated also autophagic activity in cerebral vessels,
decreased tight junction expression, and elevated BBB
permeability. Finally, exposure to nanoalumina increased
brain infarct volume in mice subjected to a focal ischemic
stroke model. Collectively, our study reveals that autophagy
constitutes one of the critical mechanisms involved in
nanoalumina-induced neurovascular toxicity in the central
nervous system. Supported by American Heart Association
Postdoctoral Scholarship, NIH ES 07380, DA027569,
MH63022, MH072567, and NS39254.
Methamphetamine Reduces Influenza AVirus Replication
in Human Lung Epithelia Cells. YH Chen, KL Wu, CH
Chen; Division of Mental Health and Substance Abuse,
National Health Research Institutes, Miaoli County, Taiwan,
35053, ROC.
Methamphetamine is a highly addictive psychostimulant
that is among the most widely abused illicit drugs, with an
estimated 15–16 million users in the world. Several lines of
evidence suggest that chronic methamphetamine abuse is
the major factor for the increased risks of infections with
human immunodeficiency virus and possibly other patho-
gens, due to the immunosuppressive property of this drug.
Influenza A virus infections frequently cause epidemics and
pandemics of respiratory disease. However, there is little
known about whether methamphetamine has the ability to
enhance influenza A virus replication, increasing suscepti-
bility to infections in methamphetamine abusers. Herein, we
investigated the effects of methamphetamine on influenza A
virus replication in the human lung epithelia cell line A549.
We report the first evidence that methamphetamine reduces
expression and delays localization of viral proteins, resulting
in a reduced viral propagation. The underlying mechanism(s)
responsible for the action of methamphetamine on attenuating
viral replication was explored and discussed.
Bone-Derived Mesenchymal Stem Cells (B-MSCs)
Provided Protection Against Morphine-Induced Splenic
and Thymic Cell Depletion. K Cheng
1, D Kumar
1,D
Salhan
1, S Rehman
1, A Malhotra
1, S Gupta
2, P Singhal
1;
1Feinstein Institute for Medical Research, Long Island
Jewish Medical Center, New Hyde Park, NY 11040, USA,
2Liver Center, Albert Einstein College of Medicine, Bronx,
NY 10461, USA.
Morphine has been reported to promote splenic and thymic
atrophy. Usefulness of B-MSCs transplantation in immune
regulation and degenerative diseases is increasingly recog-
nized. To better understand the effects of B-MSCs on
morphine-induced immune suppression, we studied B-
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S27MSCs transplantation in morphine-treated mice. Donor B-
MSCs were isolated from compact bone of male FVB/N
mice. Cellular phenotype was verified by FACS for CD44,
CD90, CD105, CD11b, CD34, CD86 and generation of
adipocytes or chondrocytes. B-MSCs were labeled with
111In-oxine. The biodistribution of B-MSCs were deter-
mined by gamma counting and verified by SRY PCR. B-
MSCs localized mostly in lungs (76%), followed by liver
(13%) and spleen (11%). B-MSCs were transplanted i.v.
24 h after morphine pellet (75 mg) implantation. Morphine
pellet reduced splenic weight and decrease cellularity
significantly at 1 day (24%), but normalized by day 7.
Thymus remained significantly smaller (30%, 35%, and
5 0 %r e d u c t i o na t1 ,3 ,a n d7d a y s, respectively). B-MSCs
transplantation partially protected morphine-induced thy-
mic weight reduction. Moreover, spleen size returned to
normal at 1 day accompanied with restoring of cell
content. MTT assay demonstrated that the proliferation of
B-MSCs was not inhibited by morphine at 1 and 3 days.
In conclusion, B-MSCs were able to localize to specific
o r g a n sv i ai . v .d e l i v e r y .T h ei m m u n o s u p p r e s s i v ee f f e c t
induced by morphine could be partially inhibited by
transplantation of B-MSCs. Further studies of B-MSCs
on immune regulation will be helpful for therapeutic
strategies in opiate addicts.
Lipopolysaccharide Potentiates PCB-Induced Disruption of
the Integrity of Brain Endothelial Cells. JJ Choi
1, YJ Choi
1,
BZ h a n g
1,HP u
1,LC h e n
1,S YE u m
1,BH e n n i g
2, M Toborek
1;
1Department of Neurosurgery, University of Kentucky, Lex-
ington, KY 40536, USA
2College of Agriculture, University of
Kentucky, Lexington, KY 40536, USA.
Polychlorinated biphenyls (PCBs) are worldwide spread
environmental toxicants that are associated with numerous
adverse health effects in humans. We reported that oral
administration of individual PCB congeners (PCB153,
PCB118, or PCB126; 150 μM/kg) to C57Bl/6 mice can
disrupt the barrier function of intestinal epithelium. Thiseffect
was associated with translocation of lipopolysaccharide (LPS)
from the intestine into the blood, resulting in a significant
increase in plasma LPS levels 24 h post PCB treatment. In the
present study, we evaluated whether LPS can contribute to
cerebrovascular toxicity of PCBs using cultured brain endo-
thelial cells (hCMEC/D3 cell line). A combined treatment
with PCB118 (2 μM) and LPS (2 ng/ml) for 24 h reduced to a
higher extent the levels of tight junction proteins occludin and
ZO-2 as compared to exposure to PCB118 or LPS alone.
These effects were associated with increased permeability to
FITC-labeled dextran (20 kDa). Compared to the effects of
PCB118 or LPS alone, a combined treatment also resultedin a
higher activation of transcriptional factor IRF-3, suggesting
stimulation of toll-like receptor pathways. These data support
the hypothesis that LPS may be a contributing factor in PCB-
induced dysfunction of the brain endothelium. Supported by
ES 07380, DA027569, MH63022, MH072567, and
NS39254.
Astrocytic Nef Expression in Sprague–Dawley Rats
Impairs Spatial Memory. GC h o m p r e
1,EC r u z
2,L
Maldonado
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2, RJ Noel
1;
1Biochemistry Depart-
ment, Ponce School of Medicine, Ponce, PR 00731, Puerto
Rico,
2Pharmacology and Physiology Department, Ponce
School of Medicine, Ponce, PR 00731, Puerto Rico.
Even with antiretroviral therapy, people with HIV-
associated neurocognitive disorders (HAND) suffer from
memory impairment such as remembering to take
medication. HIV infects several cell types in the brain
including microglia and astrocytes. Astrocytes are non-
productively infected by HIV since they only support
production of viral proteins such as Nef. Nef is found to
be highly expressed in astrocytes in post-mortem brain
tissues from patients with HIV-associated dementia and
rhesus macaques infected with SIV. We tested if unilat-
eral infusion of astrocytes expressing Nef into the
hippocampus produces memory loss in Sprague–Dawley
rats. To test the hypothesis, we delivered a Nef gene into
astrocytes and infused the cells into the right hippocam-
pus of rats. After recovery, novel location and object
recognition were performed. Rats implanted with astro-
cytes expressing Nef showed impaired novel location
recognition in comparison with controls. Nef-exposed rats
showed a reduced number of neurons in the CA3 field.
These results suggest that even unilateral delivery of Nef
is sufficient to impair spatial memory and may play a
role in neuronal loss producing HAND. Supported by
RR03050 and R25GM082406.
Morphine Withdrawal Stress Synergized with
Corticosterone to Inhibit IL-12p40 Expression by
Hyperactivating ERK1/2. S Das
1, S Roy
1,2;
1Department
of Surgery, University of Minnesota, Minneapolis, MN
55455, USA,
2Department of Pharmacology, University of
Minnesota, Minneapolis, MN 55455, USA.
Very few studies have examined the effects of morphine-
withdrawal (MW) on immune functioning, and of these
even fewer describe the mechanisms underlying
withdrawal-induced immunosuppression. Although stress
has been well documented to be immunosuppressive, the
role of corticosterones in MW-induced immunomodulation
has not been investigated. This study explores the role of
corticosterone in MW-induced suppression of IL-12p40, a
major soluble mediator playing a pivotal role in immuno-
protection. Using WT and Mu opioid receptor knock-out
S28 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59mice and a murine alveolar macrophage cell line, we show
that MW significantly reduced LPS- induced IL-12p40
promoter activity, mRNA levels and protein expression both
in vivo and in vitro. This suppression is due to decreased
consensus binding of transcription factors NF-κB, AP-1 and
C/EBP to IL-12p40 protein. MW effects were abolished in
the MORKO mice. While corticosterones alone do not
significantly modulate these transcription factors, in combi-
nation with MW, a synergistic reduction was observed. The
synergistic effects were non-genomic since nuclear translo-
cation of glucocorticoid receptor was not significantly
different between MW and corticosterone treatment. In
contrast, in MW samples in the presence of LPS and
corticosterone, a significant hyperactivation of ERK1/2
MAPK was observed while other MAPKs are inhibited.
These data clearly indicate a synergistic role for cortico-
sterones in morphine-withdrawal induced inhibition of IL-
12p40 production through a mechanism that involves
ERK1/2 hyperactivation. Supported by R01DA12104,
R01DA022935, K02DA015349, and P50DA11806.
Neuronal MicroRNA-142 is Up-Regulated in HIVE/
SIVE and Inhibits the Expression of Key Proteins. A
Datta Chaudhuri, SV Yelamanchili, HS Fox; Pharmacology
and Experimental Neuroscience, University of Nebraska
Medical Center, Omaha, NE 68198 USA.
Human immunodeficiency virus-1 (HIV-1)-associated
neurocognitive disorder (HAND) and the pathological
entity of HIV encephalitis (HIVE) are significant compli-
cations of HIV infection. Our understanding of upstream
factors driving alterations in gene and protein expression
in HAND is nascent. Recently, microRNAs (miRs), small
non-coding RNAs fine-tuning gene expression, have been
implicated in many neurodegenerative diseases. We
carried-out miR profiling of the brains of rhesus
macaques suffering from simian immunodeficiency virus
encephalitis (SIVE, the rhesus equivalent of HIVE) and
of HIVE patients. In addition to miR-21 (Yelemanchili,
Datta Chaudhuri et al., 2010), we found that miR-142-3p
and -5p are up-regulated in the caudate nucleus and
hippocampus in infected monkeys and humans. We
hypothesize that miR-142, by inhibiting expression of
key neuronal proteins, contributes to neuronal dysfunc-
tion in HIVE. Combined fluorescent in situ hybridization
and immunofluorescence labeling demonstrated that miR-142
co-localizes with neuronal marker MAP2. To determine miR-
142 targets, gene expression was compared in neuroblastoma
celllines transduced tostably express miR-142 ora scrambled
miR. Microarray analysis indicated significant down-
regulation of 61 mRNAs in miR-142 expressing cells.
Quantitative proteomics using SILAC revealed significant
down-regulation of 28 proteins. DAVID pathway analysis
showed enrichment of key functional molecules. Validation of
miR-142 targets in vitro and in HIVE/SIVE brain is underway
to reveal mechanism of neuronal dysfunction in this disease.
Supported by NIMH, MH062261.
Cocaine Increases Platelet-Derived Growth Factor
Expression in Human Brain Microvessel Endothelial
Cells Through Notch-1 Signaling. MD Duan, HY Yao,
SB Buch; Department of Pharmacology and Experimental
Neuroscience, University of Nebraska Medical Center,
Omaha, NE 68198, USA.
Neuroinflammation associated with advanced HIV-1 infec-
tion is often exacerbated in cocaine-abusing, HIV-infected
individuals. The underlying mechanisms could, in part, be
attributed to the increased impairment of blood brain barrier
integrity in the presence of cocaine. Platelet-derived growth
factor-BB (PDGF-BB) has been implicated in a number of
pathological conditions, specifically attributable to its potent
mitogenic effects. Its modulation by drug abuse, however,
has received very little attention. In the present study, we
demonstrated cocaine-mediated induction of PDGF-BB and
Notch1 in human brain microvascular endothelial cells. In
this study, we link Notch1 signaling to PDGF-BB and show
that PDGF-BB is a novel immediate Notch target gene.
PDGF-BB expression induced by cocaine was abrogated by
gamma secretase inhibitor-DAPT. Furthermore, over-
expression of intracellular domain of Notch1 significantly
increased PDGF-BB expression. Functional implication of
up-regulatedPDGF-BBasavascularpermeantwasconfirmed
in cell permeability and transmigration assays. In vivo
relevance of these findings were further corroborated in
cocaine-treated mice that were administered DAPT (i.p.
40 mg/kg). Cocaine exposure resulted in increased permeabil-
ity of the endothelial barrier and this effect was abrogated in
mice exposed to DAPT, thus underscoring its role as a
vascular permeates. Understanding the regulation of PDGF-
BB expression may provide insights into the development of
potential therapeutic targets for neuroinflammation associated
with HIV infection and drug abuse.
Differential Migration of Ly6C+ (Monocytes) and CD3+
T Cells Following Morphine and Tat Exposure. R Dutta
1,
R Charboneau
2,HY u
1,JM e n g
1,RB a r k e
2,SR o y
1;
1Department of Surgery, University of Minnesota, Minne-
apolis, MN 55455, USA,
2Department of Surgery, Veter-
ans Affairs Medical Center, Minneapolis, MN 55417,
USA.
HIV affects the host nervous system by producing distinct
neurological complications or by causing immunodeficien-
cy with susceptibility to opportunistic infections. Incidence
associated with this condition is more profound in opiate
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S29drug users. The mechanism associated with the immuopa-
thogenesis of this co-infection among morphine (MS) drug
abusers is poorly understood. We delineate peripheral
leukocyte subsets and immunoregulatory factors present in
the brains of S. pneumoniae infected wild type (wt) and tat-
transgenic (tat-tg) mice following chronic MS exposure. In
vivo imaging showed significantly greater bacterial dissem-
ination in MS-treated mice in contrast to controls. FACS
data showed a differential migration pattern of Ly6C+ and
CD3+ cells in MS-treated tat-tg compared to wt. Morphine
treatment in wt resulted in a fivefold increase in Ly6C+
cells compared to placebo but no significant difference was
observed between MS treated tat-tg compared to MS treated
wt. Morphine treatment resulted in a marginal increase in
CD3+, however in tat-tg mice the migration was threefold
higher than wt. Results suggest that MS and tat recruit
differential immune cells to the CNS and the migration of
CD3+ cells is synergistic. Significant increase in CCR5
expression on CD3+ cells was observed on MS-treated
mice. CD45 low CD11b+ and CD45 high CD11b+ cells
showed 1.2- and twofold increase in CCR5 expression in
mice brain treated with MS, respectively. Thus, differential
trafficking of Ly6C+ and CD3+ cells may be responsible for
the neuropathogenesis observed in opiate drug abusers
having co-infection. Supported by RO1 DA 12104; RO1
DA 022935; KO2 DA015349.
Amelioration of HIV-1 Tat-Induced Neuronal Injury by
Phytoestrogens. V Espensen-Sturges,SB e r t r a n d ,M V
Aksenova, MY Aksenov, S Adams, CF Mactutus, RM
Booze; Department of Psychology, University of South
Carolina, Columbia, SC 29208, USA.
Development of new strategies to prevent the neuro-
behavioral abnormalities associated with chronic HIV-1
infection is critical to the advancement of care of these
patients. Our previous studies have indicated that estro-
gen and phytoestrogenic compounds, namely genistein
and diadzein, may offer neuronal protection against HIV-
1 Tat-initiated mitochondrial apoptosis via an estrogen
receptor (ER-beta)-dependent mechanism. In this study,
dose–response curves of neuroprotection provided by
genistein and diadzein were generated. At the low
concentration of 0.1 μM, both genistein and diadzein
provided neuroprotection (8 5 %o rh i g h e r )a g a i n s tT a t
(50 μM) toxicity. In addition, we found cytomorphological
evidence for the ability of different phytoestrogens to
ameliorate degeneration and promote rebuilding of neu-
ronal dendrites following HIV protein (Tat)-mediated
neurotoxic insults. Supported by University of South
Carolina Research Foundation Grant, NIH Grant
DA013137, and University of South Carolina Magellan
Scholars.
Human Astrocytes Regulate miRNA Expression During
Neuroinflammation. JA Fields, A Ghorpade; Cell Biology
and Anatomy, University of North Texas Health Science
Center, Fort Worth, TX 76107, USA.
Astrocytes are known to be affected by, and reactive to
neuroinflammation, but the molecular mechanisms leading
to changes in gene expression are not well understood.
MicroRNA (miRNA) represents small noncoding RNA
molecules that are transcriptionally regulated and are
capable of influencing translation of mRNA. It is thought
that a single miRNA can regulate many genes and one or
more of these RNA species regulates most genes. A
growing body of evidence supports the assertion that
bystander effects on astrocytes lead to complications in
HIV-associated neurocognitive disorders (HAND) and
miRNA may contribute to regulation of gene expression
during inflammation. In this work, we hypothesized that
during neuroinflammation, human astrocytes regulate
miRNA that in turn regulate gene expression, ultimately
contributing to the disease process. We treated human
astrocytes with IL-1β for 8 h, isolated total RNA and then
analyzed expression of 846 human miRNA using an
Affymetrix miRNA microarray chip. Statistical analyses
revealed 16 miRNA that were significantly altered as
compared to untreated astrocytes; 12 were upregulated and
4 were downregulated. Of these, miR-155 was the most
increased and miR-432 the most decreased. Expression
levels of the 16 miRNA were confirmed by quantitative
polymerase chain reaction. Identification of miRNA that are
regulated by astrocytes during neuroinflammation may lead
to novel insights as to how these cells change during
HAND.
Morphine and HIV-1 Tat-Dependent Synaptodendritic
Injury in Striatum: Focal Increases in Ca2+ and
Differential Activation by NMDA and AMPA Receptors.
S Fitting, S Zou, PE Knapp, KF Hauser; School of
Medicine, Virginia Commonwealth University, Richmond,
VA 23298, USA.
Previous studies found correlative relationships between
synaptodendritic injury and neurobehavioral defects with
combined HIV-1 Tat and morphine exposure in the
absence of neuron death. Tat induction or morphine
treatment can disrupt neuronal synaptic organization (as
assessed in Golgi-impregnations and by electron micros-
copy) and coordination/sensorimotor activity; however, in
combination there were synergistic dendritic pathology
including the formation of bead-like varicosities and
synaptodendritic degeneration. In vitro studies revealed
nearly identical dendritic swellings and degenerative
changes as seen in vivo, which are hypothesized to be
S30 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59caused by focal excitotoxic injury influx of Na+, ATP
depletion and energetic compromise, and Ca2+ overload.
Chronic morphine has been shown by others to down-
regulate surface AMPA receptors at synaptic and extra-
synaptic sites and modify neuronal activity, which
significantly affects glutamatergic signaling. Importantly,
Tat ± morphine caused significant focal increases in Ca2+
along the dendrite that coincided with the dendritic
varicosities. Moreover, Tat ± morphine-dependent losses
in ion homeostasis and dendritic swelling were attenuated
by NMDA, while AMPA receptor antagonists are cur-
rently being explored. The convergence of Tat and
morphine-driven dysregulation of excitotoxic glutamater-
gic signaling, and the accompanying losses in ion
homeostasis, appear to be important sites of opioid-HIV-
1 Tat synergistic interactions and is likely to be critical in
underlying sublethal reductions in synaptic connectivity
and dendritic injury. Supported by NIDA P01 DA18633
and R01 DA19398.
Molecular Mechanism of Immunosuppression by
Cocaine in HIV-1 Infected Subjects: Role of TLR3.
N Gandhi, M Agudelo, ZM Saiyed, Y Adriana, C Spadola,
VB Pichili, T Samikkannu, N Jesica, P Khatavkar, MN
Nair; Department of Immunology/INIP, College of Medi-
cine/Florida International University, Miami, FL 33199,
USA.
Cocaine dependence is associated with potent immuno-
suppression and an increased risk for HIV-1 infection.
The innate immune response mediated by Toll-like
receptors (TLRs) activates multiple intracellular pathways
to release pro- and anti-inflammatory cytokines, chemo-
kines and antiviral factors. TLR3 recognizes double-
stranded RNA leading to activation of Interferon Regu-
latory Factor (IRF) -3 and -7 to induce antiviral response
by IFNs. Although the role of TLR3 in HIV-1 infection is
known, the effect of cocaine on TLR3 expression in HIV-
1 infection is not clearly elucidated. Since dendritic cells
are the first line of defense against HIV-1 infection, we
studied the expression of TLR3 in monocyte-derived
dendritic cells (MDDC) from HIV-1 infected cocaine
users. Our results indicate that TLR3 expression was
significantly downregulated in HIV-1 infected cocaine
users compared to HIV-1 infected non-cocaine users.
These findings were further confirmed in an in vitro HIV-
1 infection model and found that HIV-1 induced
upregulation of TLR3 gene and protein expression was
significantly lower in MDDC infected with HIV-1 and
treated with cocaine compared to MDDC infected with
HIV-1 only. Further, the expression of downstream-
signaling molecules, IRF-3 and IRF-7 as well as effector
molecule, IFN-γ were significantly downregulated in
HIV-1-infected cocaine-treated MDDC. Thus, our results
suggest that cocaine may downregulate innate immune
response in HIV-1-infected subjects by TLR-3-mediated
mechanism, involving dysregulation of pro- and anti-
inflammatory molecules. Supported by NIMH and NIDA.
Morphine Enhances HIV-1 Entry into Kidney Cells
Through a Novel Pathway. HG Goel, P Singh, A
Malhotra, M Husain, P Singhal; Department of Nephrology,
North Shore-Long Island Jewish Health System, Great
Neck, NY 11021, USA.
Drug addicts are considered to have increased risk for the
development of HIV-associated nephropathy (HIVAN).
Renal biopsy data suggest the role of HIV-1 infection of
kidney cells in the development of HIVAN. However, the
mode of HIV-1 entry in kidney cell is not clear. Kidney cells
do not carry conventional HIV-1 receptors. Therefore, to
determine the entry of HIV-1 in kidney cells, lymphocytes
(LY) with or without HIV-1 infection (HIV-LY) were co-
cultivated with tubular cells. FACS analysis showed the
population of CD4+ ve T cells dropped significantly in
these experiments. HIV-LY had even higher apoptosis and
resulted in enhanced tubular cell HIV-1 expression. Mor-
phine treatment not only enhanced T cell apoptosis but also
displayed enhanced tubular cell HIV-1 expression. Interest-
ingly, morphine-treated tubular cells also displayed up
regulated PD-L1 expression. On the other hand, pretreat-
ment of tubular cells with anti-PD-L1 antibody attenuated T
cell apoptosis, and thus indicating the role of PD-1:PD-L-1
pathway. Imaging studies (acridine orange, double labeling
of tubular cells and T cells, and electron microscopy)
displayed tubular cells containing T cell fragments. Since
both naloxone and cytochalasin B prevented morphine-
induced tubular cell HIV-1 expression, it appeared that both
opiate receptors and endocytic pathway contributed to Tcell
uptake. Since HIV-1 did not induce productive infection in
tubular cells directly, it appears that phagocytosed apop-
tosed T cells provided a suitable milieu for productive HIV-
1 infection. Supported by National Institute of Health.
Ethanol-Induced Upregulation of IL-6 and IL-8 in
Astrocytes is Mediated by the NF-κB Pathway. R Gupte,
A Shah, S Kumar, A Kumar; Division of Pharmacology and
Toxicology, University of Missouri-Kansas City, Kansas
City, MO 64108, USA.
Alcohol abuse has been implicated as the cause of various
health problems all over the world. Alcohol is known to be
toxic to the brain but the mechanisms contributing to
neurotoxicity have not been fully elucidated. In this study,
we measured the induction of the pro-inflammatory cyto-
kines IL-6 and IL-8 in a human fetal astrocyte cell line
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S31SVGA after treatment with ethanol. Both IL-6 and IL-
8 mRNA levels increased in a time-dependent manner after
treatment with a single dose of 50 mM ethanol. Peak
induction of both cytokines was observed at 3 h (21.5-fold
±2.93 for IL-6 and 42.76-fold ±3.02 for IL-8) and
expression levels of these cytokines declined to levels
below that of the control at 12 and 24 h. To determine if
these effects were mediated by the NF-κB pathway, time-
dependent activation of NF-κB was studied. Nuclear levels
of p50 were significantly higher as compared to cytoplasmic
levels after ethanol treatment and maximum translocation
was observed 1 h post treatment. Pre-treatment with I-κB
kinase inhibitor SC-514 abrogated the ethanol-mediated
upregulation of IL-6 and IL-8 in a concentration-dependent
manner with 50 μM dose showing maximum inhibition.
These results demonstrate that NF-κB plays a key role in
ethanol-mediated upregulation of inflammatory cytokines in
the brain. These studies will further be corroborated with
the use of siRNA against NF-κB to block the induction of
released cytokines IL-6 and IL-8. Furthermore, these results
suggest that the NF-κB pathway is a potential therapeutic
target for treatment of ethanol-induced neuroinflammation.
Interactive Effects of HIV-1 Tat and Opiates on CNS
Progenitor Cells. YK Hahn
1, CM Bull
1, S Fitting
2,PV o
1,
KF Hauser
2, PE Knapp
1;
1Department of Anatomy &
Neurobiology, Virginia Commonwealth University, Rich-
mond, VA 23298, USA,
2Department of Pharmacology &
Toxicology, Virginia Commonwealth University, Rich-
mond, VA 23298, USA.
Injection drug abuse and HIV infection are interlinked
epidemics, and HIV patients with a history of opiate abuse
appeartohavehigherincidenceofneurologicdysfunction.We
hypothesize that neuron/glial progenitors (NPC/GPCs) may
be targets of HIV-1/viral proteins and opiate drugs of abuse,
leading to effects on gliosis, inflammation and CNS repair.
Previous work showed that HIV-1 Tat, but not gp120, altered
progenitor chemokine secretion (Hahn et al., J Neurochem,
2010). Here, we report that Tat ± opiate exposure profoundly
affects progenitor cell motility/migration, proliferation and
lineage progression in vitro. Tat exposure reduced prolifera-
tion (BrdU), first in Sox2+, and then in Olig2+ populations,
but only when the cells were co-exposed to morphine. Using
an inducible transgenic mouse, we examined Tat effects in
vivo. In adult mice, similar to in vitro findings, Tat expression
reduced overall proliferation (Ki67+) in the striatum, largely
through effects on Olig2+ cells. Such effects likely led to the
reduced numbers of oligodendrocytes (OLs) that we observed
in the corpus callosum. Based on reports of gender differences
in OL populations, we tested gender-specific responses to
HIV-1 Tat in vivo. Although OLs and NeuN + neurons in
males and females showed similar responses to Tat ± opiates,
male mice with chronic Tat induction (3 months) performed
significantly worse than female mice in a behavioral study
(rotarod).Malesalsohadsignificantlyincreasednumbersof3-
nitrotyrosine + microglia, suggesting that their behavioral
deficits may relate to enhanced inflammation. Supported by
DA024461 and NS069216.
CB2-Selective Cannabinoids Directly Inhibit T-Cell
Function in the Mixed Lymphocyte Reaction (MLR).
RR Hartzell
1,2, JJ Meissler
1, MW Adler
1, TK Eisenstein
1,2;
1Center for Substance Abuse Research, Temple University
School of Medicine, Philadelphia, PA 19140, USA,
2De-
partment of Microbiology and Immunology, Temple Uni-
versity School of Medicine, Philadelphia, PA 19140, USA.
The MLR is considered to be an in vitro correlate of skin
and organ transplant rejection. In this assay, spleen cells
from two different mouse strains are incubated together. The
T-cells of one strain respond to the foreign cells by
proliferating. We have previously shown that the CB2-
selective agonists JWH-015 and O-1966 inhibit the MLR
when added to unfractionated murine spleen cells. To
corroborate whether T-cell function was decreased by
CB2-selective agonists, IL-2 release was quantitated by
ELISA using MLR culture supernatants of unfractionated
spleen cells. It was found that both CB2 agonists inhibited
IL-2 release in a dose-dependent manner, indicating that the
cannabinoids inhibit this parameter of T-cell function. To
test whether the cannabinoids act directly on the T-cells or
via effects on accessory cells, murine splenocytes were
separated into highly purified subpopulations using flow
cytometry. Specifically, CD3+ (T-cells) and CD11b+ (my-
eloid derived cells) fractions were sorted and individually
treated with JWH-015 or O-1966 before being added back
to the remainder of the spleen cells, which were either CD3
or CD11b depleted. Inhibition of the MLR was observed
only when the CD3+ population was treated with a
cannabinoid, and not when the CD11b+ population was
treated, indicating that the CB2 agonists act directly on T-
cells. These results elucidate the mechanism of CB2
compounds in the MLR, and provide additional support
for the potential of CB2-selective cannabinoids as immu-
nosuppressive agents that may be useful therapies to block
graft rejection. Supported by NIDA grants DA13429,
DA06650, and T32-DA07237.
Cytokine, Chemokine and their Receptors’ Expression on
Exposure to Endotoxin in the HIV-1 Transgenic Rat. N
Homji-Mishra
1, X Mao
1, EF Langsdorf
1, SL Chang
1,2;
1Institute of NeuroImmune Pharmacology, Seton Hall
University, South Orange, NJ 07079, USA,
2Department
of Biological Science, Seton Hall University, South Orange,
NJ 07079, USA.
S32 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59Prior exposure to endotoxin renders innate immune cells
to become refractory to subsequent endotoxin challenge
in endotoxin-tolerance (ET).H I V - 1a f f e c t st h ei m m u n e
system and thus it is clinically relevant to study ET
during HIV-1 infection. In this study, the gene-expression
of 84 cytokines, chemokines and their receptors, in the
brain, spleen, and serum were studied in lipopolysaccha-
ride (LPS) treated rats. We also studied the protein levels
of 7 of these 84 genes. HIV-1 transgenic (HIV-1Tg) rats
(animal-model for HIV-1 infection controlled by
HAART) and control animals, F344 rats (n=12 ea) were
randomly treated with two doses of 250 μg/kg LPS (LL) or
saline (SS) and then with a lethal dose of 5 mg/kg LPS
(+L) or saline (+S). Tissues and blood were collected 2 h
p o s t - l a s t - d o s e .W ef o u n dt h a tt h es a m ec y t o k i n ea n d
chemokine genes in brain (21) and in spleen (41) were
modulated ≥twofolds in both strains of rats. However, the
m a g n i t u d eo fm o d u l a t i o no fm o s tg e n e sf o rt h es a m eL P S -
treated group was different in F344 versus HIV-1Tg rat
brain or spleen. Pro- and anti-inflammatory cytokines were
most up-regulated in SS+L group followed by LL+L group
compared to control (SS+S) suggesting that the animals in
LL+L group were in an ET state. These results give a
systemic picture of the cytokine/chemokine profiles and a
clearer understanding of the neuroimmune (brain and
spleen) response during ET. The differences between
F344 and HIV-1Tg cytokine/chemokine profiles show that
the presence of HIV-1 viral proteins may alter the
expression profile of inflammatory molecules during ET.
Supported by NIH DA007058 and DA016149 to SLC.
HIV-1 Transgenic Rats: Alterations in the Preattentive
Process of Sensorimotor Gating. LL Hord, KM Webb, LM
Moran, CF Mactutus, RM Booze; Behavioral Neuroscience
Program, University of South Carolina, Columbia, SC
29223, USA.
With the great success of combination antiretroviral therapy
(cART) regimens, AIDS has transitioned from an acute
disease with rapid loss due to AIDS-related mortality to a
chronic neurological disease with normal longevity. Despite
undetectable HIV-1 infection under cART, HIV-1 associated
neurological disorders (HAND) occur in more than 50% of
individuals. In the present study we utilized the Sprague–
Dawley (SD) HIV-1 transgenic (HIV-1 Tg), which
expresses seven of the nine HIV-1 genes, to examine the
preattentive process of sensorimotor gating. SD HIV-1 Tg
rats and non-transgenic controls (ns=11) were obtained
from the supplier (HSD) and studied beginning at 90 days
of age. At three monthly intervals, all animals were
individually tested for their auditory startle response
(ASR) and prepulse inhibition (PPI) of the ASR. Each
animal was tested using an acoustic startling stimulus
[100 dB(A) broad-band noise stimulus] and an acoustic
prepulse [85 dB(A) broad-band noise stimulus] in a sound
attenuating double-wall chamber with a continuous white
noise 70 dB(A) background. The protocol used a 5-min
acclimation period, 6 ASR trials, and 36 PPI trials [ISIs of
0, 8, 40, 80, 120, and 4,000 ms, six-trial blocks, Latin
square design]. Alterations in the ASR and PPI were
observed at all time points, suggesting the HIV-1 Tg rat
develops long-term alterations in the preattentive process of
sensorimotor gating, despite its aviremic state. Such subtle
and early-detected cognitive alterations may have signifi-
cant utility in predicting progression of central nervous
system disease markers. Supported by NIH grants:
DA13137 and HD043680.
MIR-29 Regulates Morphine and HIV Protein-
Decreased Platelet-Derived Growth Factor Expression.
GH Hu, SB Buch; Department of Pharmacology and
Experimental Neuroscience, University of Nebraska Medical
Center, Omaha, NE 68198–5880, USA.
Extensive neuronal damage and loss is a hallmark of
HIV-associated neurological disorders (HAND), a term
used to describe the range of cognitive and motor
impairments that occur in individuals suffering from
AIDS. Opiate drug abuse accelerates the incidence and
progression of HAND, however, mechanisms underlying
the ability of these drugs to enhance the pathological
effects of HIV-1 in the brain remains elusive. Morphine is
often abused by HIV-1 infected patients. Platelet-derived
growth factor-BB (PDGF-BB) has been reported to
provide tropic support for neurons in the central nervous
system. In the present study, it was demonstrated that
PDGF-BB expression was decreased in basal ganglia in
virus (SIV)-infected macaques with or without chronic
morphine administration with concomitant increased miR-
29b expression compared with the saline control group.
In vitro relevance of this finding was further corroborated
in conditioned medium from morphine and HIV-1 protein
Tat treated A172-astrocyte cell line, which decreased
PDGF-BB and increased miR-29b expression with con-
comitant decreased cell viability. Furthermore, it was
shown that PDGF-BB was a target for miRNA-29b as
evidenced that binding of miR-29 to the 3'-untranslated
regionofPDGF-BmRNA results intranslationalrepressionin
SH-SY5Y cells. Understanding the regulation of PDGF-BB
expression may provide insight into the development of
potential therapeutic targets for neuronal loss in HIV-1
infection with morphine drug abuse.
PPAR-α and PPAR-γ Agonists Differentially Protect
Against HIV Tat-Induced Alterations of Claudin-5
Expression and Activation of Redox Signaling in FVB/
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1, L Chen
1, B Zhang
1, B Hennig
2,M
Toborek
1;
1University of Kentucky, Neurosurgery, Lexington,
KY 40536, USA,
2University of Kentucky, College of
Agriculture, Lexington, KY 40536, USA.
Tight junctions (TJs) are the main structural and functional
elements that regulate the blood–brain barrier (BBB)
integrity. In the present study, we investigated the mecha-
nisms of peroxisome proliferator-activated receptor (PPAR)-
mediated protection against HIV Tat-induced alterations of
the BBB integrity and claudin-5-expression in vivo.
Delivery of HIV-1 Tat via the internal carotid artery induced
transmicrovessel migration of monocytes and increased the
BBB permeability in wild-type FVB/NJ mice; however,
these effects were attenuated in mice treated with fenofi-
brate (PPAR-α agonist, 100 mg/kg) or rosiglitazone (PPAR-
γ agonist, 10 mg/kg) once daily for 1 week. Surprisingly,
the baseline expression of claudin-5 was lower and
treatment with HIV-Tat induced disruption of the BBB
integrity to a higher extent in matrix metalloproteinase
(MMP)-9 knockout mice as compared to wild-type controls.
Exposure to HIV-1 Tat decreased claudin-5 levels and
activated ERK1/2 and Akt in the microvessels of wild-type
controls. These effects were attenuated by co-treatment with
fenofibrate but not by rosiglitazone. In contrast, ERK1/2
and Akt were not affected by treatment with Tat or PPAR
agonists in MMP-9 deficient mice. The results of the
present study indicate that HIV-1-Tat-induced alterations
of TJ protein expression and redox-regulated signaling
proteins are differentially regulated by PPAR-α and
PPAR-γ agonists depending upon MMP-9 activity. Sup-
ported by in part DA027569, MH63022, MH072567,
NS39254, and AHA09POST2060217.
The Role of Cytochrome P450 on Alcohol/Nicotine-
Mediated Oxidative Stress in U937 Macrophages. M
Jin, R Earla, AK Shah, R Gupte, AK Mitra, A Kumar, S
Kumar; School of Pharmacy, University of Missouri—
Kansas City, Kansas City, MO 64108, USA.
Substance abuse, especially alcohol and tobacco, is preva-
lent among HIV-1 infected individuals. Cytochrome P450
(CYP) enzymes are involved in the metabolism of alcohol
(CYP2A6, CYP2E1) and nicotine (CYP2A6), both of
which are known to cause oxidative stress in the liver.
There are some reports that alcohol- and nicotine-induced
oxidative stress increases HIV-1 replication. However, the
mechanism by which they increase oxidative stress and
HIV-1 replication is not known. This study is designed to
explore the role of CYPs in alcohol- and nicotine-mediated
oxidative stress in U937 macrophages. We analyzed the
expression levels of CYPs and determined the levels of
oxidative stress in acutely alcohol- and nicotine-treated
U937 macrophages. Alcohol (100 mM) showed significant
induction of CYP2A6 and CYP2E1 compared to the
control. Furthermore, alcohol increased the production of
reactive oxygen species (ROS), a marker of oxidative stress.
1 μM nicotine significantly increased CYP2A6 expression
and ROS production, which was consistent with nicotine
metabolism. Furthermore, the CYP2A6-selective inhibitor,
tryptamine completely blocked the production of ROS,
suggesting the involvement of CYP2A6 in nicotine-
mediated ROS production. Overall, the results demonstrate
the role of CYP2A6 and CYP2E1 on alcohol/nicotine-
mediated oxidative stress in U937 macrophages. We are
now in the process of examining the acute and chronic
effects of the combination of alcohol and nicotine on CYPs-
mediated oxidative stress and their impact on HIV-1
replication. Supported by University of Missouri Research
Board Grant.
Chemokine CXCL8 is Regulated in Activated Astrocytes
t h r o u g hM A P K sa n dS H P - 2 . MK a u r , L Tang, K
Borgmann, A Ghorpade; Department of Cell Biology and
Anatomy, University of North Texas Health Science Center,
Fort Worth, TX 76107, USA.
CXCL8 is an important chemokine implicated in HIV-
associated dementia. Interleukin (IL)-1-beta activated
astrocytes exhibit significant upregulation of CXCL8,
and the mechanisms involved are being elucidated. In the
present study, we demonstrate that astrocytes produce
C X C L 8i nM i t o g e na c t i v a t e dp r o t e i nk i n a s e( M A P K )a n d
Src homology domain 2 protein tyrosine phosphatase
(SHP-2) dependent mechanism. MAPKs are family of
kinases that transduce variety of external signals and
SHP-2 is implicated to act upstream of MAPKs. Primary
human astrocytes were treated with or without MAPK
(p38-SB203580; JNK-SP600125; and ERK-U0126) and
SHP-2 inhibitors (sodium orthovanadate and PHPS1),
followed by activation with IL-1β. Brain tissues from
HIV infected individuals were also analyzed for CXCL8
levels, compared to age matched controls. Astrocytes
were transfected with SHP-2 overexpression and domi-
nant negative control plasmids. Changes in mRNA
and protein levels were analyzed by real-time PCR,
ELISA and western blot analysis to establish the role of
these signaling pathways in astrocyte CXCL8 regulation.
Significant downregulation (p<0.001) in IL-1β-mediated
CXCL8 mRNA and protein expression was found in
astrocytes pre-treated with MAPK and SHP2 inhibitors.
Elevated levels of CXCL8 mRNA and protein were
found in brain lysates of HIV infected individuals.
Overexpressing SHP-2 in astrocytes resulted in higher
CXCL8 levels. These results indicate that the proinflam-
matory chemokine CXCL8 upregulation in activated
S34 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59astrocytes is MAPK and SHP-2 dependent. Supported by
NIH/NIMH/1RO1MH087345-01.
Tumor Necrosis Factor-α Enhances Astrogliogenesis
and Inhibits Neurogenesis of Human Fetal Neural
Progenitor Cells though JNK/STAT3 Pathway. X Lan,
H Peng, J Zheng; Laboratory of Neuroimmunology and
Regenerative Therapy, University of Nebraska Medical
Center, Omaha, NE 68198, USA.
Active neurogenesis, which relies upon the proliferation,
migration, and differentiation of neural progenitor cells
(NPC), occurs throughout life and is very important for the
development and the well-being of the brain. Impaired
neurogenesis has been suggested to add to the woe of
neurodegenerative disorders such as HIV-1-associated neu-
rocognitive disorders. Our previous studies demonstrated
that HIV-1-infected and LPS-activated monocyte-derived
macrophages inhibit neurogenesis while enhance astroglio-
genesis through secretion of tumor necrosis factor-α (TNF-
α) and activation of transcription factor signal transducers
and activator of transcription 3 (STAT3). Here, we further
test the hypothesis that TNF-α-mediated astrogliogenesis is
through the JNK/STAT3 pathway. Fetal neural progenitor
cells were treated with recombinant TNF-α together with or
without c-Jun N-terminal Kinase (JNK) inhibitor SP600125
in the differentiation medium. Results showed that TNF-α
dramatically activated JNK and STAT3, and also signifi-
cantly enhanced astrogliogenesis. Both the STAT3 activa-
tion and enhanced astrogliogenesis were abrogated by the
addition of SP600125. These observations demonstrated
that TNF-α could enhance astrogliogenesis and/or inhibit
neurogenesis through the JNK/STAT3 pathway. This study
generates important data elucidating the role of TNF-α in
neurogenesis and may provide insight into new therapeutic
strategies for brain inflammation. Supported by the National
Institutes of Health: R21 NS 066841 to HP, R01 NS041858,
R01 NS061642 and R01 NS043985 to JZ.
Negative Regulation of Neuronal Differentiation by
TLR4 Activation. JL Li, L Ye, X Wang, YZ Wang, Y
Persidsky, WZ Ho; Department of Pathology, School of
Medicine, Temple University, Philadelphia, PA 19140,
USA.
Neurogenesis is the process by which functionally integrat-
ed neurons are generated from neural stem cells (NSCs).
However, the mechanisms underlying the regulation of
neurogenesis are largely unknown. In this study, we
examine the role of Toll-like receptors (TLRs), a family of
highly conserved pattern recognition receptors, in the
differentiation of NSCs. We observed that NSCs expressed
TLR2, TLR3, and TLR4, which were differentially regulat-
ed during NSCs differentiation. The activation of TLR4
inhibited NSCs differentiation to neurons. Investigation of
the mechanisms showed that TNF-α plays a crucial role in
LPS-mediated inhibition of NSCs differentiation to neurons.
The knockdown of IRF3 attenuated TNF-α induction by
LPS, restoring NSCs differentiation. These data indicate
that TLR4 activation has a negative impact on neurogenesis.
Supported by NIDA, DA012815, DA027550, and
DA022177.
HIV-1 Nef Expression in Rat Hippocampus Induces
Inflammatory Cytokines in Serum and Peyer’s Patches
in the GI Tract. R Loucil
1, G Chompre
1, M Cruz
2,C
Appleyard
2, R Noel
1;
1Biochemistry Department, Ponce
School of Medicine, Ponce, PR 00731, Puerto Rico,
2Physiology Department, Ponce School of Medicine, Ponce,
PR 00731, Puerto Rico.
Gastrointestinal pathology is a recurrent problem during
HIV infection and disease progression. HIVenteropathy can
often be associated with a specific cause, such as an
opportunistic pathogen; however, some HIV-positive indi-
viduals present idiopathic enteropathy that appears to
involve inflammatory processes. In HIV-associated demen-
tia, the presence of increased LPS in plasma due to
gastrointestinal inflammation suggests a brain–gut connec-
tion. Our previous work has shown that HIV-1 Nef
expression by astrocytes in rat hippocampus produces
spatial memory deficits, but did not address the possibility
for systemic effects. Here we tested our rat model for
inflammatory responses in the small intestine and blood.
Primary rat astrocytes expressing Nef from a plasmid were
unilaterally infused into the hippocampus of 30-day-old
Sprague–Dawley rats. After a week, rats were euthanized
and examined for systemic inflammation by serum cytokine
analysis and macroscopic inspection of the small intestine
for Peyer’s patches. An increased number of Peyer’s
patches were found in Nef-treated animals that correlated
with memory impairment. Both Nef and GFP control
groups showed detectable RANTES in serum; however,
Nef animals uniquely showed increases in IL-1β, IL-2, and
TNF-α. These studies suggest that communication from
brain to gut can be induced by known HIV-1 neurotoxins
such as Nef. Supported by GM082406, RR003050.
Mechanism Underlying Methamphetamine Induced
Autophagy and Apoptotic Death in Endothelial Cells. J
Ma
1, S Ramakrishnan
2,HY u
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3,S
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1;
1Department of Surgery, University of Minnesota,
Minneapolis, MN 55455, USA,
2Department of Pharmacolo-
gy, University of Minnesota, Minneapolis, MN 55455, USA,
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Minneapolis, MN 55417, USA.
Methamphetamine (METH), a potent stimulant with strong
euphoric properties, has a high abuse liability and is capable
of dysregulating blood–brain barrier (BBB) function. Our
previous studies have shown low dose (1 μM) of METH
treatment evokes an autophagic response in endothelial cells
that is specific and initiated even in the absence of
nutritional stress. Here, we report that endothelial cells
exposed to METH up-regulated Beclin −1 levels through
kappa opioid receptor. METH ligation of kappa opioid
receptor lead to inhibition of the mTOR signaling
pathway by activation of Akt and Extracellular Signal-
Related Kinase (ERK)1/2 signaling and antagonized by
PD98059. Furthermore, progressively decreasing amounts
of the apoptosis-inhibiting protein Bcl-2 were also found.
P r o l o n g e de x p o s u r et oM E T Hu l t i m a t e l yl e dt oa p o p t o s i s
via caspase8-dependent pathway but independent of
caspase9 activation in endothelial cells. There was an
i n c r e a s e dn u m b e ro fe a r l yapoptotic cells (annexin V
positive) following chronic METH exposure. Studies are
in progress to determine if knock-down of Beclin 1 levels
by RNA interference decreases METH-induced autoph-
agy but accelerates METH-induced apoptosis. These
observations provide a basis for interfering with the
autophagic survival response following endothelial injury
induced by chronic METH exposure. Supported by RO1
DA 12104; RO1 DA 022935; KO2 DA 015349, and P50
DA11806 (to S.R.)
Dynamics of Dendritic Cells and T Cells in HTLV-1-
Associated Neuroinflammatory Disease: Implications in
Immunomodulatory Therapies and Diagnostic Tools. SL
Manuel
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2,M RB e t t s
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1Drexel Institute
for Biotechnology & Virology Research, Drexel University
College of Medicine, Doylestown, PA 18902, USA,
2Department of Microbiology and Immunology, University
of Pennsylvania School of Medicine, Philadelphia, PA
19104, USA,
3Division of Cancer Epidemiology and
Genetics, National Cancer Institute, Bethesda, MD 20892,
USA,
4Institute for Molecular Medicine & Infectious
Disease, Drexel University College of Medicine, Philadel-
phia, PA 19102, USA.
HTLV-1-associated myelopathy/tropical spastic parapare-
sis (HAM/TSP) is a debilitating neurodegenerative dis-
ease characterized by a robust immune response
including the oligoclonal expansion of cytotoxic T
lymphocytes (CTLs) specific for the viral oncoprotein
Tax. However, the underlying mechanism resulting in the
disease process is currently unknown. The CTL response
is affected by many factors including the efficiency of
epitope processing and presentation. In this respect,
dendritic cells (DCs), the most potent antigen presenting
cells, have long been recognized as key regulators of the
immune system. We have previously demonstrated that
DCs are capable of priming a pronounced Tax-specific
CTL response in naïve PBLs and in HLA-A*0201
transgenic mice. Since DCs are such crucial cells of the
immune system, an extensive assessment of their function
and interaction with T cells in HAM/TSP is critical.
Therefore, utilizing a newly standardized DC and a pre-
standardized T cell polychromatic antibody cocktail, we
have investigated the immune activation of these cells in
HTLV-1 infected samples from the Jamaican region
including seronegative controls, asymptomatic carriers
(ACs), and HAM/TSP patients. The extensive immune
cell profiling was compared to the matched proviral loads
and Tax mRNA levels leading to the identification of
unique signatures distinguishing ACs from HAM/TSP
patients. Collectively, these studies possess great potential
to enable immune cell monitoring and development of
diagnostic and therapeutic strategies for the HTLV-
associated neuroinflammatory disease. Supported by
NIH grant R01 AI077414 (NIAID) to Pooja Jain and a
Philadelphia NeuroAIDS Research Training Grant T32
MH079785 (NIMH).
Bryostatin Protects Neurons Against HIV-Induced
Inflammation. R Mehla, S Bivalkar-Mehla, A Chauhan;
Department of Pathology, Microbiology and Immunology,
University of South Carolina, School of Medicine, Columbia,
SC 29209, USA.
Patients with prolonged HIV infection develop HIV-
associated neurocognitive deficits. Neurological compli-
cations during HIV infection are largely a result of direct
neuronal damage imparted by either HIV-infected or
uninfected macrophages and microglia. In the current
study, we have demonstrated that among the proinflam-
matory cytokines, CXCL10 was distinctly upregulated
over 1,000-fold in activated astrocytes and macrophages.
Consistently, cytokine profile from HIV-infected dement-
ed patient’s CSF showed elevated levels of CXCL10 but
not the HIV-infected non-demented patient's. Further,
CXCL10 in combination with HIV synergistically en-
hanced neuronal toxicity and also revealed chemotactic
activity (~40-fold) for PBMCs. These results suggest that
signaling events induced by HIV and CXCL10 after
binding to their respective surface receptors, CXCR4 and
CXCR3 present on neurons must be intersecting. In
accordance, blocking of CXCR3 and its downstream
S36 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59MAP kinases using specific inhibitor SB203580, showed
suppression of neurotoxicity. Interestingly, bryostatin, a PKC
modulator known to downregulate CXCR4 receptor expres-
sioninlymphocytes,showedstrongsuppressionofCXCR4in
neuro-glial cells and conferred neuroprotection against HIV
and CXCL10. In addition, bryostatin also suppressed HIVand
CXCL10 induced PBMC chemotaxis and may be a potential
neuroprotective agent. In conclusion, we have demonstrated
the potential of bryostatin in neuroprotection in the setting of
HIV infection. Supported by NIH.
Morphine Induces Spontaneous Sepsis in Mice by
Modulating TLR Signaling. JJ Meng
1, J Wang
2,JM a
2,
R Charboneau
3, S Roy
1;
1Department of Pharmacology,
University of Minnesota, Minneapolis, MN 55455, USA,
2Department of Surgery, University of Minnesota, Minne-
apolis, MN 55455, USA,
3Department of Surgery, Veterans
Affairs Medical Center, Minneapolis, MN 55417, USA.
Morphine is widely used for chronic pain management.
Increased clinical reports showed that morphine may
induce a group of adverse gastrointestinal symptoms such
as constipation, bloating and nausea. In addition, a large
amount of studies have been conducted to show that
morphine treatment can suppress normal function of the
intestinal immune system and contribute to induction of
sepsis. However, the correlation between how morphine
impairs gastrointestinal immune system and pathogenesis
of sepsis is still illusive. In this study, we showed that
morphine treatment induced extraintestinal growth of
bacteria in blood, liver, and mesenteric lymph node
(mLN) in mice and the most frequently detected bacterial
species were all commensal intestinal bacteria. Results
from confocal microscopy revealed that morphine treat-
ment disrupted the organization of tight junction proteins
in small intestinal epithelium but did not show any effect
on colon epithelium. Disruption of epithelial barrier lead
to increased microbial translocation to the mLN and
activation of mLN T cells to produce IL-17. Meanwhile,
morphine treatment upregulated TLR2 and TLR4 expres-
sion in gut epithelial cells. Upregulation of TLR signaling
in gut epithelium induced production of IL-6, a proin-
flammatory cytokine which can regulate tight junction
protein organization. Furthermore, the expression levels
of miR155 and miR146a in gut epithelial cells were also
modulated by morphine treatment, which suggested that
the effects of morphine on TLR signaling are mediated
by modulation of miR155 and miR146a expression.
Supported by RO1 DA12104; RO1 DA022935; KO2
DA015349, and P50DA11806.
HIV-1 Transgenic Rats: Disruption of Sensorimotor
Gating by Methamphetamine Challenge. LM Moran,
KM Webb, LL Hord, RM Booze, CF Mactutus; Behavioral
Neuroscience Program, University of South Carolina,
Columbia, SC 29223, USA.
Since the introduction of combination antiretroviral therapy
(cART) in the mid-1990s, the most severe forms of HIV-1
induced cognitive deficits have diminished, however, HIV-1
associated neurocognitive disorders remain as prevalent as
before cART. Basic and clinical studies implicate alterations
in the dopaminergic (DA) system in HIV-1 infection.
Presently, we used the Fisher-344 HIV-1 transgenic (HIV-
1 Tg) rat, which expresses seven of the nine HIV-1 genes, to
examine potential DA alterations in the preattentive process
of sensorimotor gating. HIV-1 Tg rats and non-transgenic
controls (ns=8) were studied beginning at 35 days of age.
At 48-h intervals, animals were administered a single dose
of methamphetamine (METH; 0, 0.5, 1, 2.5 and 5 mg/kg/ml
SC) and individually tested for prepulse inhibition (PPI).
Each animal was assessed using an acoustic startling
stimulus [100 dB(A) broad-band noise stimulus] and an
acoustic prepulse [85 dB(A) broad-band noise stimulus] in a
sound attenuating double-wall chamber with a continuous
white noise 70 dB(A) background. The protocol used a 5-
min acclimation period, 6 startle trials, and 36 PPI trials
[ISIs of 0, 8, 40, 80, 120, and 4,000 ms, six-trial blocks,
Latin square design]. As the dose of METH increased, PPI
of the startle response decreased; however, the HIV-1 Tg
rats were significantly more responsive to the METH-
induced disruption of PPI. Early detected cognitive alter-
ations in the preattentive process of sensorimotor gating
may have significant predictive utility regarding the
progression of DA alterations in HIV-1 infection. Supported
by NIH grants DA013137 and HD043680.
Cannabinoid Receptor Expression on Peripheral Blood
Mononuclear Cells of HIV Subjects and Marijuana Users
by Flow Cytometry. SM Munsaka, U Feger, M Andres, L
Chang; Department of Medicine, John A. Burns School of
Medicine, Honolulu, HI 96813, USA.
Cannabinoids are known to have immunomodulatory
effects, which are thought to be mediated primarily by
CB2 receptors that are expressed on immune cells. However,
immune cells also have CB1 mRNA and may express these
receptors when the cells are activated. We developed a flow
cytometry assay using anti-CB1-allophycocyanin and anti-
CB2-biotin probed with streptavidin-phycoerithrin and mea-
sured CB1,CB2, activation markers andCCR5 expressions on
lymphocytes (CD4+Th-cells, CD8+Tc cells, CD19+B cells)
andon CD14+monocytes ofseronegative (SN) controls (n=8),
marijuana smokers (n=7), HIV+ marijuana smokers
(n=7), and HIV+ non-marijuana smokers (n=7). CD4+ cells
of HIV+ marijuana users had lower CB1 expression (p=
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S370.027) compared to those found in SN controls. Interestingly,
CD8+ cells of marijuana smokers had higher CB2 expression
(p=0.026) than in SN controls. Regardless of serostatus,
marijuana users exhibited higher levels of inflammatory
activated monocytes (CD14+CD16+) compared to non-users
(p=0.002). Although there was no difference in the expres-
sion of the HIV chemokine co-receptor CCR5 between HIV+
subjects and SN controls (p=0.48), CCR5 expression
tended to be higher among marijuana smokers than among
non-users (p=0.11). These preliminary data suggest that
HIV infection and marijuana-use affected CB1 and CB2
expressions and that smoking marijuana may increase
monocyte activation and HIV chemokine co-receptor
CCR5 expression, thus making these individuals more
vulnerable to HIV infection. Supported by NIMH (2R01-
MH61427); NIDA (2K24-DA16170); NINDS & NIDA
(U54-NS56883).
Memory T-Cells Persisting in the Brain Following
MCMV Infection Induce Long-Term Microglial Activation
via IFN-γ Production. MB Mutnal, S Hu, MR Little, JR
Lokensgard; CIDMTR, University of Minnesota,
Minneapolis, MN 55455, USA.
Murine cytomegalovirus (MCMV) brain infection stimu-
lates microglial cell-driven proinflammatory chemokine
production which precedes the presence of brain-
infiltrating systemic immune cells. Here, we show that in
response to MCMV brain infection, antigen-specific CD8
(+) T-cells migrated into the brain and persisted as long-
lived memory cells. The role of these persistent T-cells in
the brain is unclear because most of our understanding of
antimicrobial T-cell responses comes from analyses of
lymphoid tissue. Strikingly, memory T-cells isolated from
the brain exhibited an effector phenotype and produced
IFN-g upon restimulation with viral peptide. Furthermore,
we observed time-dependent and long-term activation of
resident microglia, indicated by MHC class II up-regulation
and TNF-α production. The immune response in this
immunologically restricted site, persisted in the absence of
active viral replication. We then investigated the role of
IFN-γ in chronic microglial activation by using IFN-γ-
knockout (GKO) mice. At 30 d p.i., GKO mice demon-
strated a similar phenotypic brain infiltrate when compared
to wild-type mice (Wt), however, MHC class II expression
on microglia isolated from these GKO mice was signifi-
cantly lower compared to Wt animals. When IFN-γ
producing CD8(+) T-cells were reconstituted in GKO mice,
MHC class II up-regulation on microglial cells was restored.
These results suggest that MCMV brain infection results in
long-term persistence of antigen specific CD8(+) T-cells
which produce IFN-γ and drive chronic microglial cell
activation. Supported by NINDS R01 NS-038836.
Human Immunodeficiency Virus Type 1 (HIV-1) Infects
Human Brain Pericytes in Vitro. S Nakagawa,M
Toborek; Department of Neurosurgery, University of Kentucky,
Lexington, KY 40536, USA.
Human immunodeficiency virus type 1 (HIV-1) infection of
the central nervous system (CNS) causes disruption of the
blood–brain barrier (BBB) and contributes to the develop-
ment of neurological dysfunctions. The BBB strictly
regulates the transport of blood-borne cells and substances
into the brain. Brain capillary endothelial cells are a major
component of the BBB and have a dynamic interaction with
other neighboring cells, namely, astroglia, pericytes, peri-
vascular microglia, and neurons. The cross-talk between
cells of the neurovascular unit is crucial for the formation
and maintenance of a functional BBB. There are many
reports related to the effects of HIV-1 on astrocytes,
microglia, neurons, and endothelial cells. However, no
study addressed the effects of HIV-1 infection on pericytes.
The purpose of this study was to evaluate whether pericytes
can be infected with HIV-1. To determine the expression of
HIV-1 receptors on human brain pericytes, confocal
microscopy and western blots were performed. Human
brain pericytes expressed the HIV-1 receptor and co-
receptors (CD4, CXCR4, and CCR5). Confirmation of
HIV replication in human brain pericytes was performed
by HIV-1 p24 ELISA. Low viral replication was detected
after exposure to the X4 and R5 strains of HIV. These
findings indicate that human brain pericytes can be infected
with HIV-1. Infected pericytes may be involved in progres-
sion of the HIV-1-induced CNS damage. Supported by in
part by ES 07380, DA027569, MH63022, MH072567, and
NS39254.
Evidence of Neuroprotection by PDIA3 in SIV/
Methamphetamine Rhesus Macaques. C Ninemire,G
Pendyala, HS Fox; Pharmacology and Experimental Neu-
roscience, University Nebraska Medical Center, Omaha, NE
68198, USA.
Methamphetamine (METH) is a highly abused drug, and
its use is particularly prevalent among HIV-infected
individuals. The progressive state of neurodegeneration
with the combination of HIV+ METH is much more
harmful than either one alone. The effect of METH on the
brains of simian immunodeficiency virus (SIV)-infected
rhesus macaques is an outstanding model for the drug
abuse/HIV-infection scenario. We hypothesized that reactive
changes would manifest by alterations in gene expression,
and focused on the caudate nucleus. Microarray studies of
the caudate revealed a significant increase for expression of
protein disulfide isomerase family member A3 (PDIA3),
known to be induced by cellular stress. qRTPCR confirmed
S38 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59this increase in the caudate as well as the hippocampus of
METH-treated SIV animals compared to SIV alone.
PDIA3 has previously been implicated as a neuroprotec-
tive factor against prion neurotoxicity, therefore, we
hypothesized that over expression of PDIA3 is associated
with a neuroprotective role in chronic SIV and METH
comorbidity. In vitro studies using rat striatal neurons
indicated a METH-concentration-dependent up-regulation
of PDIA3 by confocal imaging. With PDIA3 responding
to METH toxicity, could an increase in PDIA3 expression
affect cell viability during METH treatment? In vitro
studies using SK-N-BE(2) neuroblastoma cells and
siRNA for PDIA3 following METH treatments, led to a
significant enhancement of cell toxicity. Conversely, over
expression of PDIA3 reversed the effect implicating
PDIA3 as a neuroprotective factor during METH neuro-
toxicity. Supported by NIDA, DA024467.
Impact of Chronic Opioid Exposure on HIV-1 Infection
i nt h eB o n eM a r r o w . N. Parikh, B. Wigdahl, M.
Nonnemacher; Microbiology and Immunology, Drexel
University College of Medicine, Philadelphia, PA 19102,
USA.
Intravenous drug use has been responsible for more than
36% of AIDS cases. Opiates are known to modulate the
immune system, augment susceptibility to HIV infection by
increasing the number of chemokine receptors present on
the cell surface and promote HIV disease progression by
increasing viral replication. However, the molecular basis
for accelerated HIV-associated disease progression and
effects on cell physiology has yet to be fully understood.
Within the bone marrow (BM) microenvironment, progen-
itor cells proliferate and give rise to precursor cells, which
normally do not enter the peripheral circulation; however,
upon changes in the chemokine levels, cells are induced to
traffic into circulation. Stromal cell-derived factor-1 (SDF-
1) is the major chemoattractant for hematopoietic progenitor
cells (HPCs) and a CXCR4 ligand. Thus, opiate exposure
boosts the number of chemokine receptors on the cell
surface and increases levels of SDF-1, leading to increased
trafficking of HIV-infected HPCs. We have established the
CD34+ BM progenitor cell line, TF-1, as a model for HPC
differentiation. The TF-1 cells express the HIV-1 receptor,
CD4, and co-receptors, CXCR4 and CCR5 and thus, are
susceptible to HIV-1 infection. We hypothesize that chronic
opiate exposure impacts HIV-1-infected cell differentiation,
proliferation, and/or cell viability and leads to modulation
of chemokine levels allowing for trafficking of progenitor
cells from the bone marrow compartment into peripheral
circulation, thus accelerating HIV-1 disease progression.
Supported by NIH/NIDA DC19807 and NIH/NINDS
NS32092.
Methamphetamine Translocates Occludin to Endosomes in
HumanCerebralEndothelialCells. M Park
1, B Hennig
2,M
Toborek
1;
1Department of Neurosurgery, University of
Kentucky Medical Center, Lexington, KY 40536, USA,
2College of Agriculture, University of Kentucky, Lexington,
KY 40536, USA.
Methamphetamine (METH) is a drug of abuse with
neurotoxic effects including blood–brain barrier (BBB)
disruption. Indeed, the loss of occludin expression occurs
as early as 1 h after 10 μM METH treatment in the
membrane fraction of HCMEC/D3 cells (human cerebral
microvascular endothelial cell line). The present study
focused on the role of caveolin-1 (cav-1) as a possible
modulator of METH-induced occludin changes in HCMEC/
D3 cells. Exposure to 10 μM METH resulted in increased
actin polymerization and localization of phospho-cav-1 at
the ends of actin filaments. In addition, occludin co-
immunoprecipitation with cav-1 and actin was decreased
in HCMEC/D3 cells treated with METH for 1 h. Exposure
to METH resulted in a shift of occludin localization from
caveolae fraction to endosome-rich fraction as determined
by sucrose-gradient fractionation. These changes were
associated with co-staining of occludin with Rab11, a late
endosome marker. Blocking of actin polymerization with
latrunculin A protected against alterations of occludin levels
in the cellular membranes. The present findings suggest that
under normal conditions, occludin is localized in cav-1-rich
regions; however, its localization is altered to the endosomal
pathway upon METH exposure. The change of cav-1
dynamics by actin polymerization may be responsible for
this phenomenon. The results of the present study suggest
the role of cav-1 in the regulation of occludin localization to
tight junctions. Supported in part by DA027569, MH63022,
MH072567, and NS39254.
Suppression of Tat-Mediated Neurotoxicity and Glial
Inflammatory Signaling through Modulation of the CC
Chemokine Receptor 5. EP Podhaizer
1, PE Knapp
2,K F
Hauser
1;
1Department of Pharmacology & Toxicology,
Virginia Commonwealth University, Richmond, VA
23298, USA,
2Department of Anatomy & Neurobiology,
Virginia Commonwealth University, Richmond, VA 23298,
USA.
CCR5 is critical to HIV-1 infection as well as aberrant HIV-
1 gp120-mediated signaling. Additionally, CCR5 has been
shown to interact on multiple levels with the mu opioid
receptor, whose signaling in response to opiates, such as
morphine, exacerbates HIV-1 Tat-mediated inflammatory
signaling and neurotoxicity. The Tat inflammatory signaling
cascade involves a drastic increase in RANTES/CCL5, an
endogenous ligand of CCR5, from glia. Therefore, we
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S39hypothesized that inhibition of CCR5 would interfere with
Tat-mediated inflammatory signaling and suppress neuronal
toxicity while potentially altering morphine-mediated exac-
erbation of these effects. To address this hypothesis,
neurotoxicity in response to morphine (500 nM), Tat
(100 nM), or the combination was assessed alone or
following pretreatment with the CCR5 antagonist, Mara-
viroc (50 nM), in mixed neuron-glial cultures using time-
lapse microscopy. CCR5 inhibition was neuroprotective
towards treatments of Tat and Tat+morphine. To determine
the mechanism(s) of this effect, nuclear translocation of the
NF-κB subunit p65, which is critical to glial mediated
cytokine and chemokine release, was assessed using
immunocytochemistry. Maraviroc blunted Tat mediated
nuclear immunopositivity of p65 at times when RANTES
has been shown to be upregulated by Tat (6 and 12 h), and
suggests one mechanism by which CCR5 inhibition
provides neuroprotection against Tat toxicity. Ongoing
studies aim to extend these findings and identify the
contribution of both glial and neuronal CCR5 to the
neurotoxic effects of Tat and morphine. Supported by NIH
P01 DA019398 and T32 DA007027.
Physical Activity Protects Against Methamphetamine-
Induced Blood–Brain Barrier Dysfunction. CS Rashid,
MJ Seelbach, L Chen, IE András, B Hennig, KA Esser, M
Toborek; Graduate Center for Nutritional Sciences, Univer-
sity of Kentucky, Lexington, KY 40536, USA.
Moderate voluntary exercise promotes overall health and
decreases the risk of developing cardiovascular and cere-
brovascular diseases. It is our hypothesis that exercise
increases antioxidant potential of brain microvessels thereby
attenuating CNS toxicity associated with drug abuse. To
address this hypothesis, mice were subjected to voluntary
wheel running for at least 5 weeks while sedentary mice had
no access to running wheels. At the end of the exercise
regimen, mice were injected with a single dose of
methamphetamine (meth, 10 mg/kg) for 1 or 24 h. Exercise
protected against meth-induced BBB dysfunction as
evidenced by in situ brain perfusion. The brains of
sedentary meth-treated mice showed elevated accumulation
of sodium fluorescein compared to exercised and vehicle
injected control mice, with the hippocampus appearing most
susceptible. Consistent with our functional results, isolated
brain microvessels from sedentary but not exercised mice
showed meth-mediated disruption of tight junction proteins
(claudin-5, occludin, and ZO-1) localization and contiguity.
In addition, meth exposure induced oxidative stress in
sedentary mice which was not seen in our exercised
animals. Interestingly, exercise tended to attenuate meth-
induced hyperthermia, which may also modulate BBB
function. Taken together, these results indicate that exercise
is a modifiable behavioral factor that protects against meth-
induced CNS toxicity. Supported by 2T32DK7778-11,
DA027569, MH63022, MH072567, NS39254, and from
the University of Kentucky Center for Muscle Biology.
Down Regulation of Longevity Gene P66ShcA Rescues
HIV-1- and Opiate-Induced T Cell Apoptosis. S Rehman,
D Kumar, A Malhotra, M Husain, PC Singhal; Department
of Nephrology, North Shore-LIJ, 100 Community Drive,
Great Neck, NY 11021, USA.
Patients with HIV-1 infection and opiate addicts have been
reported to develop loss of Tcells. Both HIV-1 and opiates are
known to induce cellular injury through the induction of
oxidative stress. Recently, a pivotal role of p66ShcA protein
has been identified in the generation of oxidative stress and
induction of Tcell apoptosis. We hypothesized that both HIV-
1 and opiates stimulate the p66ShcA pathway which deacti-
vates redox-sensitive stressresponseprogram (RSSRP). Inthe
present study, we examined the effect of HIV-1 and opiates on
theactivationoftheRSSRPinTcellsbothinvitroandinvivo.
Both HIV-1 and opiates promoted ROS generation which was
associated with T cell apoptosis. These effects of HIV-1 and
opiates were attenuated in p66ShcA-knockout T cells as well
as cells pre-treated by antioxidants such as SOD and catalase.
Moreover, both opiates and HIV-1 enhanced Tcell expression
of phospho-p66ShcA and phospho-Foxo3A. In in vivo
studies, both HIV-1 transgenic mice and mice receiving
morphine not only showed enhanced splenic tissue ROS
generation, apoptosis, expression of phospho-p66ShcA
and phospho-Foxo3A but also displayed diminished
production of antioxidants such as SOD and catalase.
These findings indicate that both HIV-1 and opiates
stimulate the p66ShcA pathway which deactivates RSSRP,
resulting into the accumulation of ROS (by attenuating
antioxidant generation) and thus facilitates the entry of Tcells
into apoptotic phenotype. Supported by National Institute of
Health.
Effect of Opiates in a HIV-Infected Human Glia-Neuron
Crosstalk System. M Rodriguez-Martinez
1, K Hauser
2,E
Rios-Olivares
1, JW Rodriguez
1;
1Department of Microbiology
and Immunology, Universidad Central del Caribe School of
M e d i c i n e ,B a y a m o n ,P R0 0 9 6 0 ,P u e r t oR i c o ,
2Department of
Pharmacology and Toxicology, Virginia Commonwealth
University, Richmond, VA 23298, USA.
Since there is frequent use of opiates in the HIV-1
population, it is significant to appreciate how these drugs
impact HIV-1 replication at the cellular and molecular level.
Previous studies have indicated that methadone (MTD)
enhances HIV-1 replication in microglia raising a major
concern that MTD and perhaps buprenorphine (BUP) could
S40 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59also play a role in the pathogenesis of HIV-associated
neurocognitive disorders (HAND). HIV-1 infection pro-
vokes immune activation of macrophages enhancing migra-
tion to the brain and secretion of neurotoxins affecting glial
cells and neurons. In this study, we used an HIV-infected
glia-neuron crosstalk system to investigate whether BUP
and MTD modulate HIV-1 replication using quantitative
RT-PCR, measuring pro-inflammatory cytokine production
using a cytometric bead array (CBA), and neurotoxicity
using MTT and caspase-3 assays. We show that both
MTD and BUP enhanced HIV-1 replication in human
glial cells in single culture and co-culture. This enhance-
ment was associated with a significant increase in the
production of inflammatory cytokines. Furthermore,
supernatants from single culture and co-culture of HIV-
infected human glial cells treated with MTD and BUP
augmented the neurotoxicity. These results suggest that
addition of either MTD or BUP to an HIV-infected human
glia-neuron system was detrimental for neuronal survival. The
findings also provide further information about the cellular
and molecular mechanisms through which MTD and BUP
may modulate HAND pathogenesis. Supported by NIH-
RCMI grant G12 RR03035.
Glycogen Synthase Kinase 3β (GSK3β) Inhibition
Prevents Monocyte (Mo) Migration Across Blood Brain
Barrier (BBB) via Rho/Rac Suppression. S Rom, S Fan,
H Dykstra, N Reichenbach, S Ramirez, Y Persidsky;
Department of Pathology and Laboratory Medicine, Temple
University School of Medicine, Philadelphia, PA 19140,
USA.
GSK3β was identified as a potent regulator of immune
responses. Our work showed GSK3β inhibition in human
brain microvascular cells (BMVEC) reduced adhesion
molecules, monocyte adhesion and migration across
BMVEC monolayers. Mo interactions with TNF-α activat-
ed BMVEC led to barrier disruption and GSK3β suppres-
sion restored barrier integrity. Mo migration across BBB
requires activation of small Rho GTPases regulating
cytoskeleton. We hypothesize that GSK3β inhibition in
Mo blocks their adhesion/migration across BBB via GTPase
inhibition. TNF-α BMVEC stimulation increased Mo
adhesion/migration (three to fourfold) and Mo pretreatment
with inhibitors resulted in decrease in adhesion (35–80%)
and migration (50%). Using G-LISA assay measuring
active, GTP-bound RhoA and Rac1, we demonstrated
increase in GTP-RhoA (3.8-fold) and GTP-Rac1 (1.8-fold)
in Mo stimulated with lysophosphatidic acid or LPS and
significant inhibition by three inhibitors (19–63%). To
mimic endothelial-cell Mo interactions we stimulated
VLA4 by fibronectin or by cross-linking with CD49d
antibody resulted in RhoA and Rac1 GTPases activation
in monocytic cell line U937 (twofold and threefold,
respectively). Mo pretreatment with GSK3β inhibitors
significantly attenuated activation of both RhoA and
Rac1 (50% and 35% decrease, respectively). Cells treated
with GSK3 inhibitors showed increased levels of phos-
phorylated (inhibitory) sites of GTPase binding proteins,
Coffilin and VASP indicating that inhibition of GSK3
directly affects cytoskeleton rearrangement and adhesion
via suppression of Rho GTPases. Supported by
AA015913 and MH65151.
Biodistribution and Efficacy of Nanoformulated
Antiretroviral Drugs. U Roy, P Dash, S Balkundi, PR
Bathena, A Nowacek, L Poluektova, J McMillan, K
Fletcher, Y Alnouti, H Gendelman; Department of Pharma-
cology and Experimental Neurosciences, University of
Nebraska Medical Center, Omaha, NE 68198, USA.
Antiretroviral therapy (ART) has substantively reduced
mortality of HIV disease. However, complex dosing
regimens and tissue toxicities limit therapeutic efficacy. To
this end, nanoformulated ART (nanoART) was developed to
improve therapeutic outcomes. Nanoparticle formulations of
efavirenz (EFV), ritonavir (RTV), and atazanavir (ATV)
were milled and characterized in cell-based laboratory
assays (J. Contr. Rel. 2010). The best ART formulations
wereassessedfor drugpharmacokinetics(PK),biodistribution
and toxicity in normal Balb/C mice. PK and biodistribu-
tion of nanoART were determined by mass spectrometry
following intraperitoneal, subcutaneous and intravenous
administration. Drug efficacy was determined in com-
bined immunodeficient mice reconstituted with human
peripheral blood lymphocytes (hu-PBL-NOD/SCID) and
infected with the HIV-1. PK studies of the nanoART
combination in Balb/C mice revealed levels of all three
drugs in serum, peaking at 6 h (4 μg/ml EFV, 2–3 μg/ml
ATV and 1.5–2 μg/ml RTV) and detectable in liver,
spleen, kidneys and lungs up to 14 days (0.1–10 ng/ml)
post administration. Treatment of infected hu-PBL-NOD/
SCID mice with combined nanoART resulted in a 100-
fold reduction in viral antigen compared to control. After
as i n g l ed o s eo fn a n o A R T ,d r u gl e v e l sw e r ed e t e c t e di n
serum and tissues up to 14 days post-treatment and were
effective in reducing viral levels in infected humanized
mice. These studies demonstrate the potential of nano-
ART to simplify drug regimens and better elimination of
HIV-1 from its tissue reservoirs. Supported by NIH.
Elevated Expression of HIV Viral Proteins in the Liver
and Spleen of HIV-1 Transgenic Rats Treated with High
Concentration of Ethanol. S Sarkar, EF Langsdorf, C Liu,
SL Chang; Institute of Neuro-Immune Phramacology, Seton
Hall University, South Orange, NJ 07079, USA.
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S41Ethanol concentration [alcohol by volume (ABV)] signifi-
cantly differs in various alcoholic beverages ranging from
12% in wine to 40% or higher in hard liquors. Ethanol
activates the hypothalamic–pituitary–adrenal axis, subse-
quently activating the supraoptic nucleus (SON). We have
previously reported that SON was activated at 48%, 64%, or
80% ethanol, but not 16% or 32%. Therefore, we hypothe-
sized that choosing high ABVover low ABV beverages can
result in different outcomes such as differential gene expres-
sion inhealthanddisease. Inthisstudy,wehavecomparedthe
gene expression of HIV viral proteins tat and nef in liver and
spleen of HIV-1 transgenic rat model (rodent model of HIV
patients on HAART). Animals were administered water, 20%
or 52% ethanol (4.8 g/kg per-day) by gavage for 3 days. Two
hours after the final treatment blood was collected for serum
preparationtodeterminecorticosteronelevels,liverandspleen
were harvested for RNA isolation to determine expression of
tat and nef using absolute quantitative real-time PCR (aqPCR)
developed specifically for HIV viral proteins. No significant
difference among groups was observed in the serum cortico-
sterone levels. Our data shows that copy number of tat and nef
is52.35±1.47and764.2±165.4inliverand647.7±91.85,and
22,218±1,887 in spleen, respectively. The tat and nef
expressions are significantly higher in the animals given
ethanol of 52% but not 20% in comparison to control. These
results indicate that high ABV beverages can increase the
expression of HIV-1 viral proteins in HIV-infected patients on
HAART. Supported by RC2 AA019415/K02 DA016149.
Effect of Antioxidant Response Modulation on HSV-
Induced Oxidative Damage. SJ Schachtele, S Hu, MR
Little, JR Lokensgard; Center for Infectious Diseases and
Microbiology Translational Research, University of Minne-
sota, Minneapolis, MN 55455, USA.
Using a murine model of herpes simplex virus (HSV)-1
encephalitis, our laboratory has shown that microglial cells
are the principle mediators of neuroinflammation during
viral infection, including production of proinflammatory
cytokines and chemokines. Addition of HSV-1 to purified
murine microglial cell cultures results in the generation of
reactive oxygen species (ROS), an additional mechanism to
damage invading pathogens. ROS production, while bene-
ficial in combating infection, can also cause irreparable
harm through bystander damage to crucial host cells.
Indeed, HSV-infected microglia induce neuronal oxidative
damage and mediate neurotoxicity in vitro. Antioxidant
responses, preferentially in astrocytes, have been shown to
be neuroprotective during exposure to oxidative insults such
as hydrogen peroxide. In the present study, we utilized the
transducing power of lentiviral particles for the efficient
delivery of the antioxidant transcription factor nuclear
factor-E2-related factor 2 (Nrf2) and the antioxidant protein
heme oxygenase-1 (HO-1) cDNA to murine astrocytes.
Immunocytochemistry and western blot confirmed lentiviral
delivery and functional expression of antioxidant protein.
We hypothesize that this antioxidant protein overexpression
in murine astrocytes will be protective from HSV-induced
microglial cell-mediated neurotoxicity. Conversely, we
hypothesize that delivery of short hairpin RNA for either
Nrf2 or HO-1 to murine astrocytes will increase the
neurotoxic effect of HSV-stimulated microglia. Supported
by NIMH (MH-066703) and NIDA (T32DA007097).
HIV-1 Glycoprotein 120 Induces the Pro-Inflammatory
Cytokine IL-6 via the NF-κB Pathway and
Methamphetamine can Synergistically Potentiate
gp120-Mediated IL-6 Induction. A Shah,AK u m a r ;
Division of Pharmacology & Toxicology, University of
Missouri—Kansas City, Kansas City, MO 64108, USA.
HIV-1 gp120 facilitates the viral attachment and entry into
the CNS leading to infection of various regions of the brain,
resulting in HIV-1 associated neurocognitive disorders. In
this study, we sought to address whether gp120 can induce
the pro-inflammatory cytokine interleukin-6 (IL-6). We also
addressed whether exposure to methamphetamine can
induce IL-6 expression in astrocytes, either alone or in
synergy with gp120. The transfection of gp120 showed a
time dependent induction of IL-6 mRNA and protein
expression, with peak levels of 51.3±2.1-fold and 11.6±
2.2-fold, respectively. The induction of IL-6 could be
successfully abrogated by gp120-specific siRNA. Using
chemical antagonists and siRNA for the NF-κB pathway,
we demonstrated the involvement of this transcription factor
in gp120-mediated IL-6 induction. Both I-κB-α and IKK2
inhibitors could abrogate the gp120-mediated IL-6 induc-
tion by 56.5% and 60.8%, respectively. In this study, we
also report that exposure of SVGA cells to methamphet-
amine results in an increase in IL-6 expression by 4.9±2.3-
fold, which was blocked by mGluR5 inhibitor MPEP. The
expression of IL-6 increased further (76.0±12.1-fold) when
meth exposure was combined with gp120 transfection.
Together, our results suggest NF-κB to be a potential
therapeutic target for HIV-1 infected patients. We also
demonstrate that methamphetamine can act synergistically
with gp120 to induce IL-6 expression. Thus, HIV-infected
individuals who consume methamphetamine are at higher
risk of developing neuro-inflammation than non-abusers.
Methamphetamine and HIV-1 Tat Cooperate to
Down-Regulate a Prominent Pro-Survival Pathway in
Astrocytes, the Wnt Signaling Pathway. A Sharma
1,X
Hu
2, C Napier
2, L Al-Harthi
1;
1Department of Immunology/
Microbiology, Rush University Medical Center, and Chi-
cago CFAR, Chicago, IL 60612, USA,
2Department of
S42 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59Pharmacology/Center for Compulsive Behavior & Addic-
tion, Rush University Medical Center, and Chicago CFAR,
Chicago, IL 60612, USA.
Methamphetamine (Meth) exacerbates HIV-associated neu-
rocognitive disorders (HAND). The mechanism by which
Meth exacerbates HAND is not entirely clear but is likely to
involve cooperation between Meth and HIV verotoxins
such as the transactivator of transcription (Tat) to heighten
dysregulation in the CNS. We evaluated the impact of Meth
on the Wnt pathway in astrocytes transfected with Tat. Meth
(10 μM–1 mM) and Tat cooperated to downregulate Wnt/β-
catenin signaling by >35%, as measured by Topflash
reporter activity. Meth and Tat also down-regulated LEF-1
transcript, a key downstream effector of the canonical Wnt
pathway, by >30%. Meth also downregulated NFAT, an
important mediator of non-canonical Wnt signaling by
>70%. Interestingly, estrogen, an activator of β-catenin
signaling, at physiological concentrations of 1.5 and 3 nM
normalized individual Meth and Tat effects on Wnt
signaling but not their combined effects. Collectively, these
findings demonstrate that Tat and Meth cooperate to down-
regulate Wnt signaling. The net outcome of which may be a
critical mechanism for exacerbated Meth- and Tat-mediated
pathogenesis in the CNS. Supported by NIDA 1R03
DA026723-01, Chicago D-CFAR P30 AI082151.
Phosphorylation of Serine Resides in both the First
Intracellular Loop and C-Terminal Region Differentially
Regulates the Signaling Properties of CCR5. C Song,L
Zhang, TJ Rogers; CILR, Temple University School of
Medicine, Philadelphia, PA 19140, USA.
The cross-talk between the Mu-opioid receptor and chemo-
kine receptor CCR5 can play an important role in neuro-
immune regulation. The heterologous desensitization of
CCR5 by agonists of MOR, homologous desensitization by
agonists of CCR5, is dependent on receptor phosphoryla-
tion. We hypothesized that phosphorylation of serine
residues differentially regulates the biological functions of
CCR5. Here, we report that the phosphorylation of serine
residues in the first intracellular loop, and the C-terminal
region, differentially regulates signaling properties of
CCR5. We examined the cell signaling activity of CCR5
in various serine phoshorylation states using HEK293 cells
expressing either wild type or various serine mutants
created by site-specific mutagenesis. For example, analysis
of wild-type, or S63D and S63A, or S337A and S337D
substitutions, shows that phosphorylation of serine 63 and
S337 is important for both the calcium flux response and
chemotaxic activity. Moreover, experiments with S325A
and S325D, S336A and S336D, S342A and S342D,
indicate that the phosphorylation of these C terminal serines
is critical for the chemotactic activity of CCR5, but not the
calcium mobilization response. Taken together, our studies
show that “regulation” of CCR5, by either homologous or
heterologous desensitization, can be the result of phosphor-
ylation of specific serine residues which potentially yields a
receptor with selective partial functional activity. This
“selective phosphorylation” mechanism adds a significant
degree of precision to the regulation of this receptor.
Supported by DA14230, DA16544, DA25532, and
P30DA13429.
Exposure of TF-1 Hematopoietic Progenitor Cells to
the Mu-Opioid Agonist DAMGO Leads to Altered
Surface Expression of CXCR4 and Decreased HIV-1
Replication. M. Strazza,S .P a s s i c ,V .P i r r o n e ,O .M e u c c i ,
B. Wigdahl, M. Nonnemacher; Microbiology and Immu-
nology, Drexel University College of Medicine, Philadel-
phia, PA 19102, USA.
About one-third of the cases of human immunodeficiency
virus type-1 (HIV-1) infection leading to acquired immuno-
deficiency syndrome in the United States have been attributed
to injection drug use, frequently involving the abuse of
opioids. Previous in vitro and in vivo studies addressing the
role of mu-opioid agonists in altering levels of the co-receptor
CXCR4, and consequent HIV-1 replication, have yielded
contrasting results. The bone marrow (BM) is believed to be a
potential anatomical sanctuary for HIV-1. In this study, the
CD34+CD38+humanhematopoieticprogenitorcelllineTF-1
was usedasa model toinvestigate the effects ofthe mu-opioid
receptor-specific peptide DAMGO on CXCR4 expression as
well as infection of undifferentiated hematopoietic progenitor
cells. The results revealed the presence of the mu-opioid
receptor-1 isoform (MOR-1) in TF-1 cells. Flow cytometry
experimentsindicatedthattreatmentwithDAMGOresultedin
a shift in the relative proportion of CXCR4+ cells to the low-
expressing phenotype. This result is correlated with a greater
than threefold reduction in replication of the CXCR4-utilizing
HIV-1 strain IIIB, indicating a potential role for high level
CXCR4 expression in sustaining infection within these cells.
These experiments provide insight into the role of MOR-1-
mediated signaling with respect to inhibition of viral replica-
tion in BM progenitor cells. Supported by NIH/NIDA:
DC19807; NIH/NINDS: NS32092.
Culture Oxygen Affects Tat and Nef Toxicity in Rat
Striatal Neurons. LM Tiede, EA Cook, B Morsey, H Fox;
Department of Pharmacology and Experimental Neurosci-
ence, University of Nebraska Medical Center, Omaha, NE
68123, USA.
Neurodegeneration associated with persistent human immu-
nodeficiency virus infection continues to afflict infected
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S43individuals. Much of the research on it’s etiology focuses on
viral protein neurotoxity. In traditional tissue culture incuba-
tors, the oxygen level that cells experience is higher than in
vivo conditions. These differences can alter experimental
results, especially pertaining to mitochondria and oxidative
metabolism. Using quantitative imaging techniques, we
investigated the role that oxygen levels played in mitochon-
drial responses of rat striatalneurons tothe HIV virotoxinsTat
and Nef. We found that neurons cultured in physiological
oxygen and atmospheric oxygen both exhibited significant
increases in mitochondrial reactive oxygen species production.
However, mitochondria of neurons cultured at physiological
oxygen underwent depolarization while those cultured at
atmospheric oxygen became hyperpolarized following treat-
ment with Tat compared to controls treated with vehicle.
Compared to controls treated with heat-inactivated Nef, native
Nef treatment also increased mitochondrial reactive oxygen
species production for both conditions, but resulted in
mitochondrial depolarization and increased death only in
neurons cultured in physiological oxygen. These results
indicate a role for oxygen metabolism and redox balance in
toxicity of viral proteins, and help elucidate mechanisms of
neurotoxicity of HIV. Supported by National Institutes of
Health grants MH073490 and MH062261, Nebraska Tobacco
Settlement, NIAID Award 5T32 AIO60547.
Speedball Enhances Cytokine Production in Presence of
HIV Vpr. L Torres, LG Rivera, RJ Noel Jr; Department of
Biochemistry, Ponce School of Medicine, Ponce, PR 00716
Puerto Rico.
Human immunodeficiency virus (HIV) infected individuals
may be at an increased risk of developing neurological
abnormalities. Viral proteins, such as Vpr, are considered to
cause neuronal damage, which may be aggravated with
concurrent drug use. Studies have examined the interactions
between viral neurotoxins and individual drugs of abuse.
However, no studies to date have examined the effect of
multiple drug abuse, such as speedball, with HIV neurotoxins.
Live rats were tested by the novel object and novel location
tasks to assess cocaine and morphine effects in hippocampal-
dependent learning and memory. Concurrent in vitro cell
culture studies assessed the ability of speedball to alter Vpr-
related induction of cytokines in astrocytes. Rats treated with
cocaine have a significant increase (p<0.05). Speedball
enhances RANTES and IP10 in astrocytes expressing Vpr.
Drug use is a prominent risk factor driving the HIVepidemic.
Coincident drug abuse with HIV infection results in almost a
doubling of the risk of neurocognitive disorders. We expect
that speedball will aggravate Vpr neurotoxic effects by
increasing in pro inflammatory and apoptotic factors resulting
in exacerbated learning deficits. Supported by R03DA026722
and G12RR003050.
Astrocyte Elevated Gene-1 Contributes to HIV-1-
Associated Dementia by Modulating Astrocyte Responses
to Inflammation and Injury. N Vartak,KB o r g m a n n ,L
Tang, A Ghorpade; Department of Cell Biology and
Anatomy, University of North Texas Health Science Center,
Fort Worth, TX 76107, USA.
A novel gene, astrocyte elevated gene-1 (AEG-1), was
identified as an HIV-1 and tumor necrosis factor (TNF)-
alpha inducible transcript in astrocytes. Subsequently, AEG-
1 was found to be elevated in many cancers, and was
identified as an oncogene responsible for metastasis,
anchorage-independent growth and resistance to chemother-
apeutic drugs. However, its role in HIV-1 infection has not
been elucidated. Here, we propose that AEG-1 is a
contributing factor to HAND/HAD progression, modulating
astrocyte responses to inflammation, injury and stress by
activating the downstream nuclear factor (NF)-kappa-B
pathway. Our preliminary data in human astrocytes demon-
strate that HAD-relevant stimuli upregulate the expression
of AEG-1 at both mRNA and protein levels. A
corresponding decrease in excitatory amino acid transporter
(EAAT)-2 mRNA levels and an increase in CXCL8
chemokine production was also observed. This suggests a
probable role of AEG-1 in HAD by modulating the
expression of these proteins at the mRNA level. Further,
our immunocytochemical studies show that AEG-1 localizes
in the cytoplasm in response to HAD-relevant inflammatory
stimuli but translocates to the nucleolus in response to injury
and oxidative stress. Time-lapse imaging studies were
performed with AEG-1-GFP construct, to determine the
intracellular localization of AEG-1 in astrocytes during
migration and HAD-relevant stimuli-treatment. Differential
intracellular AEG-1 localization in response to HAD-relevant
stimuli and injury strongly implicates AEG-1 in regulating
astrocyte behavior in HAD and astrogliosis. Thus, AEG-1
may link astrocyte injury responses to the development and
progression of malignant astrocytomas and HAD. Supported
by NINDS/2RO1NS48837-06.
HIV-1 Envelope Evolution and Cognitive Dysfunction
Progression in Puerto Rican Women Infected with HIV-1.
FJ Vázquez-Santiago
1, LM Meléndez
2, M Plaud-Valentín
2,
V Wojna
2,R JN o e lJ r
1, V Rivera-Amill
1;
1Department of
Microbiology, Ponce School of Medicine, Ponce, PR
00732–7004, Puerto Rico,
2Department of Microbiology
and Medical Zoology, University of Puerto Rico Medical
Sciences Campus, San Juan, PR 00936–5067, Puerto
Rico.
HIV associated neurocognitive disorder is a clinical
neurodegenerative manifestation caused by HIV-1 neuro-
invasion. Neurodegeneration has been related, among
S44 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59other factors, to both the direct and indirect actions of
gp120 within the central nervous system. The main
purpose of this project is to characterize the contribution
of HIV envelope (env) evolution to neurological impair-
ment by studying viral evolution and compartmentaliza-
tion and correlating them with disease severity and
cognitive status/decline in HIV-1-infected women with
cognition impairments. We hypothesize that specific
sequences changes within env are linked with progression
to HIV-1 associated dementia. Viral RNA was extracted
from plasma and cerebrospinal fluid collected from
patients at various time points. Gp120, including C2V3
region, was amplified by PCR and the product cloned
into pCR2.1, and sequenced. Sequencing data showed
4.8% divergence of plasma virus between samples
obtained before and after neurological progression, with
the later sample showing 40% greater diversity among all
envelopes sequenced. In cerebrospinal fluid (CSF), the
divergence was lower than in plasma sequences but
exhibited the same trend; the sequences obtained after
progression showed greater divergence and diversity.
Sequences in plasma and CSF reflected increased viral
diversity at or near the time of progression, which
suggests envelope evolution may be a contributing factor
for development of neuropathology. Supported by NCRR-
RCMI/RR003050; R01-MH08316-01; and SNRP-
NINDS-1-U54NS431.
Involvement of 4-Aminopuridine-Sensitive K+ Current
in Methamphetamine-Induced Hippocampal Neuronal
Apoptosis. J Wang
1, H Xiao
2, H Xiong
1;
1Department of
Pharmacology and Experimental Neuroscience, University
of Nebraska Medical Center, Omaha, NE 68198–5880,
USA,
2Department of Toxicology, School of Public Health,
Nanjing Medical University, Nanjing, China 210029, USA.
Methamphetamine (Meth) is an illicit psychostimulant that
is widely abused in the world. It is reported that Meth
abuse leads to neuronal damage, such as loss of gray matter
in the cortices and the shrinkage of hippocampi. However,
the mechanism is still largely unknown. K+ homeostasis is
believed to be closely related with cell volume, and
persistent K+ efflux results in apoptotic volume decrease.
In the present study, we explored whether K+ channels were
involved in Meth-induced apoptosis in primary rat hippo-
campal neuronal cultures. Using state-of-the-art whole-cell
patching techniques, we observed that bath application of
Meth differentially increased the amplitude of 4-
amonopyridine (4-AP)-sensitive K+ current, but not the K
+ current sensitive to tetraethylammonium (TEA), which is
in line with the toxicological results that the Meth-induced
neuronal apoptosis was significantly blocked by 4-AP, but
not TEA. Further investigation >revealed that Meth en-
hanced 4-AP-sensitive K+ current by inhibition of ERK
phosphorylation. These results, taken together, suggest that
Meth increases 4-AP-sensitive K+ current by inhibition of
ERK phosphorylation, leading to apoptotic volume decrease
and ultimate neuronal apoptosis. Supported by NIH 2R56
NS041862-10A1.
Morphine Suppresses the Cellular Restriction Factors of
AIDS Virus Infection. YZ Wang, X Wang, L Ye, JL Li, L
Song, N Fulambarkar, WZ Ho; Department of Pathology &
Laboratory Medicine, Temple University School of Medi-
cine, Philadelphia, PA 19140, USA.
A key facet of innate defense mechanisms against retro-
viruses is the presence of intracellular restriction factors.
Although opioids, such as morphine, enhance HIV/SIV
infection and replication, the mechanism(s) of the action
remains to be determined. Thus, we investigated the impact
of morphine on cellular restriction factors of AIDS virus,
HIV, and SIV. We demonstrated that morphine treatment of
human blood mononuclear phagocytes significantly
inhibited the expression of several key elements (RIG-I,
IRF-3, IRF-5, and APOBEC3C/3G) in type I IFN pathway.
The suppression of these innate restriction factors was
associated with reduced production of type I IFNs and the
enhancement of HIV or SIV infection of macrophages.
These findings indicate opioid use impairs cellular innate
anti-HIV/SIV mechanism(s) in macrophages, contributing
to cell susceptibility to AIDS virus infection. Supported by
National Institutes of Health grants DA12815, DA22177,
and DA27550 (W-Z.H.).
Mycophenolate Mofetil Inhibits Hepatitis C Virus
Replication in Hepatocytes. LY e , JL Li, X Wang, YZ
Wang, H Parekh, WZ Ho; Department of Pathology and
Laboratory Medicine, Temple University School of Medi-
cine, Philadelphia, PA 19140, USA.
Hepatitis C virus (HCV) infection is a leading indication
for liver transplantation and a major cause of graft
failure. Cyclosporine A (CsA), a widely used immuno-
suppressant for people who receive organ transplantation,
has been recognized to have the ability to inhibit HCV
r e p l i c a t i o nb o t hi nv i v oa n din vitro. In this study, we
investigated the effects of several other immunosuppres-
sants, including mycophenolate mofetil (MMF), Rapamy-
cin (sirolimus), and FK506 (tacrolimus), on HCV
infection/replication in human hepatocytes. MMF treat-
ment of hepatoctyes before or during HCV infection
significantly suppressed full cycle viral replication, as
evidenced by decreased expression of HCV RNA, protein
and production of infectious virus. In contrast, Rapamy-
cin and FK506 had little effect on HCV replication.
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S45Investigation of the mechanism(s) disclosed that the
MMF’s inhibition of HCV replication is due to its
depletion of guanosine, a purine nucleoside crucial for
synthesis of guanosine triphosphate, which is required for
HCV RNA replication. We found that the supplementa-
tion of cell cultures with exogenous guanosine could
reduce MMF-mediated anti-HCVactivity. These data indicate
that although MMF is a potent immunosuppressant, it may be
beneficial for people infected with HCV. Future studies are
needed to determine clinical significance of the in vitro anti-
HCV effect of MMF. Supported by NIDA DA12815,
DA22177, and DA27550.
ZO-1 Nuclear Translocation by Rho Signaling is
Involved in HIV Tat-Induced Alterations of Claudin-5
Expression. Y Zhong
1, SY Eum
1, B Hennig
2, M Toborek
1;
1Department of Neurosurgery, University of Kentucky,
Lexington, KY 40536,
2College of Agriculture, University
of Kentucky, Lexington, KY 40536, USA.
HIV Tat protein can contribute to the dysfunction of brain
microvascular endothelial cells (BMEC) and facilitate
HIVentry into the brain. Rho signaling plays an essential role
in HIV-mediated disruption of the BBB integrity; how-
ever, the mechanisms involved in these effects remain
unclear. In the present study, we hypothesize that ZO-1
serves as a scaffold for the assembly of Rho signaling
molecules with the transmembrane tight junction proteins
and that this association may be disrupted by Tat protein.
Indeed, exposure to Tat activated the Rho signaling,
i n c r e a s e dZ O - 1t r a n s l o c a t i o ni n t ot h en u c l e i ,a n dd e -
creased claudin-5 levels. These effects were accompanied
be increased binding activity of transcription factor
CREB to the proximal region of the ZO-1-promoter.
Inhibition of the Rho signaling cascade by the C3
exoenzyme, ROCK inhibitor Y27632 or MLC inhibitor
ML-9 blocked Tat-induced CREB activation and ZO-1
nuclear translocation. In a series of experiments with
CREB-depleted and ZO-1-depleted cells, we demonstrat-
ed that MLC phosphorylation was important for Tat-
induced localization of ZO-1 into the nuclei. Interesting-
ly, inhibition of nuclear translocation of ZO-1 protected
both against Tat-mediated activation of CREB DNA
binding and claudin-5 disruption. These findings suggest
that the Rho signaling pathway can disrupt the integrity
of tight junctions in response to Tat treatment by
stimulating nuclear translocation of ZO-1, which then
induces a decrease in claudin-5 expression. Supported by
DA027569, MH63022, MH072567, and NS39254.
HIV-1 Tat and Morphine Affect Calcium Levels and
Viability of Oligodendroglia: Evidence for NMDA
Effects. SZ o u
1, S Fitting
2, KF Hauser
2,P EK n a p p
1;
1Department of Anatomy and Neurobiology, Virginia
Commonwealth University, Richmond, VA 23298, USA,
2Department of Pharmacology and Toxicology, Virginia
Commonwealth University, Richmond, VA 23298, USA.
Myelin pallor is frequently reported in HIV patients, and
can occur prior to other evidence of CNS disease. This has
largely been attributed to edema resulting from blood brain
barrier pathology, but we also found that HIV-1 Tat can
directly affect oligodendroglia (OLs) in culture and that OLs
in the CNS of Tat transgenic mice show pathology (Hauser
et al., Glia, 2009). Studies were conducted to determine if
direct effects of HIV-1 Tat on OL survival or other
functional or phenotypic changes are mediated through
interaction with NMDA receptors. We used a computer-
assisted imaging system to track individual cells at 30 min
intervals over 48 h in vitro. Both immature OLs (morphol-
ogy: multiple thin, branching processes) and mature OLs
(morphology: several thick processes and myelin-like
membranes) treated with HIV-1 Tat had a dose-dependent
(1–100 nM) decrease in survival. Initial studies in an
infectious culture model showed similar toxicity. At both
stages of maturation Tat induced a gradual increase in [Ca2
+]i that was attenuated by MK801 but not by CNQX. We
also examined interactions between Tat and the mu-opioid
agonist morphine. Morphine by itself elevated [Ca2+]i in
both immature and mature OLs in a naloxone-reversible
manner. The kinetics and amplitude of [Ca2+]i response to
combined Tat and morphine exposure was variable between
individual cells, pointing to heterogeneity even among OLs
at a similar stage of differentiation. Our results provide
evidence that OLs are targets of HIV/viral proteins and/or
opiates, and suggest that glutamatergic mechanisms are
involved. Supported by DA24461; DA19398; and
NS69216.
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Synaptodendritic Alterations Induced by HIV-1 Tat in
Hippocampal Neurons. MV Aksenova, MY Aksenov, S
Bertrand, CF Mactutus, RM Booze; Department of Psy-
chology, University of South Carolina, Columbia, SC
29208, USA.
Cognitive deficits in normal aging, non-viral neurological
disorders, and HIV-associated neuropathology are reflective
to the aberrant structure of synaptodendritic networks.
Evidence of the morphological neurodegenerative triad
of dendritic spine loss, dystrophic neurites, and dendritic
s i m p l i f i c a t i o ni nt h eb r a i nb u r d e n e db yc h r o n i cH I V - 1
infections suggests that advanced analysis of dendritic
morphology and synaptic densities is essential for proper
S46 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59assessment of neuronal injury resulting from the exposure to
neurotoxic viral proteins. The cytoskeleton of dendritic spines
is primarily made of filamentous actin (F-actin), which makes
the fluorescent phalloidin (specific F-actin-binding peptide
probe) staining an excellent method for the analysis of the
spine morphology. In this study, we report experiments
demonstrating that treatment of hippocampal cultures
with 50 nM dose of Tat 1–86 B for 4–2 4hr e s u l t s
in the decreased labeling of neuronal dendrites with
fluorescent phalloidin. Results suggest that early events
in the process of Tat neurotoxicity involve F-actin de-
polymerization and/or degradation of the F-actin-rich
synaptodendritic network. The actin cytoskeleton directly
determines the morphology of the spine, which is known
to rapidly change in responses to stimuli. Supported by
University of South Carolina Research Foundation grant
and NIH Grant DA013137.
Alcohol Redistributes Membrane Lipids and Calcium
Permeable AMPA Receptors to Focal Dendrite
Microdomains. M Bae, H Xu, VR VV Ratnam Bandaru,
NJ Haughey; Department of Neurology, Johns Hopkins
University School of Medicine, Baltimore, MD 21287, USA.
HIV-infected subjects who abuse alcohol exhibit deficits in
cognitive tasks that assess frontal lobe function compared
with HIV-infected subjects who do not abuse alcohol. The
mechanisms how alcohol can accentuate the toxic effects of
HIV products and viral proteins have not been identified.
Here, we suggest that alcohol impairs neuronal function by
modifying the membrane lipid composition, resulting in
AMPA receptor mislocalizations. Ethanol (0.03–0.3%)
extracted neuronal membrane lipids within 2 min, with the
following efficiency: cholesterol>ceramide>sphingomye-
lin. Lipids recovered within 12 h, suggesting that new
synthesis was required to restore the lipids. Based on
evidence that lipid rafts where cholesterol/ceramide
enriched are important for the surface expression of
AMPA-type glutamate receptors, we determined if ethanol
disrupted the AMPA receptor locations. Ethanol caused a
collapse of gaglioside (GM1) enriched lipid rafts and
increased the colocalization of GluR1 with GM1. Thus,
ethanol disrupted membrane lipid compositions and redis-
tributed AMPA receptors to create high receptor density
areas. These observations were consistent with functional
studies in which an ethanol exposure followed by AMPA
applied during ethanol washout increased the amplitude of
focal calcium bursts in AMPA receptor concentrated regions
with large dendrite regions unresponsive to AMPA. Thus,
alcohol abuse may contribute to neuronal dysfunction in
HIV-infected subjects by perturbing plasma membrane
structure and mislocalizing calcium permeable AMPA
receptors. Supported by NIH grant R01AA017408.
The Effect of gp120 on the Antinociceptive and
Neurophysiological Effects of Morphine. X Chen,L G
Kirby, J Palma, EB Geller, TK Eisenstein, MW Adler;
Center for Substance Abuse Research, Temple University
School of Medicine, Philadelphia, PA 19140, USA.
Recently, we showed that morphine’s analgesic activity
can be attenuated by chemokines, specifically CCL5 and
CXCL12. The HIV-1 coat protein, glycoprotein 120
(gp120), binds to the same respective receptors as do
these chemokines. Hence, the present experiments were
designed to investigate the effect of gp120 on morphine
antinociception in rats. Morphine, with or without gp120,
was infused into the PAG of young adult, male Sprague–
Dawleys via a surgically implanted cannula, or given
subcutaneously (sc)., and antinociception assessed using
the cold-water (−3°C) tail-flick test. It was found that (1)
pretreatment with gp120 itself (10–133 ng, PAG) had no
nociceptive effect; (2) gp120 (25 or 100 ng) dose-
dependently reduced the antinociception induced by sc
injected (3 or 6 mg/kg) or PAG administered (100 ng)
morphine; (3) the inhibitory effect of gp120 on morphine-
induced antinociception was reversed by AMD 3100, an
antagonist at CXCR4. The effect of gp120 on mu-opioid
receptor-mediated effects in PAG slices was also exam-
ined via whole-cell patch-clamp recordings. Pretreatment
of slices with gp120 (200 pM) prevented morphine
(10 μM)-induced hyperpolarization and reduction of
input resistance in PAG neurons. Electrophysiology
studies paralleled gp120-induced desensitization of a
mu-opioid receptor-mediated response in PAG neurons
at the single-cell level. These studies are the first to
demonstrate that the analgesic activity of morphine can
be reduced by the presence of gp120 in the PAG and that
pretreatment with AMD 3100 is able to restore the
analgesic effects of morphine. Supported by in part
NIDA Grants DA 06650 (MWA) and DA 13429
(MWA) and DA 20126 (LGK).
Morphine-Induced Reversible Inhibition of Renal
Tubular Secretion of
99mTC-MAG3 in Mice. K Cheng
1,
K Bhagarva
2, D Kumar
1, D Salhan
1, A Malhotra
1,C J
Palestro
2, S Gupta
3, PC Singhal
1;
1Feinstein Institute for
Medical Research, Long Island Jewish Medical Center,
New Hyde Park, NY 11040, USA,
2Department of Nuclear
Medicine, Long Island Jewish Medical Center, New Hyde
Park, NY 11040, USA,
3Liver Center, Albert Einstein
College of Medicine, Bronx, NY 10461, USA.
Kidney plays a key role the excretion of opiate metabolites
in general, and morphine in particular. In the present study,
we evaluated the effect of morphine metabolite excretion on
renal tubular secretion of
99mTc-MAG3 in mice. Healthy
J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59 S47FVB/N mice (n=3 each) were implanted with 75 mg
morphine pellet s.c. for 72 h. The mice were injected with
100 μCi of
99mTc-MAG3 via the tail vein and imaged with
a gamma camera. After image acquisition, the morphine
pellet was removed. Mice were imaged again after 72 h.
Control mice were implanted with placebo. The acquisition
protocol consisted of 60-s images followed by 29-min
images. Regions of interest were drawn around each kidney
to generate time-activity curves. Split renal function and
time to peak activity (Tpeak) were determined. Split renal
function was not significantly different between morphine-
treated and placebo mice (P>0.05). The peak time of
99mTc-MAG3 excretion in morphine-treated mice was
significantly longer than placebo, 24.6±3.0 min vs 1.3±
0.5 min. After 72 h pellet removal, 99mTc-MAG3 excretion
was reversed to 2.0±1.7 min, and thus indicating restoration
of tubular function. Morphine metabolites compete with
other drugs for their tubular secretion. This effect, at least
after short-term administration, appears to be reversible.
Further examine of the mechanisms of tubular transport of
99mTc-MAG3 and its interaction with morphine metabolites
will provide a basis for understanding the tubular function
abnormalities in opiate addicts.
Role of MEKK3 and TAK1 in C3 Gene Regulation by
IL-1β. P Datta, J Rappaport; Neuroscience, Center for
Neurovirology, Temple University, Philadelphia, PA 19140,
USA.
Uncontrolled synthesis of the complement component C3
by HIV-1 induced proinflammatory cytokine IL-1β in the
brain can lead to neuroinflammation and neurodegeneration.
We have demonstrated earlier that IL-1β induces C3
synthesis in astrocytes and monocytes in a C/EBP depen-
dent manner. We now investigated the role of MEKK3- and
TAK1-dependent pathways in IL-1beta mediated C3 gene
regulation. Our studies demonstrate that overexpression of
MEKK3 and TAK1 in astrocytes and monocytes induce C3
promoter activity. On the contrary, overexpression of kinase
defective mutants of MEKK3 and TAK1 inhibited tran-
scriptional response of the C3 promoter by IL-1β. These
observations demonstrate that targeting MEKK3 and TAK1
may have potential as novel therapeutic strategies for
inhibiting IL-1β mediated C3 gene regulation. Supported
by NIH-NIDA.
Opioids Block the Effects of the HIV Entry Inhibitors
Maraviroc and AMD-3100 in CNS Glia. N El-Hage
1,S M
Dever
1, T Ahmed
1, Y Zhang
2, KF Hauser
1;
1Department of
Pharmacology & Toxicology, Virginia Commonwealth
University, Richmond, VA 23298, USA,
2Department of
Medicinal Chemistry, Virginia Commonwealth University,
Richmond, VA 23298, USA.
There are currently 27 HIV medications used in various
combinations to treat HIVand AIDS, including inhibitors of
viral entry. Maraviroc is a CCR5 inhibitor used with other
HIV medications to treat CCR5 (R5)-tropic HIVand AMD-
3100, a CXCR4 antagonist, is used to reduce CXCR4 (X4)-
tropic HIV levels. Since these two inhibitors have the ability
to inhibit HIV entry in target cells and opioid abusers are
more susceptible to the neurodegenerative effects of HIV in
the CNS, the goal of this study was to investigate to the
impact of opioids such as morphine, widely abused drugs
among people infected with HIV as well as DAMGO, on
the inhibitory effects of Maraviroc and AMD-3100 on HIV
entry in human microglia and astrocytes. We first confirmed
that astrocytes and microglia express CCR5 and CXCR4
using flow cytometry. HIV binding and entry were directly
visualized by confocal microscopy using GFP-labeled R5
(BaL) and X4 (NL4-3) virions and infection was further
confirmed using a HIV Tat-activated luciferase reporter
assay. As expected, we found that Maraviroc inhibited R5
HIV entry and reduced HIV infection levels by 95% in
astrocytes and microglia. However, morphine and DAMGO
treatment compromised the anti-HIV entry effects of
Maraviroc leading to increased HIV levels in these cells.
Similar results were found with opioids and AMD-3100
using X4 HIV. Our data suggest that opioids impair the
effects of HIV entry inhibitors and may contribute to
increased susceptibility of HIV entry in opioid abusers
which could lead to accelerated CNS neuropathogenesis in
these individuals. Supported by NIH P01 DA019398
R03DA026744.
Protein Phosphatase 2A Activation Leads to Threonine
Dephosphorylation of Occludin in Human Brain
Endothelial Cells Exposed toPCB153. SY Eum, IE Andras,
JJ Choi, M Toborek; Department of Neurosurgery, Univer-
sity of Kentucky, Lexington, KY 40536, USA.
Occludin is an integral transmembrane protein associated
with tight junctions, contributing to the physical gate
function of the blood–brain barrier (BBB) of brain
endothelial cells. Exposure of human brain endothelial cells
to highly ortho-substituted non-coplanar polychlorinated
biphenyls (PCBs) including PCB153, persistent environ-
mental pollutants, results in the disruption of BBB which is
accompanied by the decrease of tight junction proteins such
as occludin and ZO-1. We hypothesized that the change of
phosphorylation status of the protein can be involved in
regulation mechanism of the occludin level in the cells. To
assess the phosphorylation level, occludin was isolated
using the immunoprecipitation method and Western Blot-
ting was employed with anti-phosphorylated amino acid
antibodies. Exposure of human brain endothelial cell line
(hCMEC/D3) to PCB153 decreased phosphorylation level
S48 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59of threonine residues in 15 min and return to basal level at
60 min after treatment. In contrast, the other phosphorylated
amino acid residues, tyrosine or serine, did not significantly
changed by exposure to PCB153. Blockage of protein
phosphatase 2A (PP2A) activity using specific inhibitors,
Calyculin A, Cantharidine, and Fostriecin, prevented the
threonine dephosphorylation and the decreased protein level
of occludin in hCMEC/D3 cells exposed to PCB153. These
results suggest that the PP2A-mediated threonine dephosphor-
ylation isa criticalstepin PCB153-induced occludin disruption
which can cause the dysfunction of tight junctions and BBB.
Supported by American Heart Association 09SDG2300037,
NIH/P42 ES 07380, MH63022, MH072567, NS39254.
Dopamine Modulation of Macrophage Function may
Facilitate Development of HIV-Associated Neurological
Disorders. PJ Gaskill, JW Berman; Pathology, Albert
Einstein College of Medicine, Bronx, NY 10461, USA.
Macrophages are a key cell type in the development of HIV-
associated neurological disease (HAND), not only as a primary
targetfor HIVbutalsoastheprimaryimmune response toHIV
infection in the CNS. The neurological complications of HIV
infection are a major health issue among HIV-infected drug
abusers. This could be due, in part, to increased CNS dopamine
levels mediating the effects of drug abuse. We previously
showed that dopamine increases HIV replication in human
macrophagesthroughactivationofD2-likedopaminereceptors
(DR), increasing the number of HIV infected macrophages.
Our current data indicate that activation of macrophage
dopamine receptors also affects the functions of uninfected
macrophages, potentially contributing to the dysregulated
inflammatory response seen in NeuroAIDS. We show that
dopamine modulates productionoftheinflammatorycytokines
TNF-α, CCL2, IL-8 and IL-6 and alters the activation of
macrophage signaling pathways. Our findings also demon-
strate that macrophages express the dopamine transporter, and
the dopamine synthesis proteins, tyrosine hydroxylase and
DOPA-decarboxylase. We also show that in addition to DR1
and DR2, macrophages express DR3 and DR4. These data
indicate that dopamine is important in the modulation of
macrophage function(s) and suggests a significant role for
dopamine in theresponse to anddevelopmentof HIVinfection
in the CNS. Further, these data suggest the drug-induced
increases in CNS dopamine may be a common mechanism by
whichdrugs of abuse exacerbate the developmentofHAND in
HIV infected drug-abusers. Supported by NIDA.
Linkages Between Cannabinoid 2 Receptor Activation
and CD38. SG o r a n t l a , HE Gendelman, L. Poluektova;
Department of Pharmacology and Experimental Neurosci-
ence, University of Nebraska Medical Center, Omaha, NE
68198, USA.
Attenuation of neuroinflammation during HIV-1-associated
brain disease remains an attractive means to restore neural
homeostasis. One possibility is through Cannabinoid type 2
receptor (CB2R) agonists which have shown considerable
therapeutic potential in their abilities to control neuro-
inflammation. Towards this end, a highly selective CB2R
agonist, GP1a was seen to reduce leukocyte infiltration and
microglial activation in a murine HIV-1 encephalitis (HIVE)
model. We now show that GP1a down-regulates CD38, a
multifunctional ectozyme involved in calcium transport,
expression on immunocytes. As a receptor CD38 partic-
ipates in cell adhesion and a range of inflammatory
responses that include immune activation. It is cited to
reflect disease progression for HIV-1 infection and to
mediate microglial activation by increasing intracellular
calcium and nitric oxide production. CD38 may influence
CB2 receptor mediated immunosuppression. Hence, we
investigated the relationship between CB2R activation and
regulation of CD38 expression. LPS activated human
primary microglia and monocyte-derived macrophages
(MDM) treated with CB2R agonists showed diminished
CD38 expression by realtime RT-PCR and flow cytometry.
Intracellular calcium levels and reactive oxygen species
were also diminished following CB2R agonist treatment of
microglia and MDM. We conclude that the selective
activation of CB2 receptor can be a pharmacological
approach to modulate CD38 expression during neuro-
inflammatory conditions including HIVE and neuroAIDS.
Mechanisms of BBB Damage and Hemorrhagic Stroke
in Chronic Methamphetamine Abuse. J Haorah,M A
Muneer, S Alikunju, A Szlachetka; Department of Pharma-
cology and Experimental Neuroscience, University of
Nebraska, Omaha, NE 68198, USA.
We examine the association between blood–brain barrier
leakage and hemorrhagic stroke observedin our animal model
of chronic METH intake. We hypothesize that oxidative
damage of VEGFR2 protein regulates VEGF signaling
pathway for activation of MMP-2, -3, -9. To test the
hypothesis, mice were given 15 mg METH/kg body weight
daily by i.p. injection for 5–6 weeks. Permeability and
immune cell infiltration across the BBB were assessed by
Evan Blue and monocyte migration assays. Tight junction
proteins, VEGFR-2, MMPs and TIMPs were analyzed by
proteome assay and Western blot. ELISA kits assayed VEGF
levels. Mechanisms of MMPs activation by VEGF via Src
kinase signaling pathway was determined in brain endothelial
cell culture with/without acetyl-L-carnitine (antioxidant) or
PP2 (Src kinase inhibitor). After METH administration, we
observed hemorrhagic injury, BBB damage and leakiness
that were positively associated with MMPs activation and
VEGFR-2 reduction. Decrease in VEGFR-2 correlated
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lation and MMPs activation. Oxidative stress regulated this
complex pathway because ALC and PP2 significantly
mitigated the METH-induced BBB damage and hemorrhagic
injury. Treatment of hBECs with exogenous VEGF-A was
able to validate the role of VEGF for MMPs activation in
relation to VEGFR-2 expression during METH-induced
stress condition. These findings suggest that VEGFR-2 is
extremely sensitive to oxidative stress, in which increase in
intracellular VEGF levels activate MMPs in a p-Src-
dependent manner leading to BBB loosening and hemor-
rhagic stroke. Supported by Faculty retention funds.
Morphine Potentiates Neuropathogenesis of SIV Infection
inRhesusMacaques. R Hegde
1, SM Bokhari
1, S Callen
2,H
Yao
2, I Adany
1,ZL i
1, PD Cheney
1, O Narayan
1, S Buch
2;
1Department of Molecular & Integrative Physiology, Uni-
versity of Kansas Medical Center, Kansas, KS 66160,
2Department of Pharmacology & Experimental Neurosci-
ence, University of Nebraska Medical Center, Omaha, NE
68198, USA.
Despite the advent of antiretroviral therapy, HIV-1 infection
and its complication with concurrent drug abuse is
becoming an emerging problem. The effect of opiates,
including morphine, on pathogenesis of HIV infections
remains controversial. Opiates are well-known to modulate
immune responses by preventing development of cell-
mediated immune (CMI) responses. In this study using
Simian Immunodeficiency Virus (SIV) macaque model of
HIV pathogenesis, we undertook investigations aimed
exploring effects of morphine on neuropathogenesis and
disease progression. Sixteen Rhesus macaques used in this
study were divided into two groups; 4 administered saline,
12 others with morphine routinely four times a day. Both
groups inoculated with SIVmacR71/17E and followed
longitudinally for disease pathogenesis. The morphine
group (M+V) exhibited higher mortality rates compared to
virus alone (V) group. Interestingly, a subset of M+V
animals succumbed to disease within weeks post-infection.
These rapid progressors (RPs) exhibited higher incidence
of end organ pathologies such as meningioencephalitis.
Despite higher numbers of circulating CD4 and CD8T cells
in M+V group the CD4:CD8 ratios remain unchanged in two
groups. Viral loads in plasma and CSF of M+V group were at
least a log higher than V alone group. Similarly, there was
trend of increased virus build-up in brains of M+V animals
compared with V group. An intriguing finding of this study
wasincreasednumbersofmonocyte/macrophagesandvirusin
brains of M+Vanimals by immunohistochemsitry, and in situ
hybridization assays respectively. Supported by Grants
DA020392 and DA024442 from the National Institutes of
Health (SB).
Herpes Simplex Virus-1-Induced Reactive Oxygen
Species Stimulate Cytokine Production in Murine
Microglia. SH u , WS Sheng, SJ Schachtele, JR Lokensgard;
Neuroimmunology Laboratory, Center for Infectious Disease,
University of Minnesota Medical School, Minneapolis, MN
55455, USA.
Production of reactive oxygen species (ROS) in the central
nervous system contribute to neuronal damage during
numerous pathological states. We have previously reported
that non-productively infected microglial cells were the
major source of inducible nitric oxide synthase during
experimental murine herpes encephalitis. In the present
study, oxidation of 2′,7′-dichlorofluorescin diacetate
(DCFH-DA) was used to measure the production of
intracellular ROS in cultures of primary murine microglia
at 3, 8, 24, 48, and 72 h following infection with herpes
simplex virus (HSV)-1. The levels of intracellular ROS
were found to be highly elevated by 48 h post-infection (p.
i.). Correspondingly, the majority of this virus-induced ROS
production was blocked by diphenyleneiodonium (DPI), an
inhibitor of NADPH oxidase. Interestingly, inhibition of
NADPH oxidase also decreased virus-induced cytokine and
chemokine production and phosphorylation of p38 MAP
kinase. In addition, HSV was found to induce oxidative
damage as assessed by 8-isoprostane levels. Finally,
inhibitors of NADPH oxidase were found to block virus-
induced apoptosis and oxidative damage. Taken together,
these data demonstrate that HSV-induced cytokine and
chemokine responses by microglia, as well as oxidative
damage and apoptosis, are mediated through oxidative
stress responses. Supported by NIMH/MH-066703.
Increased Ca2+ Influx and Pathophysiological Mechanisms
Underlying the Excitotoxicity of HIV-1 Tat. XT Hu, L Al-
Harthi, TC Napier; Department of Pharmacology, Immu-
nology/Microbiology, Center for Compulsive Behavior and
Addiction, Rush University Medical Center and Chicago D-
CFAR, Chicago, IL 60612, USA.
HIV expresses a number of verotoxins, including the HIV
transactivator of transcription (Tat). Tat can cause dysfunc-
tion and degeneration of neurons and astrocytes in the brain,
due in part to an excessive elevation of cytosolic Ca2+ to
excitotoxic levels. Tat-induced excitotoxicity is associated
with activation of NMDA-gated Ca2+ channels, but it is
unknown if voltage-gated Ca2+ channels (VGCC) are also
involved. Tat is damaging to the medial prefrontal cortex
(mPFC), a critical brain region for cognition and addiction;
thus, we hypothesized that VGCC are involved with Tat-
induced excitotoxicity in m P F C .F i r s t ,w ee m p l o y e d
electrophysiological approaches with rat mPFC slices to
reveal that in pyramidal neurons, Tat facilitated firing and
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2+ influx via L-type Ca
2+ channels in a dose-
dependent manner. The enhancements occurred even with
blockade of NMDA receptors. Second, we used in vivo
(intracerebroventricular) injections of Tat to show chronic
astrocytosis (i.e., increased GFAP) in rat mPFC ex vivo. Last,
we used cultured astrocytes to reveal that Tat decreased
active β-catenin, a central mediator of canonical Wnt
signaling, which is a pro-survival pathway that is antagonized
by excessive Ca
2+ influx. The acute effects of Tat on neurons
and astrocytes were abolished by selective blockade of L-
channels. These findings revealed a novel pathophysiological
mechanism underlying Tat excitotoxicity which could alter
transmission from the mPFC to striatum/midbrain; and thus,
may contribute to the neuropathogenesis of HIV-associated
neurocognitive disorders. Supported by USPHSGs A-START
DA-026746 to X-T.H. and D-CFAR P30AI082151.
Comparative Evaluation of Immune Cell Trafficking
Across the Blood–Brain Barrier During Steady-State
and Under the Neuroinflammation. ZK Khan, DS Sagar,
EA Acheampong, SR Rahman, SM Manuel, PJ Jain; Drexel
Institute For Biotechnology & Virology, Drexel University
College of Medicine, Doylestown, PA 18902, USA.
In the healthy individual infiltration of lymphocyte into the
central nervous system (CNS) is very low and tightly
controlled by the highly specialized blood–brain barrier
(BBB). However, during neuroinflammation circulating
lymphocytes readily cross the BBB and gain access to the
CNS leading to edema, inflammation and demyelination.
Interaction of circulating leukocytes with the endothelium
of the BBB thus represents a critical step in the pathogen-
esis of neuroinflammatory diseases. To characterize the
mechanisms of leukocyte trafficking, we have utilized a
one-cell and a three-cell in vitro model of the BBB
consisting of primary human brain-derived microvascular
endothelial cells, neuronal cells and primary fetal astrocytes.
Using these systems we investigated comparative traffick-
ing of immune cells including dendritic cells (DCs),
monocytes, CD4 and CD8 T cells under the steady state
as well as during various inflammatory conditions. To this
point, we have demonstrated that non-activated DCs (the
most potent antigen presenting cells) exhibit a greater
migratory potential compared to other immune cell tested
during steady state. Activation of these cells enhances their
trafficking across the BBB. Similarly, stimulation with the
chemokine CCL2 or MCP-1 facilitate transmigration of
both non-activated and activated leukocytes with DCs again
being the top responding cell type. Our data contribute in
the growing importance of DCs with respect to the neuro-
inflammation due to neurotropic infectious pathogens and/
or autoimmune phenomenon such as multiple sclerosis.
Supported by Drexel University College of Medicine.
Association of Dopamine Receptor D2 C957T Gene SNP
in Learning and Memory Among HIV-Positive Alcohol
Abusers. P Khatavkar
1, V Bryant
1, R Rosenberg
1,R
Malow
1, J Devieux
1,ZS a i y e d
2, S Thangavel
2, M Agudelo
2,
MN a i r
2;
1Stempel College of Public Health and Social
Work, Florida International University, Miami, FL 33199,
USA,
2Institute of NeuroPharmacology, Herbert Wertheim
College of Medicine, Florida International University,
Miami, FL 33199, USA.
People living with HIV (PLWH) show neurocognitive
deficits (e.g., memory, learning) which are secondary to
cerebral dopaminergic degeneration and may promote
unnatural reward-seeking risky behaviors like hazardous
drinking. Dopamine receptor D2 (DRD2) single-nucleotide
polymorphism (SNP) of C957T gene (T-minor allele) is
found to have decreased up-regulation of DRD2 expression
leading to decreased mRNA stability and translation to
protein synthesis reflected in decreased dopaminergic
neurocognitive functions. It is also associated with alcohol-
ism and thus prompted to study DRD2-C957T SNP allelic
discrimination and neurocognition among PLWH alcohol
abusers. Seventy-one participants (39 males, 32 females) of
mean age 46±6.7 years were consented and classified as at
Risk Drinkers (RD: AUDIT score≤8) and Hazardous
Drinkers (HD: AUDIT score>17). Neurocognition was
assessed using Auditory Verbal Learning Test (AVLT) and
blood was drawn for allelic discrimination of the C957T
gene SNP. Results: Genotype frequencies for C957T gene
were TT (70%), CT (25%), CC (5%) with no significant
age, gender, and racial differences. Significant differences
were found among the C957T genotypes in relation to
AVLT corrected total learning score (RD, χ
2=96.84, p=
0.03), proactive interference score (RD, χ
2=46.84, p=0.01)
and delayed recall score (RD, χ
2=104.90, p=0.04), and
learning rate (HD, χ
2=122.82, p=0.004). Our results reveal
that DRD2 C957T SNP which lowers dopaminergic neuro-
cognitive capacities is associated with alcohol dependence
in our study sample. Supported by RO1AA017405.
Ethanol-CYP3A4-Protease Inhibitors Three-Way
Interactions: Implications for HAART Medications in
Alcoholic HIV+ Individuals. S Kumar, M Jin, A Kumar;
Pharmacology and Toxicology, School of Pharmacy, Univer-
sity of Missouri—Kansas City, Kansas City, MO 64108, USA
CYP3A4 is the most abundant CYP in the liver and
metabolizes ~50% of the drugs, including anti-retrovirals.
Although CYP3A4 induction by ethanol and impact of
CYP3A4 on drug metabolism and toxicity is known,
CYP3A4–ethanol physical interaction and its impact on
drug binding, inhibition, or metabolism is not known.
Therefore, we studied the effect of ethanol on binding and
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Our hypothesis is that ethanol shows differential PIs-
CYP3A4 interactions. Nelfinavir, saquinavir, lopinavir,
tipranavir, and atazanavir showed type I spectral binding,
darunavir, amprenavir, and fosamprenavir showed low type
I spectral binding, and indinavir and ritonavir showed type
II spectral binding with CYP3A4. Subsequently, we
measured binding affinity (KD and IC50), maximal spectral
change (Amax), and maximal inhibition (Imax) for all the
PIs with CYP3A4 in the presence of ethanol. Interestingly,
ethanol decreased Amax, but did not alter binding affinity
and Imax with most of the type I PIs. However, it decreased
binding affinity and Imax with low type I PIs. In contrast,
ethanol increased the binding affinity without altering
Amax and Imax with type II PIs. These results provide a
model for differential ethanol–CYP3A4–PIs three-way
interactions, which can be explained by physicochemical
properties of the PIs and their binding characteristics with
CYP3A4. This is an extremely important finding because
alcoholism is prevalent in HIV-1-infected persons and
alcohol is shown to differentially alter the response to
HAART regimens. Supported by UMRB.
Modulation of Innate Immune-Related Pathways in
Nicotine-Treated SH-SY5Y Cells. MD Li
1, WY Cui
1,J Z
Ma
1, SL Chang
2;
1Department of Psychiatry and Neuro-
ehavioral Sciences, University of Virginia, Charlottesville,
VA 22911, USA,
2Department of Biology, Seton Hall
University, South Orange, NJ 07079, USA.
Although nicotine has a broad impact on both the central and
peripheralnervoussystems,themolecularmechanismsremain
largelyunknown,especiallyatthe signaling pathway level.To
investigate that aspect, we employed both conventional
molecular techniques, such as quantitative real-time PCR
and Western blotting analysis, and a high-throughput micro-
array technique to identify the genes and signaling pathways
modulated by nicotine. We found 14 pathways were signifi-
cantly modulated by nicotine in SH-SY5Y neuroblastoma
cells. Of these pathways, the Toll-like receptor (TLR; p=
2.57×10
−4) pathway is one of the most important innate
immune pathways. And death receptor (DR; p=8.71×10
−4)
pathway, whose transducers coordinate TLR signals helping
conduct host immune response to infection, was also
significantly changed by nicotine. Furthermore, we found
that many downstream pathways of TLR and DR signaling,
such as PI3K/AKT (p=9.55×10
−6), p38 (p=2.40×10
−6), and
ERK (p=1.70×10
−4), were also significantly modulated by
nicotine. Interestingly, most of the differentially expressed
genes in these pathways leading to nuclear factor kappa-B
(NF-κB) activation were up-regulated by nicotine, and the
important inhibitors of pathways leading to apoptosis,
including FLIP and Bcl-2, were also up-regulated. Taken
together, our findings demonstrate that nicotine can regulate
multiple innate-immune-related pathways. Thus, our data
provide new clues to the molecular mechanisms underlying
the contribution of nicotine to neuron survival. Supported by
DA-013783; DA-016149; DA-026356.
HIV-1 gp120 Enhances Outward K+ Current and
Resultant Neurotoxic Activity in Cultured Rat Microglia.
JL i u , CH Xu, LN Chen, H Xiong; Department of
Pharmacology and Experimental Neuroscience, University
of Nebraska Medical Center, Omaha, NE 68198–5880,
USA.
Microglia play an important role in the event of disease
such as HIV-associated dementia. We hypothesize that an
increase of outward K+ current (OKC) activates microglia,
resulting in neuronal injury. To test this hypothesis, we
studied the effects of HIV-1 gp120 on OKC in cultured rat
microglia. Bath application of gp120 produced an enhance-
ment of microglia OKC in a dose-dependent manner. The
gp120-associated enhancement of OKC was blocked by
T140, a CXCR4 receptor antagonist, suggesting the
involvement of CXCR4 in gp120-induced enhancement of
OKC. Further investigation showed that the gp120-induced
enhancement of OKC was significantly blocked by H89, a
specific protein kinase A (PKA) inhibitor, indicating that
cAMP-dependent PKA signaling pathway is involved in
gp120-associated increase of OKC. Studies on OKC
biophysical properties revealed a slow inactivation mediated
by gp120. Biological significance of gp120-induced en-
hancement of microglia OKC was demonstrated by exper-
imental results that the cytotoxic activity of gp120-
stimulated microglia, evaluated by TUNEL staining and
MTT assay, was blocked by K+ channel blockers. Taken
together, these results suggest that brain infection of HIV-1
may induce microglia cytotoxic activity by enhancing OKC
and that microglia K+ channels could be potential targets
for the development of therapeutic strategies. Supported by
NINDS 2R56NS041862-10.
H I V - 1T a tP r o t e i nE x p r e s s i o ni nM o u s eB r a i n
Potentiates the Psychostimulant Effects of Cocaine
and Reinstates an Extinguished Cocaine Craving.
JP McLaughlin
1, CF Shay
2, SM Gomes
2, AM Carey
2;
1Department of Biology, Torrey Pines Institute of Molecular
Studies, Port St. Lucie, FL 34987, USA,
2Department of
Psychology, Northeastern University, Boston, MA 02115,
USA.
While the HIV-1-accessory protein Tat is known to
synergize with psychostimulant drugs to exacerbate neuro-
toxicity, the functional consequences of Tat protein on the
behavioral response to abused drugs are little known.
S52 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59Accordingly, we hypothesized that HIV-1 Tat expression in
brain would modulate the psychostimulant effects of
cocaine. Using the GT-tg bigenic mouse model, where
brain-selective Tat expression is induced by activation of a
doxycycline (Dox) promotor, we tested the effects of Tat
protein on cocaine-induced locomotor activity and condi-
tioned place preference (CPP). Tat-induced GT-tg bigenic
mice demonstrated a significant increase in the locomotor
effects of cocaine (10 mg/kg, s.c.), but not saline, over the
responses of uninduced GT-tg littermates and Dox-treated
C57Bl/6J mice. Moreover, although GT-tg bigenic mice
expressing Tat demonstrated saline-conditioned place pref-
erences similar to uninduced littermates and Dox-treated
C57Bl/6J mice, Tat expression significantly increased
cocaine-CPP threefold. Consistent with this observation,
cocaine place-conditioned GT-tg bigenic mice subsequently
made to express Tat protein demonstrated a significant
increase in cocaine-CPP after an additional cycle of cocaine
place conditioning as compared to the response of unin-
duced littermates. Of interest, subsequent exposure to Tat
protein resulted in the reinstatement of an extinguished
cocaine-CPP in previously uninduced mice. Overall, these
data suggest that expression of HIV-1 Tat protein in mouse
brain potentiated the psychostimulant effects of and craving
for cocaine. Supported by the State of Florida.
HIV-1 Tat Protein Decreases Dopamine Transporter
Cell Surface Expression and Vesicular Monoamine
Transporter-2 Function. NM Midde, AM Gomez, J Zhu;
Department of Pharmaceutical and Biomedical Sciences,
University of South Carolina, Columbia, SC 29208, USA.
The dopamine (DA) transporter (DAT) and vesicular
monoamine transporter (VMAT2) proteins interact as a
biochemical complex to regulate dopaminergic neurotrans-
mission. We have reported that HIV-1Tat1-86 decreases the
specific [
3H]DA uptake and [
3H]WIN 35,428 binding sites
without a change in total DAT immunoreactivity in rat
striatum (Zhu et al., 2009). In the present study, the effects
of Tat on DAT trafficking and vesicular [
3H]DA uptake in
rat striatum were investigated. Rat striatal synaptosomes
were incubated with or without Tat protein (1 μM).
Subsequently, the subcellular fractions, total synaptosomal
fractions (P2), plasma membrane enriched fractions (P3)
and vesicle-enriched fractions (S3), were prepared for
Western blotting and [
3H]DA uptake assays. The DAT
immunoreactivity was greater in P3 than in S3, suggesting
that cell surface DAT expression is modulated by endocy-
totic trafficking. Tat decreased DAT expression in P3
fractions, accompanied by an increase of DAT in S3
fractions. In addition, Tat inhibited the specific [
3H]DA
uptake into vesicles (S3) and synaptosomes (P2) by 35%
and 26%, respectively. These results suggest that the Tat-
induced decrease in cell surface DAT expression is
responsible for the decrease in DAT function. Although
both DAT and VMAT2 proteins are essential for the
regulation of DA disposition in synapse and cytosol, the
inhibitory effect of Tat was more profound in VMAT2
protein than in DAT protein, suggesting that VMAT2
protein plays a more critical role in Tat-induced alterations of
extracellular DA concentrations. Supported by DA026721.
Systems Biology Analysis of Gut-Specific Mechanisms
Underlying Chronic Δ-9-THC Modulation of Simian
Immunodeficiency Virus Infection. PE Molina,N J
LeCapitaine, J Zabaleta, A Amedee, P Zhang, P Winsauer;
Physiology/School of Medicine, Louisiana State University
Health Sciences Center, New Orleans, LA 70112, USA.
We demonstrated that chronic Δ-9-tetrahydrocannabinol
(THC) administration attenuates viral load and disease
progression in simian immunodeficiency virus (SIV)-
infected rhesus macaques. Gut-associated lymphoid tissue
is an important site for HIV replication and inflammation
and is a possible site for THC immunomodulation. A
systems approach was used to examine the impact of
chronic THC administration (0.18–0.32 mg/kg i.m., 2×
daily), starting 12 months prior to inoculation with
SIVmac251 (100 TCID50/ml, i.v.), on gastrointestinal
mucosa (GI) viral load, lymphocyte phenotype, and tran-
scriptome at ~5 months post-inoculation. GI viral load was
lower in THC/SIV than in VEH/SIV (2.04±0.41 vs. 3.05±
0.68 RNA Log copies/ng tissue mRNA) macaques. One
hundred fifteen genes were differentially expressed (53 up-
& 62 down-regulated) in GI mucosa samples of THC/SIV
when compared to those of VEH/SIV macaques. A total of
12 pathway maps were identified to include three or more
differentially expressed genes (p<0.05). Of these, the
predominant cell processes were involved in cytoskeleton
remodeling (45%), immunomodulation (27%), cell adhe-
sion/integrin (18%), and cell signaling (9%). GI mucosa of
THC/SIV macaques had significantly (p<0.05) more CD8
(28%) and CD4 (51%) integrin β7 positive central memory
lymphocytes than VEH/SIV animals (19% and 5%, respec-
tively). These findings suggest that the mechanisms
involved in chronic THC modulation of SIV/HIV’s disease
progression result from structural and functional modifica-
tion of GI barrier function and lymphocyte phenotype, as
well as suppressed GI viral replication. Supported by
NIDA/1R01DA020419-05, NIDA/3R01DA020419-04S1,
NIDA/1R01DA030053-01.
AttenuationofHigh-Fat-Diet-InducedNeuroinflammation
by Momordica Charantia. PV Nerurkar
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2John A. Burns School of Medicine, University of Hawaii,
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Rising epidemic of obesity is considered a major risk factor
for neurodegenerative diseases. Increased metabolic flux
during overnutrition and obesity can orchestrate stress
response, blood–brain barrier (BBB) disruption, recruitment
of inflammatory immune cells from peripheral blood and
microglial cells activation leading to neuroinflammation.
The lack of an effective treatment for obesity-associated
brain dysfunction may have far-reaching public health
ramifications urgently necessitating the identification of
appropriate preventive and therapeutic strategies. The
objective of our study was to investigate the neuroprotective
effects of Momordica charantia (bitter melon, BM) on high-
fat diet (HFD)-associated BBB permeability, stress and
neuroinflammatory cytokines. C57BL/6 female mice were
f e dH F Dw i t ha n dw i t h o u tB Mf o r1 6w e e k s .B B B
permeability was analyzed using Evans blue dye.
Phosphate-buffered saline (PBS) perfused brains were
analyzed for neuroinflammatory markers such as
interleukin-22 (IL-22), IL-17R, IL-16, NF-kB, as well as
antioxidant enzymes using microarray, quantitative real-
time RT-PCR and enzymatic assays. Our data indicates that
BM ameliorated HFD-associated changes in BBB perme-
ability as evident by reduced leakage of Evans blue dye.
HFD-inducedneuroinflammatorymarkers werenormalizedin
the brains of mice supplemented with BM. Similarly, HFD-
induced brain oxidative stress was significantly reduced by
BM supplementation. Functional foods such as BM may offer
a unique therapeutic strategy to improve obesity-associated
neuroinflammation. Supported by NCCAM (R21AT003719),
RCMI, NCRR (G12RR003061), NIH.
Possible Role of GPR55 in the Cannabinoid-Induced
Increase in Serum IgE in Mice. C Newton, C Patterson, T
Klein; Molecular Medicine, University of South Florida
College of Medicine, Tampa, FL 33612, USA.
During the development of adaptive immunity to Legionella
pneumophila infection, Δ-9-tetrahydrocannabinoid (THC)
induces a shift from cell-mediated Th1 responses to
humoral Th2 responses and this involves CB1 and CB2
cannabinoid receptors. In in vivo IgE induction models
using OVA/ALUM or KLH/RIBI, we studied the role of
another cannabinoid receptor, GPR55A, in cannabinoid
effects on antibody production. BALB/c (B/c), C57BL/6
(B6), or B6 CB2 deficient (CB2−/−) mice were pretreated
with THC or L-α-lysophosphatidylinositol (LPI) LPI prior
to injections with OVA/ALUM or KLH/RIBI followed by
boosting with same antigens. The mice were then bled on
various days after boosting and total serum IgE was
determined. The IgE levels were elevated in THC treated
B/c mice in response to either OVA/ALUM or KLH/RIBI.
Interestingly with OVA/ALUM, CB2−/− mice had in-
creased levels of IgE over wildtype (B6) mice and
pretreatment with THC augmented this effect. CB1 antag-
onist treatment of B6 and CB2−/− mice prior to THC
dosing slightly elevated the IgE response suggesting neither
CB1 nor CB2 were involved in the IgE response. With
KLH/RIBI, THC treatment increased IgE levels greater than
OVA/ALUM; however, there were no differences between
B6 and CB2−/− or THC/B6 and THC/CB2−/− mice.
Pretreatment with the GPR55-selective agonist LPI, en-
hanced IgE levels in B/c mice given OVA/ALUM. These
studies suggest that GPR55 is involved in enhancing IgE
production following treatment with THC and LPI. Sup-
ported by NIH grant DA019824.
HIV-1 LTR Single-Nucleotide Polymorphisms Correlate
with Use of Drugs of Abuse in the DrexelMed HIV/
AIDS Genetic Analysis Cohort. MR Nonnemacher
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Drexel University College of Medicine, Philadelphia, PA
19102, USA,
3B-Tech Consulting, Ltd, Philadelphia, PA
19104, USA,
4Department of Biostatistics and Epidemiol-
ogy, University of Pennsylvania, Philadelphia, PA 19104,
USA.
HIV infection is prevalent among substance abusers. The
effects of specific illicit drugs on HIV-1 disease progression
have not been well established. We evaluated the relation-
ship between illicit drug use and HIV-1 disease progression
in 418 HIV-1-infected patients enrolled in the DREX-
ELMED HIV/AIDS Genetic Analysis Cohort in Philadel-
phia, PA. History of illicit drug, alcohol, and medication
use, CD4+ and CD8+ T cell count, and viral load were
performed approximately every 6 months. Drug abuse was
common in the cohort with 55% of patients admitting past
use, 31% current drug abuse, and 27% testing positive for
drug use at the time of visit. Cocaine and marijuana were
heavily favored, with 82% of patients admitting to past or
current cocaine use and 72% admitting to marijuana use.
The cohort currently contains a total of 30 non-users, 70
cocaine only (preferential) users, and 36 cannabinoid only
(preferential) users. Non-users were more likely to remain
on ART (90%), while the cocaine- and cannabinoid-only are
less likely to remain on ART (67% and 78%, respectively).
Drug users had both a lower current CD4+ T cell count as
well as lower nadir CD4+ T cell and higher current viral
S54 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59loads and higher peak viral loads as compared to non-
users. In addition, single nucleotide polymorphisms
(SNPs) were identified that are unique to cocaine,
marijuana, or non-users. In conclusion, illicit drug use
appears to facilitate HIV-1 disease progression. In
addition, use of drugs of abuse selects for genetic
variations unique to mono- and multi-using HIV/AIDS
patient cohorts. Supported by R01 NS032092, R01
DA019807, T32 MH079785.
Inhibition of Antibody Class Switching to IgE By SiRNA
Targeting Cannabinoid Receptors. CE Patterson,C
Newton, TW Klein; Department of Molecular Medicine,
University of South Florida, Tampa, FL 33612, USA.
Work in our laboratory has shown that cannabinoid
treatment of primary mouse B cells results in antibody
class switching favoring increased IgE production. IgE
expression is one hallmark of a Th2 immune response that
can be directly linked to many allergic conditions. Use of
CB2-KO mice, a non-selective cannabinoid receptor ago-
nist, CP55940, and selective agonist for CB1 showed the
dependence on CB2 for this Th2-biased response both in
vivo and in vitro. Immune cells express CB2, with B cells
expressing it the most. We discovered that CB2 expression
in mouse cells occurs through three different transcriptional
start sites. We show here that siRNA to CB2 receptor
message indeed knocks down RNA levels (qPCR) as well
as total protein levels (ICC flow cytometry). Targeting
the coding region reduces these levels more than
specifically targeting one of the three unique 5′-UTR
regions, as expected. Currently, we are evaluating the
inhibitory potential of siRNA in the suppression of IgE
production from B cells following stimulation with the
CB2 receptor agonists. Lowering IgE levels by suppress-
ing CB2 receptor expression could be a valuable tool to
manage allergic disease. Supported by NIDA grant
DA19824.
Deciphering Synaptic Perturbations During HIV/METH
CNS Dysfunction. G Pendyala, HS Fox; Department of
Pharmacology & Experimental Neuroscience, University of
Nebraska Medical Center, Omaha, NE 68198, USA.
HIV and drugs of abuse have a substantial effect on the
CNS and in synergy have been implicated to increase
cognitive impairments. In order to investigate mechanistic
clues to the effects of substance abuse at the synapse, we
performed proteomics profiling on synaptosomes isolated
from the caudate nucleus of SIV-infected and methamphet-
amine (METH)-treated nonhuman primate model for AIDS.
Among the differential synaptic fingerprints identified, we
focused on one protein Na
+/K
+ ATPase alpha 3 subunit
(ATP1A3) was upregulated in the SIV and METH treated
group compared to the SIV only. ATP1A3 aids in active
transport of the Na
+ and K
+ ions across the cell plasma
membrane and maintains the chemical gradients of these
ions via hydrolysis of adenosine triphosphate (ATP).
Emerging studies have also demonstrated signal transducing
ability for ATP1A3 specifically acting via mitogen activated
protein kinases (MAPK). Treatment of primary rat neurons
with METH revealed an up regulation showing that
independent of SIV, there is a direct effect of METH to
increased neuronal ATP1A3 expression. An interesting
observation was a sustained increase in extracellularly
regulated kinases 1/2 (ERK1/2) phosphorylation until
30 min after METH treatment. These parallels, while
indirect, point to one novel mechanism of action of METH
in the CNS is to interact with ATP1A3 and elicit signaling
responses. Current studies are focused on deciphering a
possible ligand–receptor relationship and associated results
will be presented at the meeting. Supported by NIH grants
P30 MH062261, R01 MH073490 and P01DA026146
(HSF).
Activation of the Antioxidant Defensive Enzymes
Against HIV-1 gp120 are Mediated by Oxidative Stress
and Elevated Intracellular Calcium Levels. VB Pichili,Z
Saiyed, T Samikkannu, M Agudelo, N Gandhi, A Yndart,
MP Nair; Department of Immunology, Institute of Neuro-
Immune Pharmacology, Florida International University,
Miami, FL 33136, USA.
HIV infection has been shown to significantly affect the
functioning of the central nervous system leading to HIV
associated neurocognitive disorder (HAND) which is
characterized by depression, behavioral and motor dys-
functions. The viral envelope protein, gp120 is known to
stimulate the release of neurotoxic factors thereby causing
the apoptotic cell death. HIV virus, and its viral
components TAT, gp120 have been demonstrated to
elevate the generation of reactive oxygen species and
induce oxidative stress. We hypothesize that the oxidative
stress caused by the HIV-1 gp120 protein induces the
expression of antioxidant defensive enzymes Hemoxygenase-
1 (HO-1) and NADPH quinone oxido-reductase (Nqo1) in
cultured astrocytes. Cultured astrocytes were treated with
gp120 protein for different time periods, RNA was
isolated, reverse transcribed and analyzed by qRTPCR.
Total cell lysates were analyzed using western blots to
assess the protein expression. gp120 upregulates the
expression of gene and protein levels of Hemoxygenase-
1, and NAD(P)H dehydrogenase quinone1 in human
astrocytes. Suppression of the reactive oxygen species
by pretreating with antioxidants attenuates the increased
expression of HO-1 and Nqo1. Further, inhibitor of
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and Nqo1 implicating the role of elevated calcium in
HAND. Our results suggest that the astrocytes upregulate
their antioxidant defense mechanisms in response to the
gp120 induced oxidative stress and the consequent
elevation of intracellular calcium levels. Supported by
RO1DA012366, RO1DA021537 and R37DA025576.
Methamphetamine Alters T Cell Cycle Progression:
Role in Immune Dysfunction. R Potula, J Cenna, S Fan;
Pathology and Laboratory Medicine, Temple University
School of Medicine, Philadelphia, PA 19140, USA.
The underlying mechanisms secondary to methamphet-
amine (METH) abuse, in particular T cell responses,
remains largely unknown and warrants further consider-
ation. Our earlier studies have demonstrated that METH
exposure results in the loss of T cell functions (IL-2
production and T cell proliferation). The current study was
carried out to gain new insights into the effects of METH on
T cell cycle entry and progression. Results obtained from
cell cycle analysis indicated that compared to the controls,
significant number of T cells exposed to METH remain
arrested in G0/G1 phase suggesting that METH modulate
the normal cell cycle. Genomic analysis of cell cycle
performed to determine the effects of METH on cell cycle
exit of T lymphocytes showed differentially regulated
genes: that both positively and negatively regulate the cell
cycle, associated with transitions between the each of the
phases, DNA replication, checkpoints and arrest. Taken
together, our results provide reasonable evidence for our
hypothesis that METH exposure results in altered cell cycle
entry and progression. Studies are underway to examine if
tainted expression of cell cycle progression markers (cyclins
and the cyclin-dependent kinases) are contributory to the
impaired cell cycle progression of METH exposed T cells.
Supported by NIDA/R01 DA031064.
Cannabinoid Receptor Expression in Primary Human
Microglia: The Role of CB2. RB Rock, S Hu, WS Sheng,
PK Peterson; Center for Infectious Diseases and Microbi-
ology Translational Research, University of Minnesota,
Minneapolis, MN 55455, USA.
Cannabinoid receptors (CBs) in the CNS play an important
role in modulating brain development and inflammatory
responses. We and others have found that CB2 is expressed
on microglial cells. Activation of CB2 receptors have been
reported to regulate many physiological functions, therefore
CB2 is considered a therapeutic target. In this study we
demonstrated CB expression in human primary microglia
obtained from different brain specimens. We found that
often the CB1/CB2 ratios were variable in resting microglial
cells. The specific binding of 3H-CP55,940 was around 55–
70%. Using selective CB antagonists, SR141716A and
SR144528, displacement of 3H-CP55,940 binding was
observed demonstrating both CB1/CB2 receptor expression.
Human primary microglia express CCR2 receptors, en-
abling the cells to migrate toward CCL2 in a concentration-
dependent manner. Pretreatment with CB ligands
(WIN55,212-2, CP55,940 and JWH015) downregulated
microglial migration toward CCL2 and CB2 selective
antagonist SR144528 significantly reversed the inhibitory
effect of WIN55,212-2, suggesting a CB2mediated mecha-
nism. No effect of CB ligand treatment on CCR2 expression
was found indicating that migratory inhibition was not due
to CCR2 expression change. Using real-time PCR, we
found that CB1 mRNA expression was relatively unaffected
by several cytokine, bacterial and viral products. However,
CB2 expression was markedly down-regulated by products
such as LPS and Tat. These findings suggest that CB2
expression can be regulated by external stimuli, which has
important therapeutic implications. Supported by NIDA/
DA025525.
Tobacco Cembranoid 4R Attenuates HIV Neurotoxicity
by Glutamate Release Reduction Independent of Viral
Replication and Inflammation. JW Rodriguez
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1, E Rios-Olivares
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Wang
2,AN a t h
2, VA Eterovic
1;
1Department of Microbiology
and Immunology, Universidad Central del Caribe School of
M e d i c i n e ,B a y a m o n ,P R0 0 9 6 0 ,P u e r t oR i c o ,
2Department of
Neurology, Johns Hopkins University School of Medicine,
Baltimore, MD 21287, USA.
HIV-associated neurocognitive disorders (HAND) has be-
come the most common neurologic complication of AIDS,
affecting approximately 50% of HIV-infected patients.
There is a major need to identify a compound that can
prevent or alleviate the damaging effects following HIV-1
infection in the brain. Our laboratory has identified a non-
toxic compound from the tobacco leaf called cembranoid
4R that readily penetrates into the brain. Using PBMC and
glial cell lines as a test model, RT-PCR for HIV-1
replication, cytometric bead array for inflammatory cyto-
kine production, glutamate assay, and MTTwere preformed.
We show that 4R suppressed HIV-1 replication in PBMC by
fourfold, but that was not the case in human glial cells
which 4R enhanced it by twofold. However, PBMC
secretions attenuated HIV-1 infection in glial cells in the
presence of 4R using a transwell system. We also
demonstrate that 4R downregulated inflammatory cytokines
such as IL-1β and TNF-α in PBMC whereas it upregulated
inflammatory cytokines such as IL-6, IL-8 and MCP-1 in
human glial cells. In addition, 4R attenuates glutamate
release and reverse significantly the neurotoxicity induced
S56 J Neuroimmune Pharmacol (2011) 6 (Suppl 1):S4–S59by HIV-infected supernatants. Neuroprotection by 4R
occurs independently of viral load levels and inflammatory
cytokines release. This study reveals new properties of the
novel compound 4R and provides new understanding of the
mechanisms by which this compound may elicits its
properties. Further knowledge of the mechanism by which
4R exerts neuroprotection could lead to the development of
therapy for treating HAND. Supported by NIH/NIMH grant
5R25MH0806603 and RCMI grant G12RR03035.
MicroRNA Profiling in Human Brain Microvascular
EndothelialCellsafterInflammatoryInsultandInhibition
of Glycogen Synthase Kinase 3β (GSK3β). S Rom, S Fan,
S Dykstra, N Reichenbach, S Ramirez, Y Persidsky;
Department of Pathology and Laboratory Medicine, Temple
University School of Medicine, Philadelphia, PA 19140,
USA.
Immune mediators and BMVEC-leukocyte engagement
contribute to blood–brain barrier (BBB) impairment during
neuroinflammation. We identified GSK3β as a potent
regulator of immune responses in vitro BBB system and
animal model. Inflammatory response induces several
hundred genes, a process that is tightly regulated to prevent
the consequences of unregulated expression. miRNAs have
emerged as gene expression regulators. The relationship
between inflammation and miRNA expression remains
largely is unexplored. We used microarray technology
(miR Base version 16 screening of 1212 miRNAs) to
identify miRNAs induced in human primary BMVEC after
exposure to pro-inflammatory cytokine, TNF-α with or
without GSK3β inhibitor, LiCl miRNA array showed that
123 microRNAs were downregulated after TNF-alpha
exposure (less than or equal to onefold), and 193 micro-
RNAs to be upregulated (greater than onefold) in cells
treated by TNF-α/LiCl. 14 miRNAs were common for two
groups. qPCR confirmed microarray results for 3 miRNAs
with largest fold change (mir-98, mir-629* and let-7g*).
Treated with TNF-α of the immortalized human brain
endothelial cell line D3 also resulted in down regulation of
the same miRNAs, and GSK3β inhibition partially reversed
TNF-α effects. Among the top ranking predicted targets of
3 miRNAs are several inflammatory molecules such as
VCAM-1, CD99, L1CAM, IL8, IL6, CXCL1, and IP-10.
Our previous studies indicated VCAM-1, IL8, IP-10 and
CXCL1 were upregulated by TNF-α in BMVEC and
suppressed by GSK3β inhibitors. We are in process of
further validation of these results by overexpression of
miRNAs in BMVEC or D3 cells. Supported by AA015913,
MH65151.
Differential Regulation of Neuroplasticity Associated
Genes by HIV-1B and C Clades. ZM Saiyed, NH Gandhi,
J Napuri, AYndart, M Agudelo, VB Pichili, T Samikkannu,
MN Nair; Immunology, Institute of NeuroImmune Pharma-
cology, College of Medicine, Florida International Univer-
sity, Miami, FL 33199, USA.
Experimental and clinical evidence suggests difference in
manifestation of HAND between clade B and C-infected
subjects with clade B being more neuropathogenic than
clade C. However, the exact mechanism underlying the
differences in the neuropathogenesis by both the subtypes
remains elusive. Previous studies with HIV-1B have
implicated that HIV-induced neurocognitive deficits could
be due to dysregulation of genes such as CREB, CaMKIIa
that are known to regulate neuronal plasticity. Recently, it
was also shown that MEF2C, a neurogenic transcription
factor that promotes expression of ARC and SynGap was
downregulated in the brain of SIV infected macaques. We
therefore hypothesize that clade B and C exert differential
effects on CNS cells leading to differential expression of
genes that regulate synaptic plasticity and neuronal activity.
Primary human astrocytes were separately infected with
HIV-1 clade B and C virus and the RNA was extracted,
followed by quantitative real time PCR for CREB, MEF2C
and ARC genes and the cell lysate was tested for protein
levels by western blot. Results indicate that HIV-1B
significantly downregulated expression of synaptic plastic-
ity genes, CREB, MEF2C and ARC by primary astrocytes
compared to HIV-1C infected cultures. This suggests that
infection with HIV-1B and C virus differentially modulates
the expression of genes involved in synaptic plasticity and
neuronal function. The results emanating from these studies
may elucidate the differential mechanisms of clade specific
infection in development of HAND and may be of
therapeutic significance. Supported by NIMH.
Differential Regulation of Thiol Modification by HIV-1
Clade B and C Protein. T Samikkannu, Z Saiyed, M
Agudelo, PV Reddy, D Nwankwo, N Gandhi, P Khatavkar,
Y Yndart, MP Nair; Department of Immunology, Institute
of NeuroImmune Pharmacology (NIP), College of Medi-
cine, Florida International University, Miami, FL 33199,
USA.
Previous studies have demonstrated that infections with
HIV-1 clades differentially contribute to the neuropatho-
genesis of HIV-associated neurocognitive disorder
(HAND). The thiol modification leads to down regulation
of rate limiting enzyme glutathione (GSH) which is known
to play a significant role in neuropathogenesis of HAND. We
hypothesize that clade B and C Tat proteins exert differential
effects on human primary neurons by down regulation of
glutathione synthetase (GSS) and altered GSH/GSSG. RNA
extracted from human primary neurons treated with HIV-1
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analyzed by quantitative real-time PCR to determine GSS
gene expression and the cell lysates were analyzed for GSH/
GSSG levels. Our results indicate that HIV-1 clade B gp120
protein significantly down regulated GSS gene expression,
and altered GSH/GSSG compared with clade C Tat protein.
Thus, our studies for the first time demonstrate that HIV-1
cladeBTatproteinappearstosignificantlydownregulateGSS
gene expression and altered GSH/GSSG as compared to HIV-
1 clade C Tat protein. This suggests a differential effect of
HIV-1 clade B leading to increased neuropathogenesis and
associated HAND in HIV-1B infected subjects compared to
HIV-1C infected subjects.
Inhibition of Reactive Oxygen Species Production from
Activated Human Astrocytes by Synthetic Cannabinoids.
W Sheng, S Hu, A Feng, PK Peterson, RB Rock; Center
for Infectious Diseases and Microbiology Translational
Research, University of Minnesota Medical School,
Minneapolis, MN 55455, USA.
Reactive oxygen species (ROS) have been shown to be a
contributor to aging and disease. ROS also serves as
trigger switch for signaling cascades leading to
corresponding cellular and molecular events. In the
central nervous system microglial cells are likely the
main source of ROS production. However, activated
astrocytes have also been reported to produce ROS. The
anti-inflammatory and neuroprotective properties of can-
nabinoids have been reported to involve cannabinoid
receptor- or non-receptor-mediated mechanisms, and the
expression of CB1/CB2 receptors has been demonstrated
in astrocytes. In this study, we investigated the effect of
cannabinoid ligands on ROS production by human brain
astrocytes stimulated with IL-1β and interferon (IFN)-γ
using H2DCFDA to assess ROS generation. Although
IFN-γ alone had minimal effect, it potentiated IL-1β-
induced ROS in a time-dependent manner. Pretreatment
with DPI (diphenylene iodonium), an inhibitor of
NADPH oxidase, blocked the IL-1β/IFN-γ-induced
ROS production effectively. Meanwhile, the antioxidant
enzyme mRNA expression such as glutathione reductase
and catalase were inhibited and superoxide dismutase-2
enhanced by IL-1β but not IFN-γ. When pretreated with
cannabinoid ligands downregulation of IL-1β/IFN-γ-
induced ROS production was observed in astrocytes.
Our results support the notion that synthetic cannabinoids
have anti-oxidant property and that they may have
therapeutic potential for ROS-induced damages.
Lipopolysaccharide Differentially Regulates MDR1 and
MRP1 in Human Macrophages. PS Silverstein, A Kumar;
Division of Pharmacology and Toxicology, School of
Pharmacy, University of Missouri—Kansas City, Kansas
City, MI 64108, USA.
Multidrug resistance-associated protein 1 (MRP-1, ABCC1)
and P-glycoprotein (MDR1, ABCB1) are both members
of the ATP-binding cassette transporter family. Both of
these proteins transport antiretroviral therapeutics, such as
HIV-1 protease inhibitors (PI). Previous reports have
demonstrated that the intracellular concentrations of HIV-
1 protease inhibitors may be below their EC50 or EC90
in chronically infected macrophages. Our hypothesis is
that inflammation will alter the expression and function
of these transporters in macrophages. We treated THP-1
macrophages to LPS and determined the expression
levels of both MRP1 and MDR1 in these cells. Our
results demonstrate that at the levels of mRNA, protein,
and functional activity, LPS increased MRP1 expression
and decreased the expression of MDR1.These results
indicate that the effectiveness of antiretroviral therapy
may be affected by inflammation and opportunistic
infections. Furthermore, the differential regulation of
MDR1 and MRP1 that was observed suggests that the
effects of LPS on the intracellular concentration of
protease inhibitors in macrophages may be specific for
each PI. Supported by NIH.
HIV Induce Differential Interclade Human Neuronal
Responses by Proteomic Fingerprinting. K Trujillo-
Nevarez, G Gonzalez, L Cubano, E Rios-Olivares, JW
Rodriguez, NM Boukli; Department of Microbiology and
Immunology, Universidad Central del Caribe, Bayamon, PR
00960, Puerto Rico.
It is suggested that the degree of neuroAIDS vary according
to the HIV-1 clade, but the molecular mechanisms behind
the differences still remain unclear. Exploiting proteomics,
we hypothesize that HIV-1 clade B and C induce differential
protein profiles on human neurons. Proteins from neurons
treated with HIV-1 clade A and B were separated with two-
dimensional gel electrophoresis, followed by mass spec-
trometry to establish homologies and dissimilarities in
protein expression. 2D maps of the clade B and clade C
2D maps indicated that a total of 164 and 214 proteins were
modulated with HIV-1 clade B and clade C treatments
respectively compared to 325 proteins control. Our results
suggest that among differentially expressed proteins, HIV-1
clade B upregulates significantly (1) a BRCA1-associated
RING domain protein involved in neuronal injury and
apoptosis, (2) a serotransferrin involved in oxidative stress
defense and, (3) a ketohexokinase (fructokinase) that play
an important role in the epidemic of metabolic syndrome as
compared to HIV clade C. In addition, HIV-1 clade C
significantly upregulates the expression of (1) ankyrin
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and, (2) cysteine sulfenic acid (the initial product of
oxidation of cysteine) by cellular ROS as compared to
HIV clade B. Taken together, the data suggest that HIV-1
clade B appears to specifically induce key markers of HIV-1
pathogenesis as compared to HIV-1 clade C which
upregulated molecules mainly involved in protein oxidation
and in the suppression of HIV-1 entry. Supported by NIH-
RCMI Biomedical Proteomics Facility 2G12RR03035.
Modulation of Intracellular Restriction Factors
Contributes to Methamphetamine-Mediated
Enhancement of AIDS Virus Infection of Macrophages.
X Wang, YZ Wang, L Ye, JL Li, L Song, N Fulambarkar,
WZ Ho; Department of Pathology and Laboratory Medicine,
Temple University School of Medicine, Philadelphia, PA
19140, USA.
Epidemiological studies have demonstrated that the use of
methamphetamine (METH), a sympathomimetic stimulant,
is particularly common among patients infected with HIV.
In vitro studies also have determined that METH enhances
HIV infection of CD4+ T cells, monocyte derived dendritic
cells, and macrophages. In addition, animal studies have
showed that METH treatment increases brain viral load of
SIV infected monkeys and promotes HIV production and
viremia in HIV/hu-CycT1 transgenic mice. However, the
mechanism(s) of these actions have not been well deter-
mined. In this study, we investigated the impact of METH
on intracellular restriction factors against HIV and SIV. We
demonstrated that METH treatment of human blood
mononuclear phagocytes significantly inhibited the expres-
sion of anti-HIV microRNAs and several key elements
(RIG-I, IRF-3, SOCS-2, 3 and PIAS-1, 3, X) in type I IFN
pathway. The suppression of these innate restriction factors
was associated with reduced production of type I IFNs and
the enhancement of HIV or SIV infection of macro-
phages. These findings indicate METH use impairs
intracellular innate antiviral mechanism(s) in macro-
phages, contributing to cell susceptibility to AIDS virus
infection. Supported by NIH DA12815, DA22177 and
DA27550.
TRPC Channel-Mediated Neuroprotection by PDGF
Involves Pyk2/ERK/CREB Pathway. HH Yao; Pharma-
cology, University of Nebraska Medical Center, Omaha, NE
68198, USA.
Platelet-derived growth factor-BB (PDGF) has been
reported to provide tropic support for neurons in the central
nervous system. The protective role of PDGF on dopami-
nergic neurons, especially in the context of HIV-associated
dementia, however, remains largely unknown. Herein we
demonstrate that exogenous PDGF was neuroprotective
against toxicity induced by HIV-1 Tat in primary midbrain
neurons. Furthermore, we report the involvement of
transient receptor potential canonical (TRPC) channels
in PDGF-mediated neuroprotection. TRPC channels are
Ca2+-permeable, nonselective cation channels with a
variety of physiological functions. Blocking TRPC
channels with either a blocker or short interfering RNAs
(specific for TRPC 5 and 6) in primary neurons resulted
in suppression of both PDGF-mediated neuroprotection as
well as elevations in intracellular Ca2+. PDGF-mediated
neuroprotection involved parallel but distinct ERK/CREB
and PI3K/Akt pathways. TRPC channel blocking also
resulted in suppression of PDGF-induced Pyk2/ERK/
CREB activation, but not Akt activation. Relevance of
these findings in vivo was further corroborated by
intrastriatal injections of PDGF and HIV-1 Tat in mice.
Administration of PDGF was able to rescue the dopami-
nergic neurons in the substantia nigra from Tat-induced
neurotoxicity. This effect was attenuated by pre-treatment
of mice with the TRP blocker, thus underscoring the
novel role of TRPC channels in the neuroprotection
mediated by PDGF. Supported by NIH.
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